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Abstract
The research community relies upon biorepositories’ ability to prepare for the scientific
advancement that can precipitate the discoveries of the future. Furthermore, as the
complexities, financial pressure, and quality issues biorepositories face continue to unfold, it
is imperative to explore unmet needs researchers may have for biorepository services as well
as evaluate the commercial potential, funding, and competitiveness of a new biorepository.
With the goal of contributing to medical and scientific research and the biorepository field,
this paper utilizes principles from ISO 9001:2008 “Quality management systemsRequirements” to outline and explore the challenges in establishing a state-of-the-science,
accredited, commercial BSL-2 biorepository in order to support academic, clinical, and
translational research. In addition, this paper provides detailed quality assurance strategies to
meet investigator’s needs, ensure high quality, fit-for-purpose biospecimens, and, most
importantly, protect and preserve the biospecimens entrusted to its care.
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Chapter 1: Introduction
In the era of personalized medicine, “Biobanking is recognized as a critical area
requiring development if progress is to be made in identifying clinically useful markers of
disease and disease progression, discovering new drug targets and understanding the
mechanisms of disease” (Carter and Betsou, 2011, p. 157). Hewitt (2010) defined the term
“biobank” as “an organized collection of human biological material and associated
information stored for one or more research purposes” (p. 112). Carter and Betsou (2011)
stressed that these collections of “samples need to be collected, processed and stored in
standardized ways that gives assurance to researchers that they are fit for purpose” (p. 157).
They furthermore argue that these standardized procedures require standardized collection
protocols in order to best protect sample integrity. Most importantly, they remind
investigators that well-run biorepositories make a vital contribution to scientific achievement
by collecting, processing, storing, and distributing high-quality, fit-for-purpose biological
specimens, or biospecimens.
Biospecimens and their appropriate collection and storage form the basis of modern
scientific research. Vaught, Rogers, and Myers (2011) argued that “as the source of
molecular information, human biospecimens, such as tissue or blood, are both the foundation
of personalized medicine and the fuel that drives the basic and translational research needed
to achieve this vision” (p. 1). Therefore, the needs of the research community require that
biorepositories prepare for scientific advancement that can precipitate the discoveries of the
future.
The quality of a biorepository rests both on attention to emerging science and
innovative quality assurance strategies as well as adherence to rigorous quality control
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procedures, Best Practices, and biorepository accreditation requirements. Only attention to
these details will ensure the quality of biorepository services and, most importantly, protect
and preserve the biospecimens entrusted to its care.
Despite the importance of biospecimen collection, processing, and storage in
scientific undertakings, these research needs may go unmet in certain geographic areas,
particularly if regulatory requirements in those locations are not well defined or understood.
To that end, this paper will examine various types of considerations when establishing a
commercial biorepository to support academic, clinical, and translational research. As the
complexities, financial pressures, and quality issues that biorepositories face continue to
unfold within the field, potential investors must carefully consider unmet needs investigators
may have for biorepository services as well as the commercial potential, funding, and
competitiveness of any new biorepository. Among these considerations, such investors must
be prepared to outline the requisite organizational structure, provision of resources (e.g.,
human resources, infrastructure, work environment, safety, and security), emergency
preparedness, and business continuity, in addition to other regulatory considerations and
quality methods of assessment, analysis, and continuous quality improvement. The
complexity of such factors may discourage potential investors (and the investigators an
established biorepository may serve) from undertaking the process, particularly without
guidance from experienced biorepository managers or personnel.
Need for Practical Guidance in Biorepository Establishment
Although biorepositories hold a vital place in current scientific practice, the available
literature on their function has several gaps. For instance, the biorepository community
eagerly anticipates the release of a new international standard for biotechnology
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(biorepositories) by the International Organization of Standardization Technical Committee,
ISO/TC 276 for Biotechnology, in the near future. Carter and Betsou (2011) argued that
“development and implementation of an ISO for biobanks will ensure that samples and data
collected in any biobank that conforms to the ISO requirements are suitable for use in local,
national and international research projects” (p. 159). The anticipated ISO document will
likely standardize the following: terms and definitions in the field of biotechnology,
bioresources, and biobanks; biospecimen processing, analytical methods, and data
processing; and validation, comparability and integration, and analysis and annotation
(ISO/ICE, 2015). In the meantime, the biorepository community must look to other technical
resources.
Yamada et al. (2013) reported that “a specific, practical ‘instruction manual’ outlining
each of the required elements of a successful biobank replete with regulatory considerations,
specific infrastructure recommendations, as well as pitfalls and problems to avoid, does not
exist” (p. 227). Furthermore, despite the importance of commercial biorepositories, the
existing literature regarding the establishment of biorepositories has thus far been directed
toward community-based hospital biorepositories or academic institutions and university
medical centers that have established biorepositories to support specific research studies
within their respective institutions (Mayol, Woo, & Keck, 2010; Olson, Ryu, Johnson, et al.,
2013; Vaught, Rogers, Myers, et al., 2011).
A developed framework for establishing a state-of-the-science, accredited, Biological
Safety Level 2 (BSL-2), commercial biorepository and reporting the requisite quality
assurance strategies would serve the scientific community well and provide a notable
contribution to its ongoing advancement. This paper proposes to shrink the gap in the current
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literature by providing such a framework to those who might consider establishing such a
biorepository in the future.
Checklists for Biorepository Development
Mayol, Woo, and Keck (2010) published a checklist for development of a
biorepository to aid others in establishing a similar biorepository within a hospital. However,
the summary and checklist, by necessity, were brief and small in scope. Potential founders
and investors of biorepositories need more detailed information, preferably in a single
location, to best prepare for the difficulties of undertaking such an enterprise. The current
paper will expand upon this original checklist in order to provide such a document to those
who may find it useful.
The current paper will expand upon a number of items originally outlined in Mayol,
Woo, and Keck’s (2010) checklist, including:
•

Considering initial and continued funding.

•

Identifying staff, space, equipment and supplies.

•

Selecting between retrospective or prospective collection models (the article
followed the former model).

•

Conducting an investigator needs assessment.

•

Developing various policies and procedures.

•

Listing biobanking standards (i.e., Best Practices), site visits (as a means of
gathering information), and software selection.

•

Considering regulatory considerations, including IRB review.
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•

Outlining requirements including remodeling, access security, alarms for
monitoring equipment, preventive maintenance, and backup power.

•

Identifying safety concerns, including emergency operations plans, fire safety, the
use of personal protective equipment (PPE), Occupational Safety and Health
Administration (OSHA) requirements, training in handling biological material,
labeling, transport, and waste disposal.

In a later follow-up article, Mayol-Heath, Keck, and Woo (2011) went into further
detail regarding business considerations for biorepositories, including a discussion of
stakeholder buy-in, startup costs, funding sources, conducting preliminary site visits to other
biorepositories, and developing policies and procedures. They went on to provide a
summary of important topics regarding the procedures and policies necessary to establish a
biorepository. The current paper will also expand upon several of the items included in their
summary, such as:
•

Facility procedures, including access restrictions, HVAC, alarms, oxygen sensors,
and (if using liquid nitrogen), backup power and testing.

•

Safety procedures and policies, including regulatory bodies and personnel
training.

•

Quality control procedures, including protocols, standard operating procedures
(SOPs), manuals, records and record keeping, database management, and
specimen and equipment maintenance.

•

Collection and processing procedures for all tasks and services provided including
logging in specimens for processing.
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•

Data collection procedures, including user-restricted databases, user audit trails,
coding mechanisms, sample location and volume tracking, and quality control.

•

Database requirements, including barcoding capabilities, specimen tracking, and
types of storage.

Dash et al. (2012) outlined the following considerations when establishing a
biorepository: a business model and plan, space for equipment and operations, processing
and storage equipment, adequate staffing by trained personnel, Information Technology (IT)
infrastructure, reagents and supplies, and standard operating procedures (SOPs) that include a
quality management system (QMS) for quality assurance and continuous quality
improvement.
Using the various checklists previously developed above as a starting point for further
exploration and with the goal of contributing to medical and scientific research and the
biorepository field, this paper will examine:
•

Business considerations in establishing a biorepository, including questions of
funding and advertisement.

•

Quality management systems (QMS) for a state-of-the-science, accredited,
commercial biorepository.

•

Quality assurance (QA) strategies to meet investigator’s needs and ensure highquality, fit-for-purpose biospecimens.

•

Practical information for Biorepository CAP Accreditation, including a list of
recommendations and practical information on application materials and the
inspection process.

6

DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008)
Dash et al. (2012) reminded researchers that many of the considerations for building
biobanks may be aligned with Clinical Laboratory Improvement Amendments (CLIA):
“Many of the critical steps to be followed in establishing and running a biorepository fall
within existing procedures in today’s CLIA-certified laboratories or can be implemented with
modifications to existing procedures in use in CLIA-certified laboratories” (p. 670).
Stakeholders or founders, investors, and researchers considering establishing a commercial
biorepository without the requisite infrastructure, work environment, or policies and
procedures already in place may benefit from the notable experience provided by an
operations manager with both a medical technology background and experience in building
and establishing such a biorepository and laboratory.
I have worked as an operations manager in a biorepository and lab for over 18 years.
For the last ten of those years, we maintained a Clinical Laboratory Improvement
Amendment (CLIA) certified, College of American Pathologists (CAP) accredited
laboratory. We were also among the first pilot programs to gain College of American
Pathologists (CAP) Biorepository accreditation nationwide in 2013. Throughout these
advancements, I was responsible for managing the organization, building the infrastructure,
writing the standard operating procedures (SOPs), designing quality assurance (QA)
programs, and preparing for certification and accreditation programs in order to meet our
organizational objectives and service the needs of our clients. My hope is that other
researchers will find this guide to be both a practical introduction to the inner workings of
biorepositories and a guide to reference as they design future biorepositories that serve the
needs of their own scientific communities.
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Chapter 2: Study Purposes and Methodology
Purposes of the Current Study
The purposes of this study are three-fold:
1. To construct a quality management system (QMS) utilizing the principles derived
from ISO 9001:2008 “Quality management systems-Requirements” and provide
the requisite framework in order to build, operate, and sustain a state-of-thescience, accredited, Biological Safety Level 2 (BSL-2), commercial biorepository.
2. To provide detailed quality assurance (QA) strategies for biorepositories to
onboard new studies; support specimen collection, processing, storage and
distribution; and provide the highest quality, fit-for-purpose biospecimens for
academic, clinical, and translational research.
3. To provide a practical guide to obtaining Biorepository Accreditation by the
College of American Pathologists (CAP).
To accomplish these purposes, I will outline the considerations required of a potential
investor or founder of a new commercial biorepository.
Proposed Biorepository Model
For the purposes of this paper, I will propose a biorepository model based upon a
potential Biosafety Level 2 (BSL-2) facility supporting both retrospective and prospective
samples. A BSL-2 facility, containing the appropriate primary barriers and safety equipment,
is “suitable for work involving agents that pose moderate hazards to personnel and the
environment” (U.S. Dept. of Health and Human Services, 2009, p. 33). Biosafety Level 2
agents are transmissible by ingestion, percutaneous injury, or mucous membrane exposure.
Therefore, any organization working with these agents must follow BSL-2 procedures,
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equipment, and facility design. The proposed facility would accept biospecimens classified
as Risk Group 2, agents “associated with human disease that is rarely serious and for which
preventive or therapeutic interventions are often available” (U.S. Dept. of Health and Human
Services, 2009, p. 10). Human serum, plasma, DNA, tissue, stool, and urine specimens must
be accepted according to established acceptance criteria for each type of specimen.
This proposed biorepository model will:
•

Assist investigators to develop standardized collection protocols to capture and
report all pre-analytical variables and provide high-quality specimen collection
methods according to study requirements.

•

Utilize “cradle to grave” sample tracking throughout the collection, processing,
storage, and distribution life cycle with the support of a robust inventory
management system.

•

Safely transport or ship (via commercial carrier) samples utilizing communication
procedures, sample selection, electronic biospecimen chain-of-custody
management, and risk mitigation strategies (including temperature monitoring) to
prevent the compromise or loss of biospecimens en route to or from the
biorepository.

•

Check in, process, and assess samples for quality purposes by evaluating the
integrity of the sample vial, sample label security and accuracy, barcode legibility,
and gross sample condition upon receipt; by retrieving samples from a specified
storage location; by quick-thawing and preparing aliquots or derivatives and
recording sample observations; and by snap freezing samples and returning
samples to specified storage locations.
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•

Provide safe, secure, consistently monitored storage conditions as necessitated by
study requirements to ensure the highest quality specimens for academic as well
as clinical and translational research.

Utilization of Quality Management Systems (QMS)
QMS in current biorepository model. Quality management is a continuous and
systematic process whereby key performance indicators of quality are monitored and
evaluated through a variety of activities in order to detect issues and potential trends, monitor
progress, and identify opportunities for improvement. In the context of a biorepository, an
effective QMS can accomplish the following objectives:
•

Define quality policies, processes, and strategies in order to maintain the highest
standards of biospecimen quality, integrity, and data throughout the collection,
processing, storage, and distribution life cycle.

•

Ensure compliance with biorepository policies and procedures; all applicable
federal, state, and local regulations; Best Practices; and the College of American
Pathologists (CAP) Accreditation Requirements as applicable to the scope of
biorepository services.

•

Assure potential stakeholders and clients that operations are performing to the
highest quality standards.

A well-designed QMS can prove even more valuable, however, in that it may provide
a “roadmap” and help guide the establishment, operation, and future sustainability of a
Biological Safety Level 2 (BSL-2) commercial biorepository. Furthermore, with the addition
of specific and detailed QA strategies, it may also provide assurance to researchers that
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samples are collected, processed, and stored in standardized ways to ensure they are of the
highest quality and fit for purpose.
ISO 9001. The International Organization for Standardization, commonly referred to
as ISO, is comprised of a federation of national standards (member) bodies from around the
world. Each member body may have representatives on various technical committees that
have been established in order to draft international standards. Once adopted, these drafts are
sent to the member bodies for approval. If 75% of the member bodies approve the draft, the
international standard is published (ISO 9001:2008, p. iv).
For purposes of the current paper, I will be applying principles found in ISO
9001:2008, “Quality management systems–Requirements,” to the proposed biorepository
model. Some of the key principles identified by ISO 9001:2008 include:
•

The importance of QMS design and implementation as considering the particular
needs of an organization, including:
o “its particular objectives,
o the products it employs,
o the processes it employs,
o and its size and organizational structure” (p. v).

•

A demonstrable commitment to “consistently provide product or services that
meets customer and applicable statutory and regulatory requirements and aims to
enhance customer satisfaction through the effective application of the
system…and the assurance of conformity to customer and applicable statutory
and regulatory requirements” (p. 1).
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•

A focus on customer satisfaction with the outputs (products or services) because
“Customers play a significant role in defining requirements as inputs. Monitoring
of customer satisfaction requires the evaluation of information relating to
customer perception as to whether the organization has met the customer
requirements” (p. vi).

•

The applicability of a QMS to “be used by internal and external parties, including
certification bodies, to assess the organization’s ability to meet customer,
statutory and regulatory requirements applicable to the product, and the
organization’s own requirements” (p. v).

•

Its utilization as “internal application by organizations, certification or for
contractual purposes” (p. vii).

For this research, I will examine, expand upon, and specifically tailor the principles
included in the fourth edition of ISO 9001: 2008 to construct a quality management system
(QMS) in order to support the objectives, anticipated services, operations (including
processes employed and infrastructure), and organizational structure of the proposed
biorepository model. Business considerations have been added to the QMS to address
internal requirements regarding establishing the biorepository as ongoing commercial
viability should be one of the primary concerns when establishing and maintaining a
commercial biorepository.
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Additional QMS considerations in current biorepository model. As Carter and
Betsou (2011) have argued, “Samples need to be collected, processed and stored in
standardized ways that gives assurance to researchers that they are fit for purpose” (p. 157).
However, they further conceded “compliance with ISO 9001 does not, by itself, ensure that
scientifically valid methods are used and samples and data are fit for purpose because this
standard does not give any technical requirement for the quality of the samples” (p. 158). In
an attempt to ensure that this document presents adequately detailed processes and
procedures necessary to support biorepository objectives and investigator requirements, the
proposed biorepository model will examine, expand upon, or formally introduce a number of
additional quality assurance strategies. These strategies include:
•

Assisting investigators as they design their studies in order to capture preanalytical variables, develop standardized collection protocols, and ensure
samples are of the highest quality and fit for purpose.

•

On-boarding all new IRB-approved research studies through implementation of a
study protocol and written commitment to Good Clinical Practice (GCP).

•

Designing and manufacturing study-specific specimen collection kits for
prospective samples.

•

Determining the research study’s method of sample identification for
retrospective samples and the appropriate method to incorporate the samples into
the biorepository.

•

Transporting or shipping samples to the biorepository.

•

Consistently storing academic and clinical research samples in monitored freezers
and including backup procedures in the chance of freezer failure.
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•

Implementing emergency preparedness, disaster response, and business continuity
plans using risk assessment and risk mitigation strategies.

•

Processing samples according to rigorous QC and QA procedures.

•

Returning samples to sponsors or investigators or properly disposing of them.

Research Questions
In the process of investigating and compiling this information, I attempted to address
the following questions:
•

Can the principles from ISO 9001:2008 help to establish the framework necessary
to build, operate, and sustain a state-of-the-science, accredited, commercial,
Biological Safety Level 2 biorepository?

•

What detailed quality assurance strategies may be applied to procedures for
onboarding new studies; supporting specimen collection, processing, and storage;
and providing the highest quality, fit-for-purpose biospecimens for academic,
clinical, and translational research?

•

How can biorepositories obtain CAP Accreditation?

Research Design and Methodology
The research design is based on personal qualitative research, including an extensive
literature review, development of a QMS for the proposed biorepository model, reporting QA
strategies, and providing practical information regarding the CAP Accreditation application
(including the inspection process), as well as providing a recommended list to aid other
biorepositories in their preparations for CAP inspections.
The research methodology is as follows:
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1. The ISO Standard for Quality Management System requirements (ISO
9001:2008) was purchased and reviewed. QMS principles were carefully
considered and applied to a requisite framework to meet biorepository
requirements.
2. The International Society of Biological and Environmental Repositories (ISBER)
Best Practices, the National Cancer Institute (NCI) Best Practices, and other
pertinent literature as well as applicable federal, state, and local regulations were
reviewed and incorporated into planning the biorepository.
3. All checklists prepared and disseminated by the College of American Pathologists
(CAP), including the Biorepository and Laboratory General checklists, may not
be shared outside an organization seeking accreditation or an accredited
organization and therefore may not be republished in the context of this paper.
That being said, in order to support the current research, the application materials
for CAP Biorepository Accreditation as well as the CAP inspection process were
reviewed, and a comprehensive list of recommended documentation, safety plans,
and QC and QA records were prepared for biorepositories seeking accreditation.
Analysis and Presentation of Data
As aligned to the ISO 9001:2008, the remaining chapters of this document will
address the considerations, responsibilities, requirements, and principles as outlined below.
Chapter 3 will expand upon business considerations in establishing a biorepository,
including commercial potential, adequate funding and competitiveness, business plan, initial
capitalization and monthly operating costs, marketing including advertisement, and
insurance. ISO:9001 does not directly address business considerations in the context of
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QMS. I have included this section as a reference for investors who may need specific
financial information. These examples will include initial investment with respect to
infrastructure, equipment, and supplies as well as ongoing monthly operating costs as
potential founders explore establishing a biorepository.
Chapter 4 covers documentation requirements, including a quality policy; quality
objectives; a quality manual or manual of operations; documented procedures; guidance
documents; work instructions, forms, and checklists; quality control (QC) and quality
assurance (QA) documents; the control of records and documents; a document control plan;
document control software or other manual method; and record preservation and retention.
Chapter 5 will address management responsibilities, including authority and
responsibility, communication, organizational structure, management roles and
responsibilities, management commitment, and communication.
Chapters 6 and 7 will consider two aspects of resource management. Chapter 6 will
deal specifically with human resources (such as staff selection; personnel records;
competence, training, and awareness; staff evaluation and merit program; and continuing
education and staff input) and infrastructure (such as facility infrastructure and maintenance;
equipment selection, qualification, maintenance, and replacement; property control and
disposition; and procurement and informatics). Chapter 7 will address work environment
requirements, including fire safety, electrical safety, engineering controls, administrative and
work place controls, personal protective equipment (PPE), first aid, emergency shower or
eyewash stations, chemical hygiene plan, hazard communication program, exposure control
plan, laboratory biosafety manual, freezer room safety and oxygen monitoring system,
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evacuation plan, excessive noise monitoring, color vision assessment, ergonomics, workplace
injuries or accidents, and security measures.
Chapters 8 and 9 will concern product realization, including customer requirements
(inputs), customer-related processes, procedures and quality assurance strategies to achieve
the product or service, and customer satisfaction (output).
Chapter 10 will consider emergency preparedness, particularly in the context of
previously published anecdotes and records of both pre-crisis preparation and post-crisis
management and recovery. It will also outline emergency preparedness plans within the
context of the proposed biorepository model.
Chapter 11 will outline specific methods of assessment, analysis, and improvement,
including QMS review; key performance indicators, publications and grants, peer review,
CAP Biorepository Accreditation, customer feedback and surveys, audits, ISBER SelfAssessment Tool, incident reporting, Corrective and Preventive Action (CAPA), a quality
risk management program; quality management system certification; and ISO biotechnology
(biorepository) certification in the future.
Each of these QMS items will be addressed specifically in reference to the
establishment of a BSL2 biorepository. However, investors and researchers considering
establishing any biorepository should be able to apply the methods stated in this research
paper providing they keep the needs of their potential clients (i.e., sponsors of research and
individual investigators) in mind as well as all applicable regulatory requirements.
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Chapter 3: Business Considerations in Establishing a Biorepository
Commercial Potential
When considering the commercial potential of a biorepository, potential investors
should consider a variety of factors. Mayol, Woo, and Keck (2010) proposed the following
strategies to determine commercial potential:
•

List current providers, their respective services, and if known, the costs of their
services and their cost recovery methods.

•

Identify potential clients such as universities, academic medical centers, research
institutes, hospitals, pharmaceutical companies, biotech firms, contract research
organizations, clinicians and research investigators.

•

Conduct anonymous market surveys.

•

Obtain feedback from investigators in surrounding communities regarding their
current and future biospecimen storage needs through a needs assessment.

In a follow-up article, Mayol-Heath, Keck, and Woo (2011) reported the following
five fundamental considerations in establishing a biorepository: stakeholder buy-in;
researcher needs; initial facility setup requirements; start-up costs and funding sources;
biorepository site visits, regulations, and best practices (pp. 253-257). Potential investors
must also evaluate several other topics, such as estimates of start-up costs in relation to
respective categories of services and the position of a proposed biorepository in local and
regional markets. (One resource in identifying other providers in the marketplace is the
Biobanking for Medicine: Technology, Industry and Market 2014-2024. This report is
available for purchase from Visiongain for a nominal fee/investment.)
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Before formally opening a biorepository, founders should open communication with
those most likely to utilize its services. These founders should obtain appropriate feedback
from them before opening in order to pre-establish relationships for future collaboration.
Surveys can be effective tools for obtaining such input and can contribute to the creation of a
well-designed, quality-driven biorepository. Organizers must conduct market surveys within
the scientific community as well as within specific focus groups to clarify current and future
specimen collection, processing, and storage needs as part of a larger needs assessment.
Feedback from scientific investigators regarding anticipated future requirements can help the
operations manager with accurate budget projections and ensure the biorepository will be
able to accommodate clients’ evolving needs as well as encourage repeat customers. Similar
feedback from focus groups can further identify client collection, processing, and storage
needs as well as help elicit future potential customers. In combination, these surveys would
help establish service limits for potential clients and determine how procedures and workflow
diagrams are designed when the biorepository becomes operational.
Determining biorepository type. An overall needs assessment can help determine
the vision and scope of services of the proposed biorepository and therefore establish the type
of biorepository needed as well as the types of specimens that will need to be collected,
processed, and stored. For the purposes of the current discussion, this particular biorepository
model proposes to accomplish the following:
•

To offer study design consultation and support; custom specimen collection kit
manufacture; sample pickup and delivery services; safe, consistent, and monitored
storage conditions; and a strong commitment to customer service and quality
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assurance in order to ensure the processing of fit-for-purpose biospecimens for
academic, clinical, and translational research purposes.
•

To service the following clients: researchers from universities, academic medical
centers, research institutes, hospitals, pharmaceutical companies, biotech firms,
contract research organizations, clinicians, and research investigators.
To that end, the current discussion will focus upon a proposed Biological Safety

Level (BSL) 2 facility. BSL-2 agents are associated with human disease. Therefore, all
biospecimens are considered potentially infectious. Potential routes of transmission include
percutaneous injury, ingestion, and mucous membrane exposure (U.S. Dept. of Health and
Human Services, 2009). Safety issues and regulatory requirements regarding working with
potentially infectious biospecimens have been addressed in separate sections of this paper for
the protection of all biorepository employees.
Funding and Biorepository Competitiveness
As the complexity of the collection, processing, and storage of biospecimens
continues to evolve and expand, potential investors must not only secure initial investment
capital but also plan for continued operational funding to ensure future sustainability for the
biorepository. Dash et al. (2012) reported that founders should begin by defining potential
sources of initial funding, which may include financing from institutions, government grants,
and partnerships with industry or businesses. They list several examples of possible funding
sources, including Angel and Venture capital funding or grant resources such as the Small
Business Innovation Research or Small Business Tech Transfer Grants. Research grants
from federal, state, and local sources may also be available to new business start-ups that
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provide much-needed employment opportunities in economically depressed areas. Partnering
directly with commercial end users should also be an important consideration (pp. 668-678).
Although long-term sustainable financing may be challenging to obtain, investors can
take steps to achieve a sustainable financial model. Partnering with institutions to help cover
costs of employee salaries and operating costs can help the biorepository reach financial
stability and an acceptable profit margin on an accelerated timeline. Larger biorepositories
can be more cost efficient, as the initial cost of set up does not have to be repeated and allows
for a greater volume of business. Vaught, Rogers, Myers, et al. (2011) stated that most
biorepositories are not-for-profit and receive funding through a shared or central funding
mechanism. Their objective is often to support research at a local institution, such as a
hospital, or in a larger integrated program, such as a research or academic setting.
Partnerships with outside programs in the private or public arena may provide the most
financially stable model. The authors further noted that “there may be a shift toward larger
Biorepositories that have broader applications, are more cost efficient to maintain and are
more proficient in QA” (p.5).
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Potential sources of capital. Biorepositories rarely provide a single service, and
thus, they rarely depend on a single source of income. Such organizations require a multitude
of sources to obtain the funding necessary to achieve financial sustainability (Vaught,
Rogers, Myers, et al., 2011). Such stability depends on short- and long-term contracts from
clinical research organizations. However, other sources may additionally support that
stability. For example, a biorepository may find adequate funding through large
pharmaceutical companies who find biorepositories’ services necessary for research that
leads to profitable product development. For instance, Mayol et al. (2010) propose several
relevant strategies in order to develop a business model that includes academic and
pharmaceutical research customers. They suggest a list of current providers and their
respective services followed by a list of the costs of biorepository services and cost recovery
methods (pp.139-145). Grant funding for academic and clinical research should likewise be
taken into account in budget planning with routine updates and measurable outcomes
monitored on an ongoing basis.
Additionally, processing fees may recoup some of operating costs. The operations
manager would hold responsibility for developing an overall fee structure. User fees may be
difficult to determine initially, as biorepositories often give discounts to academic research
over pharmaceutical research. Therefore, such fees and costs may be variable. The
operations manager may choose to set up a personalized fee structure on a project specific
basis to allow flexibility and competitiveness in pricing. The manager should first research
and evaluate potential competitor’s services and rates. Once these market rates have been
researched, an acceptable profit margin should be determined before finalizing any proposed
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fee structure. Proposed fees for services and cost recovery should likewise consider
depreciation of capital equipment.
Sources of capital for non-profit biorepositories. Those considering establishing a
non-profit biorepository may have additional funding opportunities. As reported by Yamada
et al. (2013), nonprofit biorepositories that serve NIH-funded investigators could seek
additional support from the NIH through R24, U42 funding mechanisms for the development
and operation of research infrastructure and resources (p. 226-231). The Office of
Biorepositories and Biospecimen Research (OBBR) typically has funding opportunities for
specific specimen collection types and data resources but not for infrastructure. The National
Center for Research Resources Division of Research Infrastructure provides grants under the
Research Facilities Improvement Program that allows the recipient to expand and remodel
their current space or build new space, but these grants would not fund the purchase of
equipment. However, the Shared Instrumentation Grant program provides funding for shared
equipment purchases to institutions with three or more NIH-supported investigators. Other
funding organizations may be able to provide grant funds for research projects other than
general research resources and infrastructure. These various funding options for non-profits
need to be explored as part of a comprehensive business plan.
Other considerations. Other financial issues to consider include permanent versus
temporary funding, staff salaries, facility costs, and safety and regulatory requirements.
Investors should consider a timeline to recover set-up costs. They must also recognize that
cost recovery potential will be affected by the number of industry-sponsored research studies
versus federally-funded academic and clinical research studies using the biorepository’s
facilities at any given time.
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Development of an Effective Business Plan
According to the National Cancer Institute Best Practices for Biospecimen Resources
(Office of Biorepositories and Biospecimen Research, 2011), “Business plans should be
specific, measureable, actionable, relevant and time bound” (p. 7). As such, any
biorepository that wishes to begin operations should evaluate all potential models and
business plans by these basic principles.
Initial capitalization and monthly operating costs. In order to create an effective
business plan for the current proposed model, the author created a detailed budget that
included the initial capitalization costs and monthly operating costs. The biggest expenses
include creating infrastructure; purchasing, customizing and implementing the Biobanking
Information Management System (BIMS); and personnel costs, while monthly operating
expenses remain quite low. Refer to Table 1 (pp. 26-28) for an itemization of the potential
initial capitalization costs of the proposed Biorepository model and Table 2 (pp. 29-30) for
its monthly operating costs. Specific facility requirements and equipment selection will be
addressed in Figure 2 (p. 53) as well.
Insurance. These initial proposed budgets do not account for insurance. Sufficient
insurance must be obtained for the facility (if purchased rather than leased), infrastructure,
monitoring systems, equipment, supplies, and transport vehicles. Similarly, liability
insurance for personnel and biological samples would be necessary to protect the
biorepository against unexpected loss. Samples collected from clinical research studies may
very well be irreplaceable; research personnel cannot go back and obtain a sample from that
same precise point in a specific participant’s life or health status (Simeon-Dubach, Zaayenga,
& Henderson, 2013). However, the availability of sufficient insurance coverage may
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adequately compensate clients for the time, materials, and personnel costs in designing a new
or revised study, including recruitment of any new participants to obtain future specimen
collection, compensation for or reimbursement incurred by potential participants, and lost
productivity on the part of the investigator. Simeon-Dubach, Zaayenga, and Henderson
(2013) noted that “a thoroughly conducted risk assessment and contingency plan can be used
to define insurance premiums, not only for the infrastructure and equipment, but also for the
biospecimens and data” (p.133).
Other considerations. In addition to consideration of these initial budgeting
estimates, Dash et al. (2012) suggested investors consider the following topics when creating
an effective business plan:
•

A realistic projection for profit and loss, with three to five year projections, in
addition to a cash flow analysis.

•

A planned “ramp up” period, clarifying which operational areas may incur a loss as
business increases.

•

A time frame estimating when operations will break even and become profitable.
These plans should be reviewed and approved by stakeholders prior to

implementation (pp. 668-678).

25

DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008)
Table 1
Initial Capitalization Costs
Cost
Expenditures
Rent
15000 gsf, with ability to expand further

Per Unit
$6.00/gsf

Initial Construction
Electrical, HVAC, generator, emergency lighting, lab/IT
Connectivity, BSC, lab sink
LN2 concrete pad, LN2 piped in, internal fill station, oxygen
monitoring system
Princetoncryo.com / Cryogenic Gases

Total
$90,000

$750,000
$150,000

Security System incl. video surveillance, gated entry
Installation

$10,000

Fire Prevention System
Installation

$5,000

Freezer Monitoring System
Smart-Vue, Fisher Scientific
Lithium batteries required for each freezer per year
wireless, probes unnecessary
dedicated computer not required

$50,000
$2,000

Freezers
1 Refrigerator, Kelvinator
2 -80 deg C Mechanical Freezers, Revco
LN2 Freezers, 25 initial freezers
*Chart MVE HEco1892-190*
Obsolescence planning and replacement (1 freezer / 4 years)
*10% freezer back up space required at all times
Battery Back up
Freezer Racks
2 mL vial
5 mL vial
10 mL-50 mL vials

Chart MVE 60 racks/freezer

Laboratory Information Management Program
5 stations, license, training and technical support
LabVantage, BioStorage, Kits

$8,000
$24,000
$54,674
$50,961

$1,366,850
$12,740

$675

$16,875

$80
$90
$90

$67,200
$21,600
$37,800

$120,000

$120,000

Label Stock, die cut, initial run

$12,000

Barcode Scanners (4 Wasp Barcode Scanners)

$360

$1,440

Cryocart (MVE #14448703)

$16,500

Vapor Shipper (Holds 675 2 mL vials, MVE XC20/3V, cat
#11016649)
Protective Shipping Container for Vapor Shipper (cat #10537506)

$1,832
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Table 1
Initial Capitalization Costs
Independent ultralow thermometers (25)

$50

$1,250

Computer Stations, Server
UPS Backup Protection
NetGear Switches

$10,000
$500
$500

Lab Benches, Desks, Chairs
Printer/ Scanner
Copier
Centrifuge
Stainless Steel Cart
Vortex/Shaker
Finn Pipets, Stand

$40,000
$600
$4,000
$15,000
$600
$600
$2,400

CAP Accreditation
Freezer Mapping (CAP requires periodically, accreditation every 3
years)

$3,000
$10,000

Waterproof Cryogloves
Lab Coats
Truck for Biospecimen Pick-up and Delivery
Truck Customization

$300
$40

$1200
$160
$40,000
$10,000

Marketing
Advertisement
Website Development
Signage

$10,000
$2,500
$5,000

Food Refrigerator, Microwave

$1,000
Expenditure Subtotal

$2,922,549
Cost

Personnel
Manager (100%)
IT (Contractual)
Lab Tech Level 1(1 hire @ 100%)

Per Unit

Total

$120,000 +
25% benefits

$150,00

$40,000 +
25% Benefits
$35,000 +
25% Benefits
$35,000 +
25% Benefits

Lab Tech Level 2 (2 hires @ 100%)
Lab Tech Level 3 (1 hire @ 100%)
Personnel Subtotal
Total Expenses

$100,000
$50,000
$87,500
$43,750
$431,250
$3,353,799
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Table 2
Monthly Operational Costs
Expenses

Budget Line Item

Annual

LN2 Bulk Tank Lease, Cryogenic Gases

Monthly

$9,600

$800

$9,450

$788

Lease includes preventive maintenance, service, emergency response, and telemetry
3000 gallon tank can support 20-40 large LN2 freezers
Note: LN2 Bulk Tank Purchase, $50,000-$150,000 Range, very rare
Increasing tank size made easy with lease option
LN2 Supply
Initial fill of 3000 gallon tank, $1200 in Jackson-Ann Arbor Area
Subsequent fills $750 in Jackson-Ann Arbor Area
Dry Ice Supply

$128

Utility Costs
Electric, Gas

$2,500

Phones—4 Lines

$2,500

Internet/WiFi /Ethernet Connectivity—High Speed

$208
$600

Biohazardous Waste Disposal, Stericycle

$2,500

$208

Regular Waste Disposal, Modern Waste/ Republic

$1,500

$125

Custodial Services

$1,800

$150

Equipment, Liability coverage for Biospecimens, Accident

$24,000

$2,000

Vehicle Insurance and Registration

$2,200

$183

Advertisement, on-going

$2,000

$167

Insurance

Fuel for Vehicle, Biospecimen pick-up and delivery

$2,500

Vehicle Maintenance

$1,200

$100

Reserve for vehicle replacement

$5,000

$417

Maintenance/Service Contract on A/C

$1,500

$125

Maintenance, Load Testing on Generator

$3,000

$250

Security System Monitoring Contract

$2,500

$208

Freezer Service Contracts starting Year 3

$5,000

$417

28

DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008)
Table 2
Monthly Operational Costs
Expenses

Budget Line Item

Annual

Monthly

Laboratory Information Management Program license fees in future years

$7,500

$625

Network Vulnerability Testing

$3,000

$250

$300

$25

Finn Pipet Calibration/Preventive Maintenance
CAP Accreditation, $3000 every 3 years

$0

External QA/ PT Materials

$2,500

$208

Freezer Batteries or Charger

$2,000

$167

ISBER membership, conference

$3,708

$308

Freezer Mapping starting Year 3

$0

Miscellaneous Supplies

$1,250

Safety Glasses/ Face Shields
Nitrile Gloves
Lab Notebooks/iPad
Printer Paper
Binders
Sharpies, Pens, Paper
Scotch tape/ Packing tape
Blue Pads
Pipet Tips
Kim Wipes
Bleach
Cleansers
Clear bags
Biohazard Bags, Stickers
Monthly Operating Budget, not including personnel

$14,707

Estimate of costs for additional services, kits, check-in, processing, third-party shipments

$4,000

Total Anticipated Monthly Expenditures, not including personnel

$18,707
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Marketing and advertisement. A successful business model incorporates an
effective marketing strategy that provides outreach to potential clients. As stated earlier, a
complete needs assessment can help identify possible clients of the biorepository to
determine which marketing strategies would be most effective in reaching both local and
national markets. A successful marketing campaign would include implementing a
marketing survey specifically targeted to the scientific community, soliciting the needs of
other potential users, and providing information on the mission and services of the proposed
biorepository. Surveys would be directed to academic medical centers, hospital systems,
reference laboratories, pharmaceutical companies, biotech firms, contract research
organizations, academic institutions, and specific researchers and clinicians. Management
may also consider conducting focus groups as another method of soliciting input and the
needs of potential users.
Marketing of the biorepository should ideally provide awareness and understanding
of the purposes of the biorepository. Therefore, appropriate marketing strategies should take
a multi-lateral approach, including word-of-mouth, direct mail, and print and website
advertising to raise such awareness. Specific services, quality of service assurance, and
competitive pricing would be addressed in more specifically directed marketing efforts.
While primary advertising regarding the benefits of the biorepository would be
accomplished through direct mailing of brochures and press releases to identifiable clients,
white papers may also be written and widely disseminated to address relevant topics in
research that may be tied to the unique benefits of the biorepository. Similarly, media
outreach might include representation at professional events such as seminars, conferences,
and lectures as well as advertising in respected and well-read trade journals within the
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scientific community. These advertising models would to promote the biorepository on a
more national level. On a local level, participation of biorepository staff in community
events and local organizations would provide an opportunity to demonstrate the benefit of
having the biorepository within the community.
Once clients are established, good business practices and marketing efforts would
continue through emphasis of the quality of services and friendly collaboration. These efforts
would ideally establish a loyal customer base and retain a large percentage of potential repeat
customers. Overall, a number of marketing strategies and public relations campaigns may be
utilized with both new and existing clients to promote the biorepository, ensuring its
profitability and utilizing its potential to contribute to the advancement of scientific research.
Business continuity
Business continuity planning ensures critical business functions will continue should
adverse conditions interrupt the flow of operations. The foundation of a successful business
continuity plan includes the requisite policies, procedures, and guidelines to ensure the
continuation of services in the event of any emergency. The biorepository must prioritize
which of its functions are most essential and then implement documented policies and
procedures to maintain continuity and recovery of essential functions after any internal or
external event impacts the organization.
A complete business continuity strategy will incorporate a risk analysis identifying all
possible risk scenarios. Any event that has the potential to interrupt normal operations, such
as geographic disaster, loss of supplies, or damage to equipment, must be anticipated and
included in a risk management plan. Henderson, Simeon-Dubach, and Zaayenga (2013)
suggested that a “specific focus on risk management and risk mitigation in the case of
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disasters and unexpected occurrences” must be an integral part in planning for biorepository
infrastructures and processes (p. 193). They assert that these plans need to be developed for
“when bad things happen” as part of a core-competency for all biorepositories (p. 193).
Risk assessment. Based on principles from ISO 22301:2012, “Societal continuitybusiness continuity management systems-Requirements,” standard operating procedures of
the current biorepository model will address risk assessment planning including the
following:
1. Identify risks of disruption to the organization’s prioritized activities and outline
all the processes, systems, information, people, assets, outsource partners, and
other resources that support them
2. Systematically analyze each risk.
3. Evaluate which disruption related risks require treatment.
4. Identify treatments commensurate with business continuity objectives.
Establishing business continuity plan. In order to maintain readiness to resume
operations, the current biorepository model must use the results of the risk assessment to
establish a business continuity plan. As part of this plan, biorepository management shall
define the “minimum level of products and services that is acceptable to the organization to
achieve its objectives” (ISO 22301:2012, page 5). An inclusive business continuity plan will
define:
•

Operating dependencies: identify what must be in place before operations can
resume.
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•

Steps to return to normal: identify tasks that must be performed before business
can normalize. These tasks may include restoring network services,
communication, and information technology systems.

•

Time frames: prioritize tasks so services can resume in the correct order and in the
most efficient and expeditious manner.

•

Necessary resources: identify required staff, alternate vendors for supplies (as
necessary), and methods for protecting information and data. The organization
should also identify resources for restoring stability of building facilities and
utilities if necessary.

Biorepository personnel must take proactive measures not only to prevent any event
from affecting services but also to shorten the duration of any disruptive event in order for
business to resume as quickly as possible. Applying these organizational principles specific
to a biorepository will help to minimize events that can potentially interrupt critical functions
and allow critical functions to continue. See “Chapter 10: Emergency Preparedness and
Disaster Response” (p. 146) for more information.
Specific business continuity plans of the proposed Biorepository model. In the
current biorepository model, the business continuity plan must address a number of issues in
order to maintain continuity of service.
LabVantage. If LabVantage software is not functional or operational, an established
LabVantage downtime procedure must be established and documented. Critical functions
must be maintained via paper processes until LabVantage function has been restored and
verified. Short- and long-term scenarios must be considered and should include pre-designed
procedures and templates for data capture when LabVantage becomes unavailable. These
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procedures must address application support, backup, recovery, and restoration procedures as
well as system management, problem management, and a Service Level Agreement for
outside contracts.
Record keeping. In the event of fire or flood, records within the biorepository
facility may become damaged or destroyed. Therefore, any business continuity plan should
include procedures for storing redundant business records off site. To that end, electronic
copies of business records will be backed up and maintained off site in case data recovery is
required. Such business records necessary for operation may include:
•

Documentation critical to biorepository functions, including research protocols,
IRB approval applications and amendments, document control software, SOPs,
reference manuals, and other laboratory records.

•

An inventory of equipment, hardware, and software, including make, model
number, serial number, ID tag, and version number as appropriate.

•

Client contact list.

•

Contact information, including names, addresses, phone numbers, and contract
numbers for all maintenance providers, equipment manufacturers, and suppliers.

•

Copies of invoices, purchase orders, credit card statements, contracts, and service
agreements.

These records that are maintained offsite must be routinely backed up from data
housed in the biorepository. Precise locations of all documented data must be recorded, and
all such scheduled backups must have documented confirmation of completion.
Finally, defining staff responsibilities in the event of an emergency and providing
training that prepares for all potential scenarios will develop a successful business continuity

34

DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008)
management system that can ensure the biorepository maintains critical functions and meets
its responsibility of protecting the biospecimens in its care, even in the event of unforeseen
interruption of biorepository functions.
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Chapter 4: Documentation Requirements
ISO 9001:2008 identifies several requirements for documentation within a quality
management system. Specifically, this documentation should include statements of policy
and objectives, a quality manual, and written procedures and record-keeping processes in line
with the aims of the organization.
Biorepository Policies and Objectives
According to ISO 9001:2008, a quality policy “is appropriate to the purpose of the
organization, includes a commitment to comply with requirements and continually improve
the effectiveness of the quality management system, provides a framework for establishing
and reviewing quality objections, is communicated and understood within the organization,
and is reviewed for continuing suitability” (p. 4). Therefore, the proposed biorepository’s
policies must define the biorepository’s direction, processes, and values. Such policies will
include a quality policy and an infectious disease policy.
Quality policy and quality objectives. Simeon-Dubach et al. (2013) argued that “a
quality biobank stands on three pillars: the number of biospecimens; the quality of the
collection and storage; and the amount and richness of the associated stored data” (p.133).
The biorepository, therefore, should establish a number of quality objectives by which all
policies should be upheld. For this particular biorepository, such quality objectives shall
include:
•

To provide the highest level of customer service and support.

•

To develop standardized collection protocols and capture and report all preanalytical variables.
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•

To support standardized collection processes by offering design and manufacture
of specimen collection kits.

•

To utilize Biospecimen Evidence-based Practices and SOPs.

•

To incorporate the latest advances in biospecimen research and cryopreservation
to ensure the highest quality, fit-for-purpose biospecimens for clinical and
translational research.

•

To utilize and incorporate ISBER and NCI Best Practices into biorepository
operations as appropriate.

•

To keep current with the latest technological advancements and quality assurance
strategies (e.g., ISO/TC 276 for biotechnology standards to include biobanking
currently being developed).

•

To obtain College of American Pathologists (CAP) Accreditation for
Biorepositories within a specified time frame.

•

To obtain ISO 9001:2008 QMS Certification.

•

To join the International Society of Biological and Environmental Repositories
(ISBER) and participate in conferences, sponsored activities, and working groups.

•

To consider joining Cooperative Alliances to share resources and expertise as
appropriate.
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Quality manual. The quality manual or operations manual for a biorepository
should outline the scope, procedures, and interactions of processes within the pre-determined
quality management system. Practically, it should therefore contain all policies, standard
operating procedures (SOPs), guidance documents, work instructions, forms, and checklists
necessary for biorepository operations.
Once established, this operations manual and the QMS it outlines should be
applicable to all operational activities performed by the biorepository. Following all policies
and procedures within the designated QMS will ensure compliance with biorepository
policies and procedures as well as all applicable federal, state, and local regulations; the
International Society of Biological and Environmental Repositories (ISBER) Best Practices;
the National Cancer Institute (NCI) Best Practices; and the College of American
Pathologists’ (CAP) Accreditation Requirements. The extent of these requirements will be
determined as applicable to the scope of biorepository services.
A limited number of hardcopies of the operations manual should be controlled and
maintained by management (see “Authority and Responsibility” for further information on
management structure). These hardcopies can then be made be readily available for staff, the
director, operations manager, and any internal or external inspectors. Electronic copies
should also be available on the biorepository website with read-only and printing privileges
for staff, clients, and inspectors. Editing privileges should be granted to the director and
operations manager only.
Biorepository Documented Procedures
Documented procedures, such as those outlined in the operations manual, ensure “the
effective planning, operation and control of the Biorepository processes” (ISO 9001:2008,
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p.2). Standard Operating Procedures (SOPs) should therefore describe tasks or processes and
be sufficiently detailed to reflect the complexity of the task or process and the requisite skills
and training of the personnel performing it. These SOPs will provide uniformity and
consistency in all biorepository activities and will incorporate all quality standards. Each
new or revised procedure will be tested and approved prior to implementation. Per ISO
9001:2008 requirements, all records and documents must remain “legible, readily
identifiable, and retrievable” (p. 3).
Guidance documents, work instructions, forms, and checklists. Guidance
documents, work instructions, forms, and checklists should be created for all appropriate
tasks within the biorepository’s structure. These documents should be controlled,
maintained, and readily available at all appropriate workstations.
Quality control (QC) and quality assurance (QA) documents. QC and QA
documents should include information on chemical hygiene, exposure control, hazard
communication, laboratory biosafety, competency evaluation, training, safety, education, and
proficiency testing. These records must be controlled, maintained, and securely stored and
made readily available for internal and external audits or review.
Control of Records and Documents
Records and historical documents must be consistently controlled, maintained,
securely stored, and made readily available for internal and external audits or review. In
addition to QC or QA documents or other documents established via standard operating
procedures, the biorepository must also retain records of specific study processes, procedures
and results. In this proposed model, such records will include laboratorians’ notebooks,
which will serve as important source documents subject to review by management.

39

DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008)
Instructions for record keeping and maintaining such a laboratory notebook would be
provided in the operations manual.
Document control plan. The document control plan should outline all procedures
regarding document creation and control within the biorepository. It should include methods
for managing the biorepository’s standard operating procedures, from creation and
development to maintenance, review, and revision as well as documenting approved protocol
deviations. It would also identify methods for locating SOPs as well as proper protocol for
distributing them to staff.
All SOP documents should undergo a routine review process to ensure the most upto-date information is included in SOPs; therefore, the documents should be reviewed,
modified as appropriate, and approved at least every two years by both the biorepository
director and operations manager (see “Authority and Responsibility” for further information).
All new policies and SOPs or substantial changes with respect to documentation will be
reviewed and approved prior to implementation. Although outdated versions will not be in
circulation to prevent unintended use, documents that have been designated obsolete will be
retained in the records. The date of obsolescence and the version number will be recorded.
Methods of document control. Document control may be adequately accomplished
manually, e.g., through a list of controlled documents in Microsoft Excel or another software
program. For larger biorepositories, particularly those that offer a multitude of laboratory
services, a document control software program may better serve the organization.
A document control software program can effectively manage and control all
document versions and revisions with a complete audit history in a secure, centralized
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location. Documents are organized in an intuitive manner with full text or metadata
searching options available.
A configured workflow can also automate the review and approval process.
Documents can be restricted and automatically routed to the appropriate personnel for review
and approval. Users are alerted to take appropriate action for document review via email
notification. Escalation procedures can be implemented if assigned actions are not
completed in a timely manner. Parallel, sequential, and voting options may also be utilized
for routing and managing documents. Upon approval, automatic sequential numbering may
be utilized and electronic signatures recorded and displayed. Documents may be distributed
electronically. Outdated versions will be tracked and archived automatically; archived
documents will be easily accessed for reference purposes.
Regardless of the method chosen, management should maintain an SOP log that
contains the date of all document revisions and disseminations, document identification
numbers, and the title of the SOP in question, and the modification and the reason for the
modification. Maintaining an effective SOP log is crucial in tracking the historical
development of an SOP (and the corresponding scientific findings based upon those
procedures) and preventing unintended use of outdated or obsolete procedures.
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Record preservation and retention. Hard copy records must be protected from loss,
damage, or deterioration and should be stored according to documented procedures in such a
manner that they may easily be referenced and retrieved from any specified storage locations.
Electronic records will be backed up and archived at regular intervals according to
documented procedures.
Records should be retained for established retention times. For instance, employment
records will need to be maintained indefinitely. Should biorepository operations cease,
policy should dictate that records be retained for five years minimum at a secure, safe
location deemed appropriate by the biorepository director. This pre-approved location
should also be provided to the operations manager for additional tracking purposes.
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Chapter 5: Management Requirements
Regardless of how the QMS is configured in any given biorepository, it is the
responsibility of management to ensure both that “the planning of the quality management
system is carried out in order to meet the requirements” of the ISO standard and the
establishment in question and that “the integrity of the quality management system is
maintained when changes to the quality management system are planned and implemented”
(ISO 9001:2008, p. 4). Therefore, the establishment of a management structure and
philosophy are central to creating a working QMS.
Organizational Structure
A readily available organizational chart should define the organizational structure of
the biorepository. This organizational chart should also outline the chain of command and
reporting relationships within the organization (NCI Best Practices, 2011). Although this
chart can be as detailed or as simple as necessary for the biorepository in question, there are a
few staff positions that are crucial to this model’s biorepository functioning. These positions
will also be referenced throughout the current document.
Authority and Responsibility
The biorepository director. In the current model, the director holds ultimate
responsibility for the biorepository. These responsibilities include defining its mission and
organizational objectives, identifying the scope of its services, and securing its funding. The
qualifications of the director, therefore, must be appropriate for the scope of activities and
services envisioned for and provided by the biorepository. In addition, the director will
review the quality management system (QMS) on an annual basis and will review all policies
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and procedures according to the document control plan at least once every two years. These
systems may be reviewed more frequently if appropriate.
In the event the director works at the biorepository while maintaining an appointment
at an academic institution, the director will document time spent and activities performed at
the biorepository as opposed to time spent in his or her primary academic capacity. In such
circumstances (or as necessary), the director may elect to delegate certain high-level
administrative and biorepository tasks; instances of this delegation of authority will be
documented and made available for review.
In the event of a change in directorship, the new director will review and become well
acquainted with the standard operating procedures. The new director will also establish
policy (if applicable), provide guidance and oversight to staff and delegate responsibilities
accordingly, and review and work to improve the quality management system.
The operations manager. In the current model, the operations manager will work in
concord with the director to manage daily operations of the biorepository and, therefore,
must have the training and expertise necessary to do so. One of the manager’s primary
responsibilities will revolve around review and implementation of all aspects of the QMS and
document control plan. For instance, the manager will review all policies and procedures
according to the document control plan every two years or more frequently, if appropriate.
The manager will also establish, implement, and maintain the QMS, its documentation, and
processes. In addition, the manager will ensure all personnel are trained to comply with the
QMS as it relates to their individual duties. The manager will maintain records of all such
education, demonstration of skills, and training. The manager will also conduct audits,
collect data on the performance of the QMS, and report the subsequent findings, including
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recommendations for improvement, to the director for review. Larger organizations may
consider appointing a quality assurance manager in addition to the operations manager in
order to provide an independent assessment of quality assurance activities. Other overall
responsibilities of the operations manager would include hiring, training and evaluating key
personnel, managing all operations and workflow, communicating with clients, and
overseeing all business activities.
Staff. Per ISO 9001:2008, management should always “ensure personnel are aware
of the relevance and importance of their activities and how they contribute to the
achievement of quality objectives” (p. 6). Staff should therefore be appropriately trained to
be proficient in and conduct tasks according to established policies and procedures.
Minimum requirements of job classifications and respective roles must also be clearly
defined and well-documented, and staff will be certified for individual tasks associated with
their respective positions.
Communication with staff must be considered of highest importance in any proposed
biorepository. In addition to management communicating assignments and policies to staff,
staff should feel comfortable making suggestions to management. Staff should be
responsible for identifying and reporting noncompliance or inadequate quality control or
quality assurance to the operations manager. The director and operations manager should
encourage staff to communicate any relevant information to other staff members wherever it
may be helpful in ensuring the effectiveness of the QMS. Furthermore, with experience and
encouragement, staff may contribute significantly to continual improvement in services,
processes, and systems by providing feedback and suggestions to management for
consideration.

45

DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008)
Management Commitment
In the proposed biorepository model, the director and operations manager will be
committed to utilizing Biospecimen Evidence-based Practices and SOPs as well as
incorporating the latest advances in biospecimen research and cryopreservation to ensure the
highest quality, fit-for-purpose biospecimens. Management will also be committed to
implementing and maintaining a complete and effective QMS, continually improving it, and
ensuring all personnel are aware of the importance of compliance with the QMS.
Management will establish quality policy, ensure quality objectives are established, conduct
management reviews, ensure the availability of sufficient resources, implement customer
requirements, and work toward continual review and improvement of the QMS.
Best Practices. As part of its commitment to quality, management will ensure the
biorepository follows designated Best Practices: the International Society for Biological and
Environmental Repositories (ISBER) Best Practices: Collection, Storage, Retrieval and
Distribution of Biological Materials for Research (2011) and the National Cancer Institute’s
Best Practices for Biospecimen Resources (2011).
Accreditation. The proposed biorepository model will also seek accreditation and
certification from several industry leading organizations. First and foremost, the
biorepository will obtain College of American Pathologists (CAP) Accreditation for
Biorepositories. After the CAP has confirmed acceptance of the biorepository’s application
materials, the Laboratory General and Biorepository Checklists will be sent to the
biorepository. Barring any unforeseen circumstances, the first inspection will be scheduled
within six months of the time of the application.
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The biorepository will also seek ISO 9001: Quality Management System
Certification. Currently the ISO 9001:2008 QMS is under review. The revised standard
should be finalized by the end of this year (International Organization for Standardization,
2015). After the revision is published, organizations that are currently certified will have
three years to transition to the new standard.
The ISO Technical Committee, TC 276, is currently developing a biotechnology
standard to include biobanking. Once it is released, the biorepository will make certification
to this ISO standard a top priority.
Networking. In order to keep current in the field of biobanking, the operations
manager will be a member of International Society of Biological and Environmental
Repositories (ISBER) and will participate in ISBER conferences and working groups.
Networking in forums such as these leads to opportunities to join or form cooperative
alliances in order to share resources and expertise.
Communication. Effective communication is essential to the success of any
organization. At the proposed biorepository, such communication will be facilitated through
an open door policy, regular staff meetings, email, and other means as appropriate.
Management will foster an environment where all individuals are treated in a respectful,
professional, and courteous manner and will encourage staff to ask questions and contribute
ideas and insights as well as suggest improvements. The biorepository will also highly
recommend implementation of a formal communication plan both for emergency response
measures as well as to communicate important information to clients and stakeholders.
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Chapter 6: Resource Management-Human Resources and Infrastructure
ISO 9001:2008 specifies parameters by which an organization should identify and
provide resources, both in terms of human resources and in terms of physical structure (p. 6).
The proposed biorepository will be committed to ensuring the highest quality and integrity of
biospecimens throughout the collection, processing, storage, and distribution life cycle. To
that end, the biorepository will provide the requisite infrastructure, safe working
environment, and necessary resources for effective operation and quality management. By
maintaining awareness of potential resourcing issues, the biorepository will attempt “to
implement and maintain the quality management system and continually improve its
effectiveness, and to enhance customer satisfaction by meeting customer requirements” (ISO
9001:2008, p. 6).
Human Resources
Human resource practices will be governed by federal, state, and local laws as well as
by policies and procedures outlined in the biorepository employee handbook. A list of
employment policies and procedures is provided in Figure 1.
Staff selection. Well-qualified staff will be recruited, selected, and employed by
virtue of their education, training, skills, and experience for their respective duties. Once
selected, staff members will be subject to continual review and personnel files will reflect all
pre-selection and post-employment records. These files will be restricted and organized in a
systematic fashion for expedited review. Personnel records must contain all staff members’
curriculum vitae, references, letters of recommendation, copies of academic degrees,
certifications, and licenses; continuing education records; current job description; a summary
of qualifications; a list of specific procedures and tasks the employee is authorized to
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perform; previous evaluations; emergency contact information; work-related incidents,
accidents, and excuses from work (for significant illnesses only); and dates of employment.

ü

ü
ü

ü

ü

ü

Employment Process
o Recruitment
o Background Screening
o Work Eligibility (Visa, I9 Form)
o Employment Oath
o Orientation
Non-Discrimination / Affirmative Action
Policy
General Policies
o Rules
o Schedules
o Lunch & Break Periods
Employment Benefits
o Health Benefits
o Holidays
o Retirement
o Tuition Reimbursement
Injury Prevention/Documentation
o Personal Protective Equipment
o Illness/Injury Reporting to OSHA
o Workman Compensation
Pay Policies
o On-Call Time
o Overtime/Compensation Time
o Garnishment
o Employment Taxes/Social Security

ü
ü

ü

ü
ü
ü
ü
ü
ü

Professional Development
o Career Development
o Tuition Support
Absences
o Illness Reporting to Management
o Sick Time
o Leaves of Absence (Paid/Unpaid)
o Funeral Time
o Vacation
o Jury Duty
Employee Evaluation
o Evaluation Process
o Salary Increase
o Promotion or Reclassification
o Fitness for Duty
Termination of Employment
o Unemployment Compensation
Employee Grievances
Discrimination or Harassment
o Mediation
Conflict of Interest
Employment Records
Travel Pay
o Per Diem
o Allowable Costs/Limits

Figure 1. List of documented employment policies and procedures.

Competence, training, and awareness. Mandatory training programs will be
conducted on an initial as well as an annual basis. Training documentation will be
maintained for all administrative and laboratory personnel. Staff members must satisfactorily
complete initial training prior to performing work with specific instruments or methods.
Annual competence assessments will be performed using various methods including but not
limited to direct observation, review of records, or an evaluation of problem-solving skills.
Staff must demonstrate appropriate knowledge of relevant policies and procedures. Training
records will include the date of the training, the training subject, materials, methods of
49

DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008)
review and subsequent outcomes as well as the signatures of trainer and participating staff. If
there is evidence of unsatisfactory performance, retraining and re-evaluation will be
mandated with documentation of results. A plan of action may also be implemented. The
operations manager will conduct laboratory-specific and administrative training.
Occupational Safety and Health Administration (OSHA) as well as law enforcement
personnel will conduct in-service training, consultation, and assistance as requested and
required.
Staff evaluation and merit program. Employee supervisors will conduct
performance evaluations for all staff members on an annual basis, or more frequently if
required. The evaluation process will be an opportunity for a supervisor and staff member to
review progress, accomplishments, and the staff member’s current job description; to discuss
issues that may be preventing progress; to work together to identify short- and long-term
career goals; to identify staff development opportunities; and to encourage open and
productive dialogue.
Competency evaluations specific to operational activities will also be performed
annually. Evaluators will generate a subsequent summary of qualifications form to reflect
the results of the evaluation. Both documents will be maintained in the personnel files.
Continuing education. Continuing education will be an important component in not
only promoting staff development but also improving biorepository services, quality control,
quality assurance, and quality improvement practices. Continuing education will be fully
supported, encouraged, and facilitated through participation in research seminars,
conferences, training and certification programs, management initiatives, participation in
literature reviews, research activities, and presentations at staff meetings. Staff presentations,
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for the purposes of promoting cross-training or implementing new projects, will be strongly
encouraged. The director or operations manager will be available to mentor staff in
preparing for such presentations. Academic study and certification will be encouraged. For
instance, staff members might attend a specific training seminar on pertinent regulations for
clinical research, such as those found in the Code of Federal Regulations, the Federal
Registrar, or training with respect to evidence-based practices. Continuing education will be
documented and these records will be made available for review.
Staff input. The biorepository will strongly encourage staff input. The organization
will therefore provide a formal mechanism for employee concerns, suggestions, or
complaints with respect to laboratory safety, quality of services, research misconduct, or
other procedural concerns.
The success of any organization depends upon TEAMWORK: Together, Everyone
Achieves More. At the biorepository, steps for creating and maintaining a productive team
will require fostering a collegial work environment where no questions or ideas are
considered silly or frivolous. Every staff member will be treated in a courteous, respectful
manner. Furthermore, the biorepository will strictly prohibit any harassment or punitive
action against any staff member for expressing concerns, suggestions, or complaints of any
kind.
Infrastructure
ISO 9001:2008 requires that organizations “determine, provide and maintain the
infrastructure needed to achieve conformity to product requirements” (p. 6). Such
infrastructure may include physical buildings, equipment, or support services as needed.
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Facility infrastructure and maintenance. The director will evaluate the facility and
infrastructure on a routine basis through the director’s assessment of facility report. A copy
of this report will be available to inspectors for review. The director or operations manager
will continually monitor biorepository resources to ensure a clean, safe working environment
as well as adequate facilities and infrastructure in order to meet organizational objectives and
customer requirements.
Once established, the biorepository will maintain posted and electronic copies of the
most current biorepository floor plan. This schematic diagram will include equipment
identification and corresponding electrical information such as panel locations and circuit
identification. It will serve as a valuable tool for strategic planning purposes, for
constructing workflow diagrams, for preparing for preventive maintenance or upgrades, and
as a quick reference in case of unanticipated difficulties.
The biorepository will contract a reputable company, with appropriate licensure and
insurance, to provide general maintenance of the facility and infrastructure. This company
will implement a procedure for placing work order requests and tracking their resolution.
Licensed electricians will provide generator maintenance and load testing per approved
procedures. The operations manager will ensure these activities are performed on a routine
basis through the use of a checklist and will escalate requests if these procedural
requirements are not met in a timely fashion. Climate control, temperature, and humidity
will be controlled by a Heating, Ventilation, Air Conditioning (HVAC) system that is
properly serviced, functioning and has a documented maintenance log. The work
environment will be clean and well-maintained at all times. A list of facility requirements,
including necessary backup and monitoring systems is available in Figure 2 (p. 54).
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ü
ü
ü
ü
ü
ü
ü
ü
ü
ü
ü
ü

Size, including square footage necessary to
expand as business grows
Separate office and freezer/lab space
In rooms larger than 1000 square feet, two
exit access doors leading directly to exit route
Hard flooring in labs/freezer rooms for ease
of moving equipment
Dock door for equipment
Room to pour concrete pad close to the
building for LN2 tank
Ability to pipe in Liquid Nitrogen with a
manual control valve
Temperature control, Humidity control
(ideally)
Telecommunication lines & IT ports
Electrical outlets (labeled) and easily
accessible electrical panels
Security system
Biological safety cabinet

ü
ü
ü
ü
ü
ü
ü
ü
ü
ü
ü

Freezer monitoring system
Oxygen monitoring system / oxygen sensors
for LN2
Gated generator (preferably natural gas)
directly connected for two -80 degree C
mechanical freezers and one refrigerator
Electrical hook up for a portable generator on
a trailer, secondary backup
Heating, Ventilation, and Air Condition
(HVAC) to ensure proper climate control &
exhaust system
Emergency lighting
Adequate water supply
Eye wash stations & emergency showers
Separate sink for biologicals
Floor drain (not required, but preferred)
Waste disposal, including Stericycle for
biohazards and a local reputable service for
trash

Figure 2. Facility requirements, including security, electrical backups, and monitoring systems.

Equipment selection, qualification, maintenance, and replacement. Laboratory
equipment will be selected based on the ability to perform specific tasks as well as to meet
the following performance requirements: precision, accuracy, sensitivity, specificity,
recovery, efficiency, reliability, method comparison, and cost accounting principles.
Management will also seek out industry references or recommendations from experienced
colleagues in similar organizations prior to purchase or leasing of equipment.
Laboratory equipment will be installed, operated, and maintained according to
manufacturer’s requirements and guidelines. Equipment will be validated prior to
implementation to ensure it adequately meets functional requirements. Validation
documentation will be subject to document control and will be readily available to all
personnel and inspectors. In addition, a log of all laboratory equipment will be maintained.
This log will include the model number, serial number, assigned equipment identification
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number, electrical requirements, and the corresponding electrical outlet and circuit panel
identified for each piece of equipment.
Daily, weekly, and monthly maintenance procedures will be performed and
documented as needed. Calibration procedures will be performed at recommended intervals.
These procedures may be performed more frequently when reagent lots change, for example,
or when service has been performed. Reference manuals will be located in close proximity
to equipment or instrumentation so staff members have readily available access to the
information. These reference manuals will be reviewed annually to ensure procedures
accurately reflect manufacturer’s requirements and guidelines with respect to operation and
maintenance. Documentation of these reviews will be maintained in the document control
software program. Appropriately trained technicians or field service engineers will perform
and document routine service and preventive maintenance certifications as appropriate.
Technical bulletins and service reports will be promptly reviewed and stored near the
equipment or instrumentation. Service contracts will be maintained and documented.
Obsolescence and subsequent replacement of equipment will be planned and incorporated
into the biorepository budget and supported through the cost of its services.
Equipment and freezer keys will be organized, labeled, and secured in a key lockbox
located in a central location. The key lockbox will contain a list of equipment and freezer
identification numbers along with the corresponding key. Keys will be controlled by
management and will be made accessible to appropriate staff members.
Property control and disposition. The operations manager or other designated staff
member will be responsible for tracking, tagging, and inventory control of all capital
equipment with a dollar value of $200 USD or more. Equipment inventories will be
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reviewed and maintained on an annual basis. Any academic equipment (e.g., National
Institute of Health or investigator-owned freezers) that may be stored at the biorepository
will be valued by government agencies according to the Office of Management and Budget
(OMB) Circular A21: Cost Principles for Educational Institutions according to 2 CFR Part
220.
The operations manager will also be responsible for the final disposition of property
designated as surplus through appropriate recycling, selling, or disposal mechanisms. A
declaration of surplus form will be utilized to process and track final disposition of
equipment.
Procurement. The operations manager will provide support and training on policies
and procedures to ensure approved buying methods and payment processes are followed.
These procedures will ensure that the biorepository selects vendors and acquires quality
goods and services that conform to product requirements at competitive pricing. Products
will be inspected upon receipt. Packing slips will be signed and dated indicating the
appropriate quantity of supplies received. Product specification sheets will be maintained.
The terms of service contracts will be negotiated based on current market rates and
thoroughly reviewed prior to approval.
Informatics. As a state-of-the-science biorepository, all data maintained within the
organization should be protected with a carefully selected information technology (IT)
system. This system must not only function properly, but it must also be maintained and
secured according to rigorous procedures. Although a number of biobanking software
products currently appear in the market, few meet all requirements needed by the current
proposed biorepository model.
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Dash et al. (2012) briefly reported on several examples of biobanking software
products. Regardless of the needs of a biorepository, Mayol, Woo, and Keck (2010) strongly
cautioned biorepositories to conduct site visits to current users of the software prior to
purchase. These site visits would allow potential users to gain insight and perspectives into
the software’s advantages and disadvantages with respect to the software itself, its technical
support, and its level of customization.
LabVantage. For purposes of the current study, the proposed biorepository has
already selected the biobanking information management system, LabVantage, as its primary
database. LabVantage was selected through a process of identifying functional requirements
and negotiating with the vendor.
LabVantage supports all necessary data and tracking activities required by the
biorepository. These valuable functions include:
•

Tracking biospecimens through the collection, processing, storage and
distribution life cycle.

•

Providing the means and mechanisms to manufacture specimen collection kits.

•

Recording shipment and sample data (see “Figure 3. List of data fields in
LabVantage for tracking purposes,” page 127).

•

Linking samples with derivatives and aliquots.

•

Maintaining a robust inventory of biospecimen freezer locations and distribution
records.

•

Recording freeze/ thaw cycles.

•

Recording temperature deviations associated with specific biospecimens.
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•

Allowing for recording sample observations that may affect biospecimen quality,
integrity, and selection.

•

Recording overall sample volume, including minimum vial and volume warnings
before quantities fall below collection specified quantities.

•

Producing storage capacity reports.

•

Supporting configuration of temperature monitoring services. (N.B.: I have
limited experience with LabVantage. Temperature monitoring records were
supported through another mechanism, not the BIMS/LIMS system maintained by
my previous biorepository organization.)

When purchased, the full-scale model of LabVantage has the capability to annotate
biospecimens' clinical and laboratory data if required in future. The biorepository also
preferred LabVantage’s training and potential for customization of the program for the
biorepository and that of its stakeholders.
LabVantage will be supported technologically as detailed in the
LabVantage/Biorepository Support Plan and IT policies and procedures detailed in the
biorepository operations manual. These policies and procedures will be approved and
routinely reviewed by the biorepository director, operations manager and IT staff. Once
LabVantage is operational, its maintenance of the biospecimen inventory will be validated
and subject to regular audits. IT and laboratory staff will validate the accuracy of data
transmitted to LabVantage prior to implementation to ensure data integrity. Audits of data
integrity will be conducted every year by IT according to established procedures.
Other biorepository software. All software programs (including custom programs)
and hardware used in the biorepository must be tested for proper functioning when installed
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and modified. Installation or modification of authorized software is controlled. Software
programs are tested for proper functioning when installed or modified and an audit log is
utilized. In addition, documentation for all custom programs must include the purpose of the
custom program, how it functions, and how it interacts with other programs trouble-shooting
and system modifications.
System security. Computer access codes will be defined, maintained, and secured to
prevent unauthorized access. Computers will be installed with timeout programs and lockout mechanisms. Installation or modification of authorized software will be controlled
through IT administrators. Policies will define which personnel can enter, access, or alter
data or programs. A written policy will likewise define all requirements for data
confidentiality and accuracy. Software programs will be tested for proper functioning when
installed or modified and an audit log will be utilized. Systems will be routinely tested to
identify and correct vulnerabilities.
Data integrity and auditing. Although LabVantage and other software programs
have been proven to be reliable products, all inventory and data must be validated and subject
to regular quality assurance audits to ensure data integrity. Software issues will be tracked
for identification and correction. Data will be routinely backed up and tested periodically for
accuracy. Interface shutdown and recovery procedures will include verifying the integrity of
the system after any necessary restoration of backup data.
Additionally, an audit trail should be established to identify all individuals who enter
or modify any data at the time of entry, and all data must be archived and accessible in a
timely manner. Similarly, an adequate tracking system will identify and report any software
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issues; an audit log will reflect all corrections made and identify all persons adding or
modifying software. The same will be true for hardware.
Finally, systems should be routinely tested to identify and correct vulnerabilities
particularly as it relates to network security. An independent service will be contracted or
utilized on a monthly basis and should provide a formal reports with recommendations for
improvement wherever applicable.
Personnel training. Approved procedures and work instructions for all biorepository
systems will be established prior to personnel training. Once these procedures have been
developed, personnel will undergo initial instruction and then future training for any
modifications or installation of software. Training records will be maintained for all
personnel.
Emergency data retrieval. A written plan should outline procedures for data
retrieval and preservation in the event of unexpected circumstances. These procedures
should ensure that both data and equipment are protected and data integrity maintained. Any
systems used to back up programs and data should to be tested periodically for effectiveness,
and backups of all files should be stored off site. See “Specific Business Continuity plans of
the proposed Biorepository model” (p. 33) for information regarding software downtime
procedures.
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Chapter 7: Resource Management-Work Environment
ISO 9001:2008 defines work environment as relating “to those conditions under
which work is performed including physical, environment and other factors (such as noise,
temperature, humidity, lighting or weather)” (p. 6). It is the responsibility of any
biorepository to manage the work environment necessary to maintain consistency across all
quality objectives, policies, and standards. The proposed biorepository model places high
priority on the work environment for its personnel.
Specific Safety Measures
Any biorepository should be dedicated to a safe working environment for its staff.
Therefore, safety procedures must begin locally within the biorepository itself. The
operations manager will be responsible for training in safety practices, policies, and
procedures. To ensure these trainings have been effective, the operations manager will also
routinely conduct self-inspections of the biorepository utilizing a self-inspection checklist,
modeled after the University of Michigan OSEH Self-inspection Checklist (University of
Michigan, n.d.). An appointed safety committee will also review all procedures annually.
In case of emergency, the operations manager or an appointed designee will be on
call at all times, including after hours and overnight. Emergency contact information as well
as a list of staff contact information will be maintained and posted throughout the facility.
The local police department, a full service law enforcement agency, and fire department will
be available around the clock for emergency response, consultation and assistance, and thus
their contact information should be posted throughout the facility.
Individual staff must also be held accountable for proper safety. Safety training for
staff will include first aid, cardiopulmonary resuscitation (CPR), fire safety, fire extinguisher
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training, fire drills, severe weather, evacuation, biological spill response, chemical spill
response, freezer room safety, and evacuation.
Finally, the biorepository will also refer to external individuals and agencies when
appropriate to ensure the safety of its personnel. The Occupational Safety and Health Act of
1970 established guidelines under which OSHA personnel strive “to assure safe and healthful
working conditions for working men and women; by authorizing enforcement of the
standards developed under the Act; by assisting and encouraging the States in their efforts to
assure safe and healthful working conditions; by providing for research, information,
education and training in the field of occupational safety and health” (para. 1). Therefore,
OSHA personnel will perform inspections of the biorepository annually.
Biorepository staff may also contact OSHA directly for assistance. The OSHA can
provide information and safety publications or answer specific questions as appropriate. They
can also provide free workplace consultations to small employers to help identify and correct
hazards and improve injury and illness prevention programs. They will also assist with
compliance, voluntary protection programs, strategic partnerships, alliances, training, and
education. Biorepository staff may also contact OSHA to file a confidential complaint.
Contact information will remain available on the OSHA website (www.osha.gov).
I have specifically modeled the proposed biorepository based upon Michigan specific
regulations. Potential biorepository founders should research state and local regulations as
appropriate.
Exterior and interior signage. Door signage will include identification of the
proposed biorepository as a BSL-2 designated facility. Emergency contact information will
be posted where appropriate. Signs identifying hazards in the biorepository, such as
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biohazard signs, will be placed where appropriate. Signs banning food or drink will be posted
in appropriate areas.
Inside the biorepository, signs with the following safety information will be posted:
•

Emergency contact information.

•

The evacuation plan diagram, which will show fire alarm pull stations, fire
extinguishers, and exits.

•

The Michigan Safety and Health Protection on the Job Document by the Michigan
Occupational Safety and Health Administration (MIOSHA). This document
details employer requirements, complaints, citations, employee requirements,
inspections, investigations, voluntary activity, and compliance assistance as well
as MIOSHA contact information.

•

The location of Safety Data Sheets (SDSs).

•

New or revised Safety Data Sheets, including the receipt date, posting date, and
location of the new or revised SDS.

•

Universal Precautions.

•

Biohazards.

•

Chemical spill kit instructions.

•

Biohazard spill instructions.

Hazard communication program. A written hazard communication program
ensures a safe work environment by informing and protecting non-research personnel,
outside contractors, and maintenance providers from chemicals used in their work and
chemicals present in the work environment. The program will specify all appropriate
procedures and ensure compliance with the Hazard Communication Standard, 29 CFR
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1910.1200. This amended federal regulation was adopted by reference in December of 2012
in the Michigan Occupational Safety and Health Act 154, commonly referred to as
“Michigan’s Right to Know Law.” It includes the Construction Safety Standard Part 42
Hazard Communication, the General Industry Standard Part 92 Hazard Communication, and
finally the Occupational Health Standard Part 430 Hazard Communication. Based upon the
requirements set forth in these laws, a hazard communication program for the biorepository
will include the following information:
•

Documentation of the hazard communication program annual review.

•

The designated roles and responsibilities of the director, operations manager,
staff, and outside contractors or maintenance providers.

•

A current list of hazardous chemicals present in the biorepository (specifics
regarding the content and maintenance of the list will be discussed in the
“Chemical Hygiene Plan”).

•

The proper identification, through labels (including identity of the chemical,
pictograms, etc.) and hazard warnings, of the hazardous chemicals present in the
biorepository.

•

The availability of Safety Data Sheets for every hazardous chemical and their
respective locations as specified on the MIOSHA SDS Location Poster.
Notification of new or revised SDSs, using the MIOSHA New or Revised SDS
Poster, will be made readily available and posted for five days after receipt of
hazardous chemical and present for a minimum of ten days. As previously noted,
Safety Data Sheets are required to be maintained for 30 years.
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•

Procedures for fire safety and evacuation, freezer room safety and oxygen
monitoring (if work is performed in that area), the proper handling of chemical
hazards, chemical spill and response, and hazardous waste disposal.

•

The location of the first aid kit, chemical spill kit, fire alarm pull stations, fire
extinguishers, and fire blankets.

•

Training in safe work practices, emergency procedures, and required PPE.

When preparing specifications for contracted work or hiring contractors,
communications will include a complete list of hazardous chemicals present in the
workplace; corresponding Safety Data Sheets; and necessary training, emergency procedures,
and required PPE to the contractor. In turn the contractor must provide a list of hazardous
chemicals they will utilize and the corresponding SDSs. All pipes and piping containing
hazardous substances must be appropriately labeled to identify materials that may be released
in the event of a leak or rupture (e.g., natural gas or LN2).
Universal Precautions. Universal Precautions are a means of infection control
required to prevent employee contact with blood or other potentially infectious material
(OPIM). All blood and OPIM must be considered potentially infectious and capable of
transmitting bloodborne pathogens regardless of the source of the material. Universal
Precautions will be required as part of the Bloodborne Pathogens Standard, specifically in 29
CFR 1910.1030(d)(1).
Engineering controls. Engineering controls may be defined as facility planning and
design as well as the appropriate selection and utilization of equipment to isolate, remove, or
reduce the hazard and establish barriers from the hazard. Examples of engineering controls
include chemical fume hoods (see page 84) and biological safety cabinets (see page 77).
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Administrative and work place controls. Administrative or work place controls
may be defined as safety policies, training and supervision to minimize exposure to hazards.
These controls may include procedures for the safe handling of hazards and maintaining a
safe laboratory environment. Examples of administrative and work place controls include
implementing chemical hygiene plans (page 83) and exposure control plans (page 89),
modifying work schedules and tasks, or rotating staff assignments in order to reduce the
frequency, duration, or intensity of exposure (Occupational Safety and Health
Administration, 2011). Refer to section titled “Administrative controls.” (page 85) for more
information.
Personal protective equipment (PPE). Personal protective equipment (PPE) will be
utilized in order to protect employees from exposure through physical contact, skin
absorption, inhalation, or ingestion of hazards in the workplace. Examples of PPE will
include lab coats, non-latex gloves, waterproof thermal gloves, safety glasses, and full-face
shields in order to protect staff’s mucous membranes from potential splashes when handling
hazardous material. PPE is selected based upon the requirements of the specific hazard,
supplied by the organization, and utilized only after proper instruction and training
appropriate to the assigned task. PPE must properly fit the staff member who will utilize it.
Whenever specific PPE is required for a particular task, management must ensure that its
proper utilization, limitation, and care and maintenance are thoroughly explained to the
personnel who will be performing the task (Occupational Safety and Health Administration,
2011).
Regulations pertaining to PPE include the following:
•

The PPE Standard, 29 CFR 1910.132.
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•

The Eye and Face Protection Standard, 29 CFR 1910.133.

•

The Hand Protection Standard, 29 CFR 1910.138.

•

Non-latex gloves are utilized to protect those with latex (derived from plants)
allergies or sensitivity according to 29 CFR 1910.1030 (c)(3)(iii).

•

Gloves when handling blood or working in contaminated areas: 29 CFR
1910.1030(d)(3)(ix).

First aid kit. A basic first aid kit must include the following items: bandages, tape,
Band-Aids, hydrocortisone cream, pain relievers, and the like. First aid and cardiopulmonary
resuscitation (CPR) training shall be provided to all personnel as part of laboratory safety to
help ensure a safe workplace.
Emergency shower or eyewash stations. Emergency showers and eyewash stations
are designed to be located in close proximity to areas where hazardous chemicals are present
and utilized with readily apparent signage posted for easy identification. Such stations
installed at the biorepository will be routinely maintained and tested on a weekly basis with
all results documented. Staff must be provided with an unobstructed path to these areas at all
times. Eyewash stations must be capable of delivering ample amounts of tepid water for 15
minutes with water flow dispensed to both eyes simultaneously. Once activated, employees
should be able to operate these stations without the use of their hands. Covers will be
utilized to protect eyewash stations from airborne contaminants. Plumbed eyewash stations
will be activated weekly and protected from unauthorized shut off. Self-contained units will
be visually examined on a weekly basis.
Workplace injuries or accidents. The Michigan Occupational Safety and Health
Administration (MIOSHA) works with both employers and employees to prevent workplace
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injuries, illnesses, and fatalities. MIOSHA establishes and enforces occupational safety and
health standards, provides extensive safety and health education and training, develops
innovative procedures and programs to prevent workplace hazards, and mandates the
reporting and recording of work-related incidents (Department of Licensing and Regulatory
Affairs (LARA), 2015)
Should a workplace injury or illness occur, staff and management may quickly
reference pre-established procedures for the appropriate actions. If an emergency response is
necessary, staff will call 911 or report to the local emergency room for medical treatment.
After affected staff have received appropriate medical treatment, the operations manager will
review the incident with the staff member, discuss current procedures or procedural changes
that may be necessary, and summarize the follow up steps taken to prevent the incident from
recurring. Reports will be filed in the Employee Accident/Illness notebook. Copies of these
reports will be filed in the staff member’s personnel file. In addition, workplace injuries and
illnesses will be routinely tracked and monitored in order to raise awareness regarding where
workplace hazards may be occurring and what corrective action might be taken.
Serious injuries or illnesses at the biorepository will be reported according to
MIOSHA requirements. New federal regulations were implemented in January of 2015 (79
Fed. Reg. 181, September 18, 2014). All employers, regardless of size or industry
classification, are now required to file a detailed report to OSHA within eight hours of fatal
workplace accidents. Severe injuries that do not result in death but require hospitalization,
such as amputations or loss of an eye, must be reported within 24 hours. Previously the
regulations required such reports only if either a single worker was killed or three or more
workers were hospitalized as a result of a workplace accident. The new federal regulations

67

DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008)
maintain the current exemption for any employer with 10 or fewer workers from the
requirement to maintain The 300 Logs of Worker Injuries and Illnesses. The State of
Michigan, managing its own OSHA program, intends to adopt these standards within six
months (Department of Licensing and Regulatory Affairs (LARA), 2015).
Security. Perimeter and access security will ensure the safety and security of
personnel, study records, and consistent storage conditions (temperature and physical
location). This security will also maintain the custody of clinical research samples, as those
that have been entrusted to our care will likely be irreplaceable.
The biorepository building shall remain locked after hours and shall employ a reliable
security system with around-the-clock monitoring. This system will include security, fire
detection and prevention, and a temperature monitoring system (detailed thoroughly in
Chapter 9). In addition, a locked gate will protect the generator and external liquid nitrogen
tanks. If the biorepository is housed in an independent building, the operations manager may
consider installing a locked gate. The biorepository may also install security cameras to
monitor external and internal activities.
The biorepository will be restricted to authorized individuals only. Staff members will
be required to wear identification badges at all times. Strict enforcement of a visitor’s sign-in
log will be required. The operations manager will review this log on a routine basis. Any
visitor including inspectors, investigators, project managers, study coordinators, and project
staff; delivery personnel from Federal Express, UPS, as well as all other carriers; and sales
representatives, field service engineers, and vendors will be required to sign their name, date,
and time when entering and exiting the biorepository. Visitors will be issued a temporary
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identification badge and will be escorted by authorized personnel at all times while in the
facility.
To prevent visitors or other non-laboratory personnel from entering the lab without
supervision, the last member of personnel in the room will be required to close and lock the
door. Freezers will be required to remain locked at all times. The only exceptions are to be
when samples are being pulled from or placed into the freezers. Freezers shall be checked at
the end of each day to ensure they are locked and the keys are stored in the designated lockbox.
All sensitive documents, such as personnel files and study records, will be kept under
lock and key.
Good Practice Day. The biorepository shall designate one day each month as “Good
Practice Day” for scientific or technical training and education of staff. All training and
educational activities will be documented. Training records will reflect the results of Good
Practice Day, and competency assessments may be performed, if applicable.
Fire safety. The biorepository will have an automatic fire detection system,
consisting of smoke alarms and fire alarm stations wired to the security system, and a
sprinkler system as detailed in the fire safety plan. Exits shall remain unobstructed at all
times. Large rooms, defined as greater than 1,000 square feet, will require two separate exits,
one of which must directly open to an exit route.
Fire inspectors from the local fire department or the State of Michigan Bureau of Fire
Safety Services will routinely inspect the facility for fire and life safety, occupant capacity,
and egress evaluations. They will be responsible for enforcing the Fire Prevention Code, Act
207 of 1941.
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All personnel must participate in fire safety training and a fire drill at least once a
year. Fire safety training will include discussion of the RACE acronym (instructions in the
event of a fire) and the PASS acronym (instructions to safely utilize a fire extinguisher) as
well as a review of the evacuation plan.
RACE. The RACE acronym identifies the primary steps employees should take in
the event of a fire:
1. Rescue or remove all individuals.
2. Activate the alarm.
3. Confine the fire by closing doors.
4. Extinguish the fire, if possible to do so safely, and evacuate the building.
When applying these steps, safety must be the first priority. The most important step should
be to safely evacuate the building and protect the lives of the individuals within it.
PASS. The PASS acronym identifies the steps of safely utilizing a fire extinguisher.
1. Pull the safety pin.
2. Aim the nozzle at the base of fire.
3. Squeeze the handle.
4. Sweep or move the extinguisher from one side of the fire to the other side.
See “Evacuation plan” (page 72) for instructions on assisting others in the event of a
fire or other emergency situation.
Fire safety training will also include instruction on proper procedures in the event that
an individual’s clothing catches on fire, such as how to apply “stop, drop, and roll”; the
proper use of a fire blanket; the use of emergency showers if appropriate; and the avoidance
of chemicals or electricity. For instance, if an affected individual panics, a bystander should
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stop and smother the individual with a fire blanket as quickly as possible. Additionally,
trainees will be introduced to the different classes of fires in order to determine the best
methods for extinguishing them. These classes of fire include:
•

CLASS A: Combustibles that produce “Ash.”

•

CLASS B: Flammable liquids and gases.

•

CLASS C: Electrical.

•

CLASS D: Oxidizing metals.

Staff members must participate in fire extinguisher training. Under close supervision
from a trained firefighter or fire safety expert, staff will practice using a fire extinguisher to
ensure they can operate the device in case of an emergency. They will practice using
extinguishers identical to those available in the biorepository (specifically, ABC
Extinguishers, pressurized dry chemical and carbon dioxide extinguishers that can extinguish
CLASS A, B, and C fires).
Additional information regarding fire extinguishers (placement, use, maintenance,
and testing) may be acquired by accessing the Portable Fire Extinguishers Standard, 29 CFR
1910.157. Fire extinguishers will be checked annually, and all fire safety training will be
documented.
As part of the annual competency evaluation, staff must be able to describe the
location of fire extinguishers, fire blanket(s), and fire alarm pulls. They must also be able to
identify the designated meeting location inside the building in the event of severe weather as
well as the pre-arranged meeting place outside of the building in case evacuation is
necessary. (This exterior meeting place will be located a sufficient distance from the
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building to ensure personnel are not in harm’s way and do not impede emergency
responders.)
Evacuation plan. A comprehensive evacuation plan will provide the necessary
procedures and tools for orderly and efficient evacuation of the biorepository facility in the
event of fire emergencies, severe weather, and disruptive or potentially dangerous situations,
e.g., a hazardous materials release. In addition to instructions on how to safely exit affected
premises, the evacuation plan will include procedures for other emergency situations, such as
the immediate treatment of an individual overcome by toxic fumes. In the event of a liquid
nitrogen spill from a bulk source, as another example, the evacuation plan will detail a
specific cleanup plan.
The evacuation plan will include designated roles and responsibilities; instructions for
what to do in an evacuation; posted diagrams showing the location of exits and evacuation
routes, fire alarm pull stations, and fire extinguishers; and a designated meeting place. Once
at the designated location, a head count will be performed to ensure all personnel and visitors
have safely evacuated the facility. Staff shall obey law enforcement direction and re-enter the
building or area only when directed by authorities.
Furthermore, the evacuation plan includes procedures for assisting staff and visitors
who may require additional assistance in the event of emergency evacuation. The operations
manager will be responsible for assigning several staff members who are committed,
responsible, adequately trained, and physically able to provide assistance to individuals who
may require it during an evacuation. The operations manager will document those
responsible for providing such assistance in the evacuation plan. In the event the assigned
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“buddies” are not available, the operations manager or other designated person in authority
will serve as a backup.
Finally, management must maintain emergency lighting, which is required in the
event of power outage or for safe evacuation of the premises.
Freezer Room Safety and Oxygen Monitoring System
Freezer rooms, if not properly maintained, can create highly dangerous situations for
personnel, particularly should oxygen levels drop below established parameters. Therefore,
the proposed biorepository will employ an oxygen monitoring system in any designated
freezer room. Such systems will alert personnel to evacuate if the oxygen level in the room is
insufficient. This system will consist of oxygen sensors, a controller, horns, and strobe
lights. The oxygen sensors will monitor the room’s air for oxygen content and transmit the
values to the controller located outside the freezer room door. The controller will
continuously monitor the sensors and display their values on the controller display to the left
or right of the freezer room door. Should any of the sensor values fall below 19.5% oxygen,
the controller will activate the horns and the strobe lights, send an alarm, and automatically
shut off the liquid nitrogen to the freezers.
In the event that the oxygen monitoring system is activated and horns sound or strobe
lights turn on, staff must evacuate the freezer room and notify the operations manager or
other designee immediately. Staff must not re-enter the freezer room to investigate the
situation under any circumstances. Personnel may quickly look through the window to
ensure no other personnel are trapped in the freezer room. If staff are in the freezer room and
unable to exit, staff must immediately call 911 for assistance. Trained responders will
investigate the situation and proceed accordingly. The audible alarm may be silenced at the
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controller, but the strobe lights will continue to flash until the controller has been manually
reset. The controller will not accept a reset until the oxygen level in the room rises above
19.8% and emergency personnel have determined that the situation has been adequately
resolved.
The freezer room will also contain an emergency liquid nitrogen manual stop button
to stop the flow of liquid nitrogen through the isolation valve from the external LN2 tanks to
the freezers. If the freezers sustain an LN2 leak, staff must immediately alert personnel
working in the room, press the manual stop button, and exit the freezer room. When the
manual stop button is pressed, an alarm notification will be sent. The push button should be
reset only after the circumstances for the alarm have been clarified and the situation has been
deemed resolved and safe. Trained responders will investigate all such occurrences, and
repairs will either be made immediately or scheduled at the earliest opportunity. The push
button must be pulled back to the normal position to return the flow of LN2 to the freezers
and to turn off the strobe lights.
Laboratory Biosafety Manual
Biosafety must be of primary concern for all individuals working within any
biorepository. Therefore, the proposed model biorepository outlined in this study must
include a laboratory biosafety manual appropriate for a BSL2-level facility.
A Biological Safety Level (BSL) refers to a “combination of safety practices, safety
equipment and facility design used to contain the hazards associated with specific risk groups
of microorganisms and is based on risk assessment” (University of Michigan, 2013, p.8).
BSL-2 agents are considered of moderate risk and are associated primarily with human
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disease. Routes of transmission include mucous membrane exposure, ingestion, and
percutaneous injury (U.S. Dept. of Health and Human Services, 2009).
Because of the similarities between the proposed model and current facilities at the
University of Michigan, the proposed biorepository’s laboratory biosafety manual will be
modeled after the manual currently in use at the University of Michigan (University of
Michigan, 2013). The proposed manual will include the following principle information:
•

The designated roles and responsibilities of the director, operations manager, and
staff.

•

A commitment to safety and safe work practices through rigorous documented
procedures, the use of proper safety equipment, and personnel training.

•

A reference to the biorepository Chemical Hygiene Plan (see p.78).

•

The specified infectious agents approved for use. (N.B.: Select agents require
special registration in order to comply with the Public Health Security and
Bioterrorism Preparedness Response Act of 2002 (Public Law 107-188) and
Select Agents regulations from the Centers for Disease Control 42 CFR 73 and
USDA 9 CFR 121, 7 CFR 331. These requirements are referenced for
informational purposes only; the proposed biorepository model will not work with
these agents.)

•

Pathogen Safety Data Sheets (PSDS) for infectious agents, including information
regarding characteristics, hazard identifications (pathogenicity or toxicity,
epidemiology, host range, infectious dose, mode of transmission, incubation
period, and communicability), dissemination, stability and viability, first aid and
medical information, lab hazards, and exposure controls (including PPE,
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handling, and storage), and regulatory information and references (Public Health
Agency of Canada, 2015).
In addition to these generic items, the biorepository laboratory biosafety manual will
include a number of other specific items as addressed in subsections below.
Potentially infectious agents. All biospecimens that meet established acceptance
criteria will be considered and treated as if potentially infectious. Research samples may be
collected without the benefit of laboratory analyses or screening. Furthermore, the health
status of participants may be incomplete due to self-reporting; therefore, the presence of an
infectious agent or disease state may be unknown. Examples of such infectious agents in a
BSL-2 facility include Human Immunodeficiency Virus (HIV) or the Hepatitis B Virus
(HBV).
Security procedures and access. Security measures were previously addressed in
“Security.” (refer to p. 68). Access to all biorepository facilities and labs will be restricted
when work with potentially infectious agents is in progress as well as in afterhours or when
personnel are not otherwise available.
Signage and labeling requirements. Entrance doors must display caution signs,
biohazard labels (incorporating the Universal Biohazard symbol), the Biological Safety Level
of the lab (i.e. BSL-2), name and contact information of biorepository director and operations
manager in case of emergency, and required procedures for entering and exiting the lab.
Biohazard warning labels must identify containers of infectious materials and will be
necessary for all refrigerators, freezers, centrifuges, and other equipment utilized in
processing and storing biohazard materials.
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Facility requirements. All biorepository facilities must include open benches
impervious to absorption, laboratory chairs that are not made from fabric, sink(s) for
biological material, and an autoclave or other available waste disposal service.
Safety equipment. A Class II Biological Safety Cabinet (BSC) is a partial barrier
system that relies on the laminar flow principle, “unidirectional air moving at fixed velocity
along parallel lines to reduce turbulence resulting in predictable particulate behavior or
movement,” in order to provide containment protecting both staff and the product (U.S. Dept.
of Health and Human Services, 2009, p.293). A HEPA filter, coupled with the laminar air
flow, aids in the “capture and removal of airborne contaminants from the air stream” (U.S.
Dept. of Health and Human Services, 2009, p.293). It protects both staff and work
environment from potentially infectious aerosols generated in the BSC and provides product
protection as well. The biorepository will also utilize other physical devices such as
pipetting aids and sharps containers to contain biological agents and to prevent spills and
splashes or the generation of aerosols.
Biosafety training. All personnel must undergo initial biosafety training and must
also complete follow up training on an annual basis. Training records must include copies of
the training materials, the date of training, and the name and title of the individual conducting
the training.
Other procedures. Other procedures documented in the laboratory biosafety manual
may include:
•

Required personal protective equipment (PPE), including protective lab clothing,
lab coats, non-latex gloves, and face and eye protection. The selection of PPE is
based on the specific biological or chemical hazard and the task at hand.
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•

A copy of “Appendix A: Personnel Sanitation and Safety” (see page 185).

•

Biological safety cabinet use, verification of proper function (such as sufficient
airflow and properly functioning filters), and records of testing.

•

All biospecimen collection and processing procedures, as well as storage
requirements.

Biospecimen receipt, transport, and shipping procedures (see “Retrospective
samples. page 117).
•

Biohazard waste disposal SOP, including documentation that procedures for
disposal are fully compliant with all applicable federal, state, and local
regulations.

•

Proper disposal of non-contaminated and contaminated sharps.

•

Workplace injuries or accident reporting and medical surveillance.

•

Hepatitis B vaccination program for staff, addressed in the Exposure Control Plan
(see page 89).

•

Documentation of annual review of the laboratory biosafety manual, workplace
injuries or accidents, corrective action reports, and inspection reports.

Chemical Hygiene Plan
A chemical hygiene plan will protect staff from exposure to hazardous chemicals
(i.e., chemicals that may cause acute or chronic health effects in exposed individuals);
promote safe work practices, policies and procedures through appropriate training and
controls; and ensure compliance with the Michigan Occupational Safety and Health Act, Part
431, Hazardous Work in Laboratories Standard R 325.70101 and the OSHA Standard 29
CFR Part 1910.1450, Occupational Exposure to Hazardous Chemicals in Laboratories

78

DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008)
(commonly referred to as the “Laboratory Standard”). A chemical hygiene plan (CHP) must
include the following principle information:
•

Location of facility and specific room designation information.

•

Emergency Contact information, including management, staff, OSHA, and
emergency response information. This information must also be posted at key
locations throughout the biorepository.

•

An up-to-date chemical inventory and hazard identification and assessment that
includes the chemical name, quantity, hazard class, carcinogenic potential,
reproductive and acute toxicity, storage location, date of inventory, date removed,
and instructions should accidental contact occur.

•

Safety Data Sheets (SDSs) for all chemicals. SDSs provide the specific physical
and toxicological hazard information for a chemical and include the following:
identification, hazard identification, composition, first aid measures, firefighting
measures, accidental release measures, handling and storage, exposure controls
(PPE), physical and chemical properties, stability and reactivity, and other
toxicological information. Optional SDS information may include ecological
information, disposal considerations, transport information, regulatory
information, and other appropriate information (e.g., date of preparation).

•

Designated roles and responsibilities with respect to the chemical hygiene plan,
including the designation of a chemical hygiene officer (CHO).

The CHO will provide technical expertise in developing and implementing the CHP.
The CHO should not necessarily be the operations manager. Instead, the CHO will help the
operations manager develop precautions and adequate facilities, know current legal
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requirements concerning regulated chemical hazards, and be qualified by training and
experience perform the functions necessary of the position. However, even if the CHO is not
the operations manager, the operations manager must still be responsible for the CHP.
Furthermore, the operations manager must ensure all staff are trained in and adhere to the
CHP, and that required PPE are not only available but utilized.
The operations manager will be responsible for performing self inspections and
facilitating OSHA inspections, ensuring emergency procedures and equipment are in place
and functioning properly, and knowing the current legal requirements concerning regulated
substances. In addition, he or she must ensure the appropriate engineering and administrative
controls, work practices, and established procedures are followed. The Manager must also
ensure that all accidents and potential exposures are immediately reported.
If a breach in any aspect of the CHP is identified, all staff, regardless of level, possess
the authority to stop or suspend work until it is safe to proceed.
Safety Data Sheets (SDSs). The location of Safety Data Sheets will be specified on
the MIOSHA SDS Location Poster. Notification of new or revised Safety Data Sheets must
be readily available and listed on the MIOSHA New or Revised DSD Poster for five days
after receipt of hazardous chemical. Safety Data Sheets are required to be maintained
indefinitely as they provide a historical record of the chemicals in the biorepository.
Chemical procurement, labeling, and storage. Procurement considerations must
include ordering minimum quantities of chemicals so excess chemicals are not present.
Management must also ensure the lab is ready to accept any chemical upon arrival and that
an approved SOP addresses proper handling, storage, and disposal of the chemical in
question. Furthermore, any personnel who receives a chemical shipment must check the
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chemical for an identification label, signs of breakage or leakage, and, in the event of a spill,
flood or fire, evaluate whether special containment may be necessary (University of
Michigan, 2010).
Proper labeling of chemicals includes all information necessary for its proper
handling, storage, use, and disposal. The MIOSHA Hazard Communication Standard is
aligned with the Globally Harmonized System (GHS) of Classification and Labeling of
Chemicals (University of Michigan, 2010). All primary container labels must have the
following information: the product identifier (the common product name or number); the
chemical’s concentration; the primary hazard; the manufacturer or supplier’s name, address
and phone number; hazard statements; signal words and pictograms; and precautionary
statements. If chemical labels are missing, damaged or incomplete, they must be replaced
immediately.
Precautionary statements, hazard statements, signal words, and pictograms. A
precautionary statement is a “phrase that describes recommended measure to be taken to
minimize or prevent adverse effects resulting from exposure to a hazardous chemical or
improper storage or handling of a hazardous chemical” (University of Michigan, 2010, p.
39). Precautionary statements include first aid measures and recommendations to prevent
adverse effects. Examples of precautionary statements may include “avoid breathing fumes,”
“keep away from heat,” or “store in a well-ventilated space.”
A hazard statement is a “statement assigned to a hazard class and category that
describes the nature of the hazard(s) of a chemical, including, where appropriate, the degree
of hazard” (University of Michigan, 2010, p.38). Hazard statements are based on the hazard
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classification and the nature of the chemical hazard. Examples of hazard statements include
“causes skin irritation” or “may cause liver damage.”
A harmonized signal word may be defined as a “single word used to indicate the
relative level of severity of hazard and alert the reader to a potential hazard on the label”
(University of Michigan, 2010, p.38). “Danger” is appropriate for the more severe hazards
and “Warning” is used for less severe hazards. Signal words are not necessarily required;
however, they are useful as they indicate the level of severity of the hazard.
A pictogram is a “symbol plus other graphic elements, such as a border, background,
pattern or color that is intended to convey specific information about the hazards of a
chemical” (University of Michigan, 2010, p. 38). As outlined by the University of Michigan
(2010):
There are eight required standardized pictograms (Health Hazard, Flame,
Exclamation Mark, Gas Cylinder, Corrosion, Exploding Bomb, Flame over Circle,
and Skull and Crossbones) and one optional pictogram (Environment), under the
GHS. Each pictogram consists of a different symbol on a white background within a
red square frame set on a point (i.e., a red diamond). All pictograms are diamond
shaped with a red border and black image. (p. 38)
There are three systems for labeling chemical hazards:
•

The Global Harmonized System utilizes severity rankings for each of the hazard
classifications. Categories range from 1 to 4, with 1 indicating the most severe
and 4 indicating the least severe. (N.B.: This ranking system conflicts with the
National Fire Protection Association System and the Hazardous Material
Information System where the number 4 indicates a severe hazard.)
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•

The National Fire Protection Association (NFPA) system utilizes a hazard
warning diamond and is designed for emergency response personnel. The color
blue signifies health, red signifies flammability, yellow signifies instability or
reactivity, and white signifies unique hazards. The number within the color stands
for least hazardous (0) to most hazardous (4) designation.

•

The Hazardous Material Information System (HMIS) utilizes a box of blue for
health, red for fire, yellow for reactivity, and white for unique hazards.

Other labeling systems. Secondary reagent labels are necessary for chemical
solutions prepared in the lab (e.g., a 10% bleach solution). Biorepositories may choose to
label secondary containers with label alternatives that still meet the requirements for
standards such as NFPA or HMIS. The information must be consistent, however, and no
conflicting hazard warnings or pictograms may be utilized. Mandatory information for
secondary reagent labels includes product identifier and health and physical hazards;
pictograms and graphics are optional. In the proposed biorepository model, a procedural
worksheet will label secondary reagent labels and contains necessary information and quality
assurance check. These QA measures must be performed on a monthly basis and will
determine whether all secondary reagent containers are properly labeled or require corrective
action.
Chemical storage. Chemicals must be stored according to hazard category and
compatibility. Common categories include corrosives, flammable solvents, toxic chemicals,
carcinogens, oxidizers, explosives, and compressed gasses. Less common categories include
pyrophoric, organic peroxides, and water reactive chemicals. All chemical containers must
be closed or capped, stored with compatible chemicals (acids and bases are stored separately,
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for example), and inspected weekly to ensure containers are in good condition. At the
proposed biorepository, sodium hypochlorite (common household bleach) would be the only
corrosive chemical stored. As such, it must be stored in a spill-proof tray and may be stored
in a chemical storage cabinet, if available; a separate cabinet, however, would not be
necessary.
CHP training. CHP training for the proposed biorepository would include lab safety
and bloodborne pathogens, chemical lab safety training, lab specific training, PPE
instruction, centrifuge training, and training on the shipping of dangerous goods and
transportation of hazardous chemicals. The operations manager would be responsible for
maintaining training records, including all handouts, PowerPoint presentations, copies of
policies and procedures (or the name of the policy identified by version number), training
date, name of the instructor, and names of the staff in attendance.
Controls to reduce exposure to hazardous chemicals. Engineering controls may
include a fume hood in order to contain hazardous chemicals, particularly those that are
volatile. Fume hoods are to be maintained according to 29 CFR 1910.1450(e)(3)(iii) and
certified by trained OSHA personnel. Documentation of all such certifications must be kept
on file.
For this proposed biorepository, these specific hazards will not necessary; therefore, a
fume hood is not included in Figure 2. Facility requirements, including security, electrical
backups, and monitoring systems (page 53). However, should additional chemicals be added
at a later date for additional laboratory services, a fume hood may become necessary.
Compressed gas cylinders must be secured in an upright position in order to prevent
them from falling and damaging the regulator or valve. A chain, bracket, or other self-
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standing restraining device must be used to secure the cylinder at all times. The valve cap
must be in place at all times, including during transport and storage, unless the cylinder is
connected for use. Compressed gas cylinders must also be positioned away from
combustible materials and excessive heat.
Chemical spill kit. The proposed biorepository must obtain a current comprehensive
chemical spill kit, if an expiration date is not indicated on the kit, it must be assessed for
viability on a routine basis. Such assessments should be conducted at least every six months.
Management should ensure that instruction sheets are posted for the containment of chemical
spills and the emergency treatment of chemical splashes or injuries at all work stations.
Administrative controls. Administrative controls must include policies and
procedures reducing the quantity of hazardous chemicals, substituting a less hazardous
chemical (whenever possible), or correcting hazards through proper labeling. Examples of
administrative and work place controls include implementing the chemical hygiene plan,
modifying work schedules and tasks, or rotating staff assignments in order to reduce the
frequency, duration or intensity of exposure (Occupational Safety and Health Administration,
2011, p.8).
The Occupational Safety and Health Administration Laboratory Safety Guidance
(2011) outlined the proper measure of exposure by the Permissible Exposure Limit (PEL) :
The chemical-specific concentration in inhaled air that is intended to represent what
the average, healthy worker may be exposed to daily for a lifetime of work without
significant adverse health effects. The employer must ensure that workers’ exposures
to OSHA-regulated substances do not exceed the PEL. (p. 11)
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Permissible Exposure Limits for hazardous chemicals are specified in 29 CFR 1910, subpart
Z.
Additionally, approved standard operating procedures must include chemical
location, special precautions, labeling, chemical spill and response procedures, storage and
transportation requirements, chemical inventory, hazardous waste management, and
procedures for reporting workplace injuries or accidents. Hazardous waste operations and
emergency response regulations may be referenced in 29 CFR 1910.120.
Personal protective equipment (PPE). Required PPE for chemical use will include
a lab coat, safety goggles, a face shield (if there is the potential for splashing), and the
appropriate selection of gloves. (N.B.: Specific chemicals often require a particular glove for
safe handling. SOPs for any given procedure must identify the requisite glove to be used.)
Staff must be trained in the appropriate use of PPE, and PPE must be readily available at all
times.
Additional documentation. Additional documentation in the chemical hygiene plan
may include:
•

OSHA inspection reports.

•

OSHA correspondence and communications.

•

The results of self-inspections.

•

The annual report and review of safety policies, procedures, and work practices.

•

Workplace injury or accident reports, as well as any corrective action reports.

It would be highly beneficial to print the OSHA Standard 29 CFR Part 1910.1450,
Occupational Exposure to Hazardous Chemicals in Laboratories and keep a copy in the
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chemical hygiene notebook for reference purposes. Finally, documentation of annual CHP
review is required.
Principle Chemical Hazards in this Biorepository Model
This specific biorepository model will have two principle hazards: liquid nitrogen
(LN2) and dry ice. Proper training in the use of these hazardous materials must be performed
and documented before staff members will be allowed to work with these hazards and in the
Biorepository. All work with these hazards must be conducted in a well-ventilated room and
staff must always wear the appropriate PPE (see “LN2 hazards” and Dry ice hazards”).
Safety Data Sheets will be available on these and all other potentially hazardous materials.
LN2 hazards. LN2 may cause cryogenic burns or injury and may result in severe
frostbite. LN2 also displaces oxygen (an asphyxiant in high concentrations) and can cause
rapid suffocation. These hazards will be addressed by installing an oxygen monitoring
system in the freezer room (see “Freezer Room Safety and Oxygen Monitoring System”) as
well as requiring staff to wear personal oxygen monitors. All work shall be conducted in
well-ventilated rooms, and special containers (designed and constructed to withstand these
extremely cold temperatures) will be required.
The appropriate PPE for handling LN2 includes a lab coat, safety goggles, full-face
shield, insulated cryogenic gloves, and proper foot attire (i.e., closed-toe shoes to protect
against potential splashing and spilling). Extreme care must be exercised when dispensing
LN2; never over-fill containers and follow manufacturer and lab-specific instructions.
Biospecimens for this facility would be stored primarily in vapor-phase LN2, so a
bulk source of LN2 is necessary for that purpose. Safety and operational training must
include freezer room safety, freezer safety and operation, LN2 training (including required
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PPE), training in evacuation, clean up in the event of an LN2 spill from a bulk source, and
the immediate treatment of an individual overcome by toxic fumes. The cryogenic system
(encompassing the bulk source of LN2) and the delivery system (pipes to individual LN2
freezers, shut off valves, and the filling station) must be properly designed, constructed, and
maintained. Records and results of inspections, maintenance and repairs on the system must
be reviewed and documented.
LN2 hazards exist due to the properties of LN2 itself as well as the pressure of the
cylinder containing it. If LN2 tanks (180L for example) are utilized, they must be secured
(via wall mount or self-standing apparatus) to prevent falling over and damaging the
regulator and the valve. Cylinders can quickly become rockets should the valve break. Wall
mount restraints should be no lower than one-third the distance from the top of the cylinder.
LN2 tanks must be transported in an upright manner utilizing a secured dolly.
Dry ice hazards. Dry ice may cause cryogenic burns or injury such as frostbite.
Dry ice sublimes to carbon dioxide vapor at -78 degrees C, and the vapor may displace
oxygen and cause rapid suffocation. Work must be conducted in a well-ventilated room. The
appropriate PPE includes a lab coat, safety goggles, and insulated cryogenic gloves. Tongs
or a scoop may be used to transfer dry ice into appropriately insulated storage or shipping
containers.
Dry ice is considered a hazardous material; training and specific procedures must be
followed when shipping and receiving shipments of biological materials with dry ice in order
to comply with the U.S. Department of Transportation (DOT) and the International Air
Transport Association (IATA) regulations. Certified shipping containers for Category B,
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Biological Substances must be utilized, and management must require training in
transporting or shipping of dry ice for any personnel member likely to handle it.
Chemical waste. As the proposed model currently exists, chemical waste would not
be generated in this Biorepository. Should that change, chemical waste would be properly
segregated and manifested to ensure proper disposal according to established procedures as
well as federal, state, and local regulations.
Exposure Control Plan
The Occupational Safety and Health Administration (2011) identified two bloodborne
diseases as particular concerns for researchers:
The Centers for Disease Control and Prevention (CDC) notes that although more than
200 different diseases can be transmitted from exposure to blood, the most serious
infections are Hepatitis B virus (HBV), Hepatitis C Virus (HCV) and human
immunodeficiency virus (HIV)… Many factors influence the risk of becoming
infected after a needle stick or cut exposure to HBV, HCV or HIB-contaminated
blood. These factors include the health status of the individual, the volume of the
blood exchanged, the concentration of the virus in the blood, the extent of the cut or
the depth of penetration of the needle stick, etc. (p.17)
In order to minimize employee risk from exposure and infection from bloodborne
pathogens in the biorepository and comply with OSHA Standard 29 CFR 1910.1030,
Occupational Exposure to Bloodborne Pathogens, the Needlestick Safety and Prevention Act
of 2001, and MIOSHA Standard R 325.70001-325.70018, Bloodborne Infectious Diseases,
management will implement an official Exposure Control Plan (ECP). The ECP will be
routinely updated as appropriately as well as reviewed on an annual basis.
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Exposure determination. An exposure determination will identify staff members
who are or may be exposed to blood and other potentially infectious materials by virtue of
their job classification and the specific tasks and procedures they perform on a routine or
infrequent basis. This determination will dictate the requisite training staff members are
required to obtain prior to performing any related task or other potential exposure. However,
the operations manager will train all personnel, regardless of their potential for exposure, in
laboratory safety, Bloodborne Pathogens and Hazard Communication in order to ensure
everyone’s safety in the workplace. This training would be necessary even for those
personnel who work solely in administration.
Risk assessment. A risk assessment will be conducted on proposed research studies
as well as on the risks associated with the type and quality of biospecimens considered for
processing and storage. Biospecimens will be accepted according to established acceptance
criteria; the biorepository will have procedures in place for specimen rejection if appropriate.
Protocol for exposure prevention. Methods of compliance with the exposure
control plan include the following:
•

All personnel must follow Universal Precautions when handling biohazard
material, regardless of the source. Biohazard material includes blood, body
fluids, Other Potentially Infectious Materials (OPIM; e.g., unfixed tissue or
organs or cell or tissue cultures) and reagents, quality control preparations and
pools from all sources. All of these biohazard materials must be considered and
treated as potentially infectious.

•

The Hepatitis B Immunization Program will be mandatory. This program will be
offered to all personnel prior to working in the biorepository (after information
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and training has been made available regarding biological hazards but before
work in the lab commences), and the vaccinations will be provided free of charge,
in accordance with 29 CFR 1910.1030(f)(1)(ii)(A)-(C). The program consists of
a series of three vaccinations; one vaccination at the initial visit, the second one
month later, and the final vaccination six months later. A titer check may also be
performed to check on hepatitis B immunity upon request. Staff may request to
opt out of the hepatitis B vaccine; however, they must sign a waiver that will be
kept on file.
•

All personnel may be subject to policies regarding screening for tuberculosis
(TB). However, if the biorepository is not located in a patient care building and
staff do not have patient contact or work with sputum samples, TB screening may
not be necessary.

•

Management will document procedures for biohazard spill and response that
includes requisite PPE, spill decontamination, and determination of biohazard
exposure.

•

Management will implement a procedure for any workplace injuries or accidents.

•

Management will document a procedure for disposal of biohazard waste,
including contaminated needles and sharps.

•

General housekeeping and waste disposal procedures will include scheduled
laboratory cleaning, the designation of clean or potentially contaminated
equipment or computer surfaces, and the proper decontamination of equipment.

Other engineering controls. A CLASS II Biological Safety Cabinet (BSC) may be
used to further prevent personnel exposure to potentially infectious agents. BSCs protect
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staff and the work environment from potentially infectious biohazard materials that may
result in splashing, spraying, or generating aerosols or droplets. These cabinets contain
biological aerosols but also protect the biospecimens. Any obtained BSC must be certified at
installation, on an annual basis, and at anytime it is relocated according to 29 CFR
1030(e)(2)(iii)(B). An approved SOP will specify how work may be performed in the BSC.
Autoclaves will not be employed in this Biorepository model; a reputable vendor
instead will be selected to provide these services.
Communication to staff. Sources of potential infection and other hazards will be
communicated to staff via the following methods:
•

Pathogen Safety Data Sheets (PSDS) for infectious agents (as developed by the
Canadian Public Health Agency.) PSDSs include information on pathogen
characteristics, hazard identification (including pathogenicity and toxicity,
epidemiology, host range, infectious dose, mode of transmission, incubation
period, and communicability), dissemination, stability and viability, first aid and
medical information, lab hazards, exposure controls (with appropriate uses of
PPE), handling and storage, regulatory information, and references (Public Health
Agency of Canada, 2015). These PSDSs will be available to staff at all times and
will be reviewed as part of the biosafety training program.

•

Lab safety and bloodborne pathogen training. These trainings will cover methods
that prevent or reduce exposure, such as utilization of PPE, Personnel Sanitation
and Safety (see “Appendix A: Personnel Sanitation and Safety,” page 180), and
approved specimen vials and storage containers. Training will also cover PSDS
data, including the risks associated with biohazard material and specific infectious
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agents. Personnel will be subject to initial training and competency assessments
with respect to all procedures and equipment that may involve exposure before
they will be permitted to perform any such tasks.
•

Additional training and procedures, including centrifuge training, usage, clean up,
maintenance, calibration, and verification of centrifuge speeds.

Documentation of compliance. Biorepository records will, by necessity include
documented evidence of compliance with applicable federal, state, and local regulations.
Required documentation regarding the exposure control plan will include the annual review
and approval of the ECP, staff training records, hepatitis B vaccination or declination
records, exposure records, an illness and injury log, and a sharps injury log.
If a staff member sustains an occupational exposure to a biospecimen or biohazard
material, a medical evaluation with a surveillance or monitoring program will be required
according to the procedure for workplace injuries or accidents. A complete review of the
incident with appropriate follow up action, additional training, corrective or preventive action
will be conducted and documented.
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Other Work Environment Considerations
Ergonomics program. An ergonomics program will be essential for the prevention
of musculoskeletal disorders (MSDs) in the workplace. All personnel will be required to
obtain ergonomic training. This training will discuss risk factors, identify physical work
activities or conditions of the job commonly associated with work-related MSDs, and
implement recommendations for eliminating MSD hazards. Documentation of training and
training materials will be maintained and made readily available for review.
In addition to standardized personnel training, an occupational therapist may inspect
the laboratory in order to make recommendations regarding equipment, engineering controls,
and areas for improvement. The operations manager will document and then review these
recommendations for implementation. The manager will also document any specific
equipment that has been evaluated or purchased to prevent MSDs. In addition to these
precautions, staff will be strongly encouraged to find a comfortable position in which to
work, to regularly leave their desks to stretch, to look away from computer screens in order
prevent eye strain, and to make recommendations regarding equipment, engineering controls
and ideas for improvement. The operations manager will review any such recommendations
for possible implementation. For example, ISBER’s Best Practices referenced automatic
pulley mechanisms to aid personnel in removing heavy racks from chest freezers (ISBER,
2011, p.40).
Excessive noise monitoring. To ensure all laboratory personnel are protected
against the effects of excessive and potentially damaging noise exposure, sound levels will be
routinely monitored using a calibrated sound level device, such as a decibel meter, and
recorded. The biorepository will define excessive and potentially damaging noise exposure
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as sound levels that are equal to or exceed a weighted average sound level of 85 decibels in
each working area or room per working shift of eight hours. Should sound levels equal or
exceed that level, the requisite ear protection will be provided to laboratory workers
immediately. Such ear protection will also be made available to laboratory workers upon
request. Regulations regarding hearing protection may be found at 29 CFR 1920.95. When
designing or selecting the biorepository facility, planners should give consideration and
deliberate planning to placing work stations away from loud equipment, e.g., freezers or
laboratory instrumentation, to the extent possible.
Electrical safety. Lab instruments and equipment must be adequately grounded and
checked for current leakage before initial use, after repair or modification, and when a
problem is suspected. These checks must be documented. Grounding configurations may not
be bypassed. Equipment requiring 240 volts will be checked for ground integrity only.
Extension cords will be prohibited. Power cords of portable electrical equipment must be
visually inspected for external defects whenever relocated. The biorepository will also
strongly recommend inspection of power cords on a routine basis for overall wear and tear.
Field service engineers or contracted electricians may be consulted as necessary. The
operations manager may also contact the manufacturers of the lab equipment for additional
information as appropriate. The manager may also reference 29 CFR 1910 Subpart SElectrical for electrical safety.
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Color vision assessment. Specimen collection kit manufacture, sample collection,
processing, and analysis all require proper color vision in order to correctly identify
collection components with their respective sample type. Therefore, staff members must
submit to color vision tests, such as the Ishihara 38 Plates Color Vision Deficiency Test
available on-line (Colblinder, 2014). During this test, staff members will read each plate,
record the information on-line, and submit the final results. Staff must print, sign, date, and
submit these results to the Operations Manager for review. Another such test is available at
http://www.egopont.com/colorvision.php (Egopont, 2013). If these tests detect a potential
color vision deficiency or impairment, personnel must contact a qualified eye care specialist
for further testing. The results of these tests will also be documented. Should testing identify
a deficiency, a staff member’s tasks will be assigned to reflect that member’s ability to
perform the task.
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Chapter 8: Product Realization
According to the standard published in ISO 9001:2008, Quality management systemRequirements (2008), product realization encompasses the following organizational
activities: communicating with the customer and determining their product requirements;
evaluating whether the organization itself possesses the resources, technical expertise, and
management of its processes to accept the proposed work; developing plans and processes in
order to meet customer requirements while abiding by applicable regulatory requirements;
validating and monitoring the requisite processes and equipment to deliver the product; and
then evaluating the final product and providing evidence of compliance and quality with
respect to the realization processes, the product, and the product requirements (ISO
9001:2008, pp.7-12).
In the context of biorepository services, the product is a high-quality, fit-for-purpose
biospecimen or collection of biospecimens, available to the investigator at any time upon
request for the purposes of scientific investigation. Product realization for the biorepository
therefore encompasses research support services starting from initial contact with the
prospective client (i.e., investigator inquiries into biorepository services and the first meeting
to discuss their research study needs) all the way through the life cycle of collected
biospecimen samples to final distribution disposition. These processes and procedures will be
thoroughly addressed in Chapter 9: Processes, Procedures, and QA Strategies with Respect to
Product Realization.
Product realization coupled with management responsibility, resource management,
measurement, analysis, and improvement will provide a process-based quality management
system for this proposed biorepository model.
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Chapter 9: Processes, Procedures, and QA Strategies with Respect to Product
Realization
Appropriate quality assurance (QA) strategies must form the backbone of any
scientific undertaking, including the creation of a biorepository. To this end, potential
directors or operational managers of newly developed biorepositories must consider ways to
strictly manage the quality of all processes and procedures, from the onboarding of new
studies to the final transfer or disposition of samples. The following suggestions represent a
selection of considerations, processes, procedures, and QA strategies for newly created or
currently operational biorepositories.
Regulatory Considerations
Sponsors, investigators, study personnel, and Contract Research Organizations
(CROs; i.e., the proposed biorepository among others) must conduct clinical studies
according to federal, state, and local regulations. Therefore, all policies and procedures of the
proposed biorepository must comply with all such regulations. A number of resources for
biorepositories already address federal regulations and guidelines pertaining to protections
for human subjects participating in research, such as informed consent, confidentiality,
security, institutional review boards, electronic records, and financial disclosure by clinical
investigators and institutions (National Cancer Institute Best Practices for Biospecimen
Resources, U.S. Dept. of Health and Human Services, 2011, and International Society of
Biological and Environmental Repositories Best Practices, 2011 among them).
For the purposes of accepting, on-boarding, and supporting the conduct of clinical
research studies, the following regulations and guidelines must be discussed in order for the
biorepository to fulfill regulatory requirements.
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The International Conference of Harmonization (ICH) E6 Good Clinical
Practice (GCP), and the compilation of federal regulations comprising GCP. Good
Clinical Practices (GCPs) encompass several internationally recognized standards that form
the basis for acceptable conduct of clinical research. They are designed to protect the rights,
safety, and welfare of human trial subjects; to ensure reliability, quality, and scientific
integrity of clinical research data; and to provide standards and guidelines for the conduct of
clinical research. Not only do GCP guidelines reflect the minimum standards necessary for
conducting clinical trials, they also have the full “force of law” in some countries, such as
Japan.
In 1990, the International Conference of Harmonization (ICH) was created to
establish internationally recognized clinical research standards in the following three major
world pharmaceutical markets: the European Union, the United States, and Japan. Six years
later, the ICH Harmonised Tripartite Guideline for GCP was written to provide unified
standards and mutual acceptance of clinical data by regulatory authorities in these countries.
This guideline provides comprehensive information of the GCP procedures, related
responsibilities, and the use of relevant documents in the conduct of clinical trials.
In the U.S., the Food and Drug Administration adopted the ICH GCP Guideline and
published it in the Federal Register and the Code of Federal Regulations (CFR). In the U.S.,
GCP is defined from current U.S. regulations as well as U.S. and global guidelines published
in the CFR, including the ICH GCP Guideline.
The compilation of federal regulations comprising GCP includes but is not limited to
the following regulations:
•

21 CFR Part 11 Electronic Records and Signatures.
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•

21 CFR Part 50 Protection of Human Subjects.

•

21 CFR Part 54 Financial Disclosure.

•

21 CFR Part 56 Institutional Review Boards.

For study sponsors, compliance with GCP improves the acceptance of trial data by
regulatory authorities. It also helps sponsors advance drug development quickly while
maintaining safe, ethical, and scientific standards.
For the investigator, compliance with GCP can increase the probability of successful
trial results, enhance the investigator’s reputation in the scientific community, and may help
reduce the investigator’s risk of legal action by authorities or subjects.
Furthermore, GCP assists subjects in understanding risks and potential benefits of
participation. Participation must be voluntary and the information presented in the consent
form must be clear and complete. A clinician must continue to offer to provide the same
quality of treatment regardless of whether a subject withdraws from the clinical study.
For a biorepository that serves as a Contract Research Organization (CRO), GCP may
be defined as a quality standard for the design, conduct, performance, monitoring, auditing,
recording, analysis (if applicable), and reporting of clinical trial data. Ethical conduct of a
clinical trial implies several assumptions: that the benefits of the study outweigh risks; that
the rights, safety, and well-being of participants are protected; that investigators will maintain
compliance with protocol; that IRB approval is obtained prior to study initiation; that study
personnel are qualified by education, training, and experience to perform necessary work;
that informed consent must be given by subjects on a voluntary basis; that study personnel
will ensure accurate reporting and analysis of data; and that confidentiality will be upheld.
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Compliance with approved policies and procedures will therefore ensure the overall quality
of any clinical study.
For the purposes of on-boarding clinical research studies, investigators will be
responsible for obtaining and maintaining the documentation of each participant’s consent
and all corresponding study records. Sponsors will be responsible for monitoring clinical site
documentation. The proposed biorepository will therefore require all investigators to sign a
statement attesting to the following:
•

Studies will be conducted according to all applicable federal, state, and local
regulations and guidelines, including GCP.

•

Ethical standards related to biospecimen collection and utilization will be upheld.

•

Clinical care will not be compromised in the process of procuring biospecimens.

•

Documentation of participant’s consent and corresponding study records will be
obtained and maintained at the clinical site and subject to inspection by the
sponsor of the research.

In the event that the biorepository chooses to offer laboratory analyses in the future,
ICH E6 GCP Guidelines require certification, accreditation, established quality control or
quality assessment, and other methods to validate and document the competence of a facility
to perform required tests and support the reliability of results. If laboratory analyses are
offered as part of future services, clinical studies will require CLIA certification through the
Clinical Laboratory Improvement Amendments of 1988; final rule. Federal Register. 1992
(Feb 28): 42 CFR 493.1407(e)(2), 42 CFR 493.1445(e)(2).
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Institutional review board. An IRB is an independent body made up of medical,
scientific, and non-scientific professionals whose responsibilities include ensuring the
protection of the rights, safety, and welfare of human subjects in a clinical trial. An IRB
must consist of at least five members who are collectively qualified to review and evaluate
the science, medical aspects, and ethics of proposed trials. The board must include at least
one physician and at least one member who has no affiliation with the institution. An IRB
may not be composed entirely of individuals from one profession, and at least one member
must be a nonscientist.
Among their responsibilities, IRBs must obtain, review, and approve all trial or study
documents, including the informed consent document, prior to the initiation of a trial. They
review this document as well as all protocol, protocol amendments, investigator brochures,
subject recruitment procedures, collection forms related to the trial, as well as the suitability
of the investigator to conduct the trial. The IRB conducts continuing reviews of ongoing
clinical trials on an annual basis and documents all materials and findings.
Investigators interested in biorepository services must provide documentation of
project-specific IRB approval in order for biorepository management to consider approving
and onboarding the study. The biorepository must obtain IRB approval for its general
protocol in collecting, processing, storing and distributing clinical research samples prior to
offering any services to research studies. In addition, the biorepository must submit an IRB
application and receive its own IRB approval for each project-specific research study prior to
the initiation of services.
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Onboarding New Studies
Prior to initiation of services, each biorepository study must complete an appropriate
Research Study Protocol template, which will be utilized to capture, review, and approve
specific protocol information. This information must include an introduction, a description
of the study’s scope and purpose, project specifications, procedures, project workflows (both
retrospective and prospective), IRB Approval, and written approval from both the
investigator and the biorepository director. These research protocols will be reviewed on an
annual basis to ensure that:
•

IRB protocols and policies are upheld.

•

Informed consent is consistent with proposed uses.

•

HIPAA is not violated.

•

Clinical care is not compromised in the process of procuring biospecimens.

•

Ethical standards related to biospecimen collection and utilization are upheld.

•

Adequate research participant protection is in place in terms of confidentiality, safety,
health, risk-benefit ratio, and security.

•

Procedures define the safety level of biospecimens as appropriate for the
biorepository.

•

Information includes parameters for specimen acceptance criteria and data, labeling,
collection, preservation, processing, conditions for transportation (including chain of
custody, check-in and storage, and retrieval), any necessary further processing, final
analysis and shipment, planned duration of storage, and final disposition.
Furthermore, the Research Study Protocol will clarify and define the roles and

responsibilities of the biorepository with respect to the specific client. Written
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communications between the organizations involved may be appended to the protocol as
documentation of the study design process.
In addition, the biorepository shall obtain a written commitment from the principal
investigator stating he or she will protect research participants and adhere to Good Clinical
Practice (GCP) guidelines and all applicable federal, state and local regulations. The
Research Study Protocol template, the specific protocol, and the written commitment will be
retained as appropriate in biorepository records.
Pre-Analytic Variables
Biospecimen Reporting for Improved Study Quality (BRISQ). As Pelagio,
Pistillo, and Mottolese (2011) reported, “Keeping records of pre-analytical variables is a gold
standard that can allow proper utilization of biospecimens according to study requirements”
(p. 144). Moore, Kelly, Jewell, et al. (2011) published a widely applied standard for
documenting these variables in Biospecimen Reporting for Improved Study Quality, or
BRISQ. This document defines biospecimen characteristics and pre-analytical variables that
may influence biospecimen quality (such as composition, structural integrity, and
characterization) and that may subsequently affect the reliability of assay results. Moore et
al. (2011) advocated improved tracking and reporting of these particular characteristics and
variables in intended publications rather than reporting only the final data. Reporting more
consistent and standardized data will allow researchers to “better evaluate, interpret,
compare, and reproduce experimental results” (p. 57). For the purposes of their paper,
biospecimens were defined as solid tissues and bodily fluids; however, biospecimen
characteristics and pre-analytical variables may be interpreted, modified, or applied to any
study as appropriate.
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BRISQ and potential publication of client studies. The current proposed
biorepository model will support the accumulation of BRISQ data standards to ensure the
highest quality, fit-for-purpose biospecimens and increase its desirability among researchers
intending to publish. Simeon-Dubach and Moore (2014) reported that reviewers for the
journal Biopreservation and Biobanking will take the inclusion of BRISQ guidelines into
account when reviewing manuscripts for publication. They further suggest that authors of
studies using retrospective samples obtain biospecimen annotation to the greatest extent
possible. Authors of prospective studies should likewise collect similar biospecimen data.
Should a study use biospecimens provided by a particular biorepository, Simeon-Dubach and
Moore (2014) recommend that researchers select a biorepository able to support and provide
BRISQ data. Several other journals and articles have reported the importance of using
BRISQ data in research.
The Biorepository and BRISQ data collection. The biorepository will support the
collection of the following BRISQ data elements (as adapted from Table 2 of Moore et al.,
2011, pp.61-63):
•

Pre-acquisition data, including biospecimen type, anatomical or collection site,
retrospective or prospective designation, pertinent SOPs, and biorepository
contact information.

•

Acquisition data, including collection mechanism, time of collection, time and
temperature from collection to stabilization, visit number, and specific collection
vial.

•

Stabilization or preservation data, including mechanism of stabilization, type of
long-term preservation, concentration and constitution of fixative or preservation
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solution, temperature during time in preservation solution, specimen size, and
aliquot volume.
•

Storage or transport data, including storage parameters (with temperature and
duration), type of storage container, storage container ID, shipping parameters
(with temperature and duration), type of transport container, and freeze-thaw
parameters (such as the number of freeze thaw cycles, duration of thaw events,
time from last thaw to processing, and temperature between last thaw and
processing).

•

Data on quality assurance measures, including specification of the measures used
to assess biospecimens, when these methods are utilized, and the results.

The biorepository is committed to work with investigators in the design of the study
to ensure they consider and capture relevant BRISQ data in the investigator’s respective
databases. Other data may include biospecimen disease status, clinical data of the
participants, vital state, disease state, diagnosis, pathology, reproductive status, and other
participant demographic information. Alternatively, if the biorepository were to consider
managing clinical annotation for biospecimens, the database may require modification in
order to support BRISQ data as applicable to research study requirements.
Specimen Collection Kits
In order to help plan the capture of some of the previously discussed pre-analytical
data as well as to assist in the execution of specimen collection, the biorepository will work
with investigators and sponsors to create standardized collection methods for prospective
samples. Such collection methods should preserve sample integrity while also maintaining
and tracking the identity of samples throughout the collection, processing, storage, and
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distribution life cycle. To that end, the biorepository will design and manufacture studyspecific, barcoded specimen collection kits for investigator use.
Specimen collection kit description. The biorepository’s pre-designed specimen
collection kits will include the following features:
•

The kit label number will be unique not only to the specific study but also to all
studies served by the biorepository.

•

A block of kit and corresponding sample label numbers will be provided based on
the expected number of kits. An additional 25% of label numbers will be provided
in anticipation for possible study expansion.

•

Sample vials and other kit components will be pre-labeled with the study ID, kit
ID, sample type, barcode, date of collection, and visit number (if applicable).
They will also include an alphanumeric representation of the barcode in case the
label is somehow damaged or unable to be scanned. These labels will be affixed
to the sample vials in a consistent manner to facilitate efficient scanning and
processing.

•

Labels also contain a colored circle to correspond with the sample type (e.g., red
for serum, yellow for urine). Caps are similarly colored as an added QA measure
during processing.

•

The kit will include a specimen collection log that will list the sample type,
specific barcodes, and the alphanumeric representation of the barcode for vials
and vacutainers. This log will capture the date and time of collection, the number
of vacutainers used, and the number of aliquots collected. It may also contain
specific processing instructions for study personnel. Most importantly, the log
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will provide the mechanism for study personnel to link the kit to participant
identification number maintained at the clinical site. The log will also list
biorepository contact information for questions, assistance, or future kit orders.
•

Cryovials and vacutainers will be carefully selected for specimen, stability,
suitability for storage conditions, and analysis. Manufacturer’s specifications and
certificates of quality will be documented and included in the kits.

•

Lot numbers and expiration dates of kit components will be recorded and tracked
so that kits containing the same lot of component may be recalled, if applicable,
and site personnel notified.

•

The sample type will be validated as appropriate for the specific method of
analysis.

•

The volume of sample and subsequent aliquots will be appropriate for intended
use. A sufficient number of aliquots for present and future studies will be
incorporated.

In order to ensure specimen collection kits will meet study specific requirements,
mock specimen collection kits (using paper labels) will be provided to investigators, study
personnel, and the sponsor, if necessary, for review. Multiple revisions may be necessary as
studies evolve, sponsor and investigator requirements change, and study personnel have the
opportunity to contribute to the process. Written approval from both the investigator and the
biorepository director will be required prior to finalizing the requisite procedures, and
subsequent manufacture and release of specimen collection kits.
Kit inventories and inventory management. The biorepository cannot slow or
impede participant recruitment and subsequent specimen collection due to an inadequate
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supply of ready-made specimen collection kits or kit components. In order to meet study
objectives, the operations manager must maintain effective communication, cooperation, and
flexibility with study personnel regarding the number of kits they require on a monthly basis,
the method and timing of the kit shipments or deliveries, and their projections over time. The
experience of this author suggests that an automated system of kit orders cannot replace the
personal contacts and the relationship building that professional, courteous, individualized
service provides.
In order to meet customer requirements, the biorepository will ensure adequate
supplies of kits will be readily available for both routine and expedited shipments. The
operations manager should anticipate a need for an excess number of specimen collection
kits that may be needed on a monthly basis. This particular task becomes easier with
experience over time. The biorepository should maintain a two- to three-month kit reserve
whenever possible. In order to accomplish this goal, the operations manager must implement
an effective inventory management system. The biorepository must maintain an accurate
inventory and ensure an adequate supply of materials and die-cut label stock in order to
manufacture kits whenever necessary. Label sets must be created from the database and sent
to the selected printer in order to keep printed label materials ready for kit manufacture as
well. The author recommends securing a six-month inventory of supplies at all times.
Maintaining such an inventory requires that standing purchase orders and supply contracts be
utilized. The manager must also have experience with supply vendors, their turn-around
times, and their ability to ship supplies. Close attention to all aspects of the supply chain will
ensure the biorepository can maintain a well-stocked inventory.
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Labeling issues. Proper labeling of samples will be absolutely vital to ensuring the
integrity of sample collection and analysis. As such, the biorepository will consider a number
of factors as it chooses its specific labeling methods.
Barcodes, die-cut label stock and printing labels. One dimensional (1D) or linear
barcodes (using Code 128 symbology, for example) are composed of a series of numerics or
alpha and numerics (Cosentino & Schoenborn, 2008). Such identifiers will be acceptable at
the proposed biorepository provided they are unique both to a particular study and specimen.
However, the biorepository will pursue two-dimensional (2D) barcodes as they are smaller
and more flexible than linear barcodes. They also have the advantage of additional available
embedded data within the barcode, improved data redundancy and scanning accuracy, and
the capability to employ any language (e.g., Data Matrix symbology) or even a combination
of languages. Studies sponsored by the National Cancer Institution likewise favor such 2D
barcodes (Cosentino & Schoenborn, 2008).
When selecting vendors, biorepository management should select an experienced
printer with demonstrated experience obtaining die-cut label stock. Other printing vendors
may be identified for backup purposes. Die-cut specifications must be determined according
to the size of select cryovial or vacutainer and specified to the vendor providing the label
stock.
Ordering label materials.

Prior to use, label materials and their printing must be

rigorously tested under all processing and storage conditions. The results of these tests must
be validated and documented before orders are placed. Label files can then be generated from
the database, tracked for both manufacturing and billing purposes, and sent to the printer.
Although bulk orders of die-cut label material can take several months to fill, large orders are
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both cost effective and ensure that labels are readily available. Once obtained, die-cut label
stock must also be properly stored at an ambient temperature or problems with the adhesive
may occur.
Additional technical information on label material, barcodes, label configuration,
printing technology, and recommended barcode scanners may be found in the white paper,
“Labeling of Biological Specimens” (Cosentino & Schoenborn, 2008).
Quality checks on printed label materials. To perform quality checks on labels
generated by the database and subsequently received from the printer, personnel may use a
procedural worksheet to ensure the correct label set, i.e., the next label set in the series, will
be manufactured. This worksheet should include a record of the kit type, label series, and
date the labels were received. If labels or log sheets are missing or poorly printed, those
specific items should be listed on the worksheet and segregated so the printer may be
contacted and corrections made.
Kit manufacture. Kits will be assembled using the appropriate series of labels and
the necessary kit components. These kits will be prepared to contain the number and type of
vacutainers and sample vials according to the instructions in the standard operating
procedure. Assemblers should utilize the specimen collection log included in the kit as it
details the specific barcodes and the corresponding type of vial in the individual kit. Two
example kits should also be maintained and readily available for reference and training
purposes.
Assembly. Assemblers first place a matching label on the bag or vial according to the
corresponding specimen collection log sheet. (All labels should include the appropriate kit
identification number.) Scotch tape should be applied over all the vial labels to ensure the
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label will continue to adhere to the tube throughout collection, processing, and storage. A
blood draw bag should contain the study-specific supplies necessary for blood collection
such as labeled vacutainers, a vacutainer needle, a vacutainer holder, an alcohol wipe,
bandages, gauze pads, and pipets. An aliquot bag should contain the barcoded vials
appropriate for the sample type, such as serum or plasma. The barcoded labels on the kit
bag, draw bag, aliquot bag, and all the sample vials and vacutainers must match the log sheet.
The kit should be checked to ensure it contains the correct number of vials and appropriate
vacutainers (e.g., size, additive, freeze dried or liquid additive, or plastic or glass) and other
collection supplies as identified on the log sheet. Specific specimen collection kit numbers,
lot numbers, and expiration dates of the vacutainers and other specific supply information
should be recorded in the laboratorian’s notebook as the database.
Preparation of preservatives for specimen collection kit manufacture. A procedural
worksheet will provide directions and check boxes for the preparation of sample-appropriate
preservative (e.g., a 50% glycerol solution may be used for urine samples). The worksheet
will also provide a mechanism to assign a lot number and expiration date, and record the
corresponding chemical manufacturer, the manufacturer’s lot number, and the expiration
date. Preservatives should be stored in secondary reagent containers and labeled accordingly.
Biorepository personnel will add preservative to the vials and cap the vials as appropriate.
Sites should be provided with corresponding Safety Data Sheets as well as any hazard
information and instructions in case of chemical spill.
Absorbent material (i.e., dry mop) will be included as part of the specimen collection
kits in case of spillage. This material causes eye irritation, so assemblers and study personnel
should be formally trained in handling this material.
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Quality control of specimen collection kits. Personnel must complete quality
control (QC) procedures for specimen collection kits at each stage of the specimen life cycle,
from preparation of the kits to their final use by investigators.
QC prior to release. All specimen collection kits must go through a QC process prior
to release. Kits will be disassembled one at a time to ensure that components from multiple
kits will not be unintentionally mixed during the QC process. The barcoded labels on the kit
bag, the draw and aliquot bags, and each vial must match that information on the
corresponding specimen collection log sheet. Each kit will be checked for the correct
number of vials and additional collection supplies. Two example kits (including sample kits
for every version or modification of the kit) will be readily available for reference purposes.
The QC date will be recorded in the database and kits will be appropriately labeled by the
next available series of kit numbers and QC date.
QC at time of shipment. Before shipment, the following information must be
recorded with respect to manufacture and shipment of specimen collection kits: kit number;
kit components (including lot numbers and expiration dates); lot and date of expiration of
preservative (if applicable); QC date; staff ID performing QC; the number of kits and the
identifying kit numbers contained in the shipment; date, method, and cost of shipment, if
applicable; staff ID releasing or shipping kits; site personnel receiving kits; and date and time
of receipt. Kits will be made available via pick up, delivery, or preferred courier service. If a
courier service is utilized, the tracking number will be recorded in the database as well. The
study-specific specimen collection kit SOP contains the preferred method of shipping kits
and the contact information.
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QC by clinical site personnel. Study personnel should be strongly encouraged to
perform their own quality control check of specimen collection kits prior to use. The
Biorepository will assist study personnel by providing training and a SOP that may be
included in their study-specific manual of operations. Study personnel can then use the
specimen collection log to verify the correct number and type of components,check to ensure
all vials have the appropriate kit identification number and unique barcode number, and
check that included vacutainers have not expired. The SOP will include instructions on what
to do should kit components become mixed or elements of the kits be deemed incorrect.
These instructions will include the immediate labeling and segregating of the incorrectly
assembled kit in order to prevent its use.
Possible QC issues. Although all personnel will follow detailed procedures
whenever performing QC on specimen collection kits, errors may occur on rare occasions.
For this reason, certain procedures should be in place to address QC issues whenever
possible. Any errors discovered during the manufacture and distribution process, including
any necessary recalls, reports of lost kits, or inquiries from sites, must be documented. These
reports will aid the operations manager in providing consistent responses to queries, writing
progress reports, and improving the quality control and quality assurance process.
Recall of specimen collection kits. Should an identified discrepancy in a kit or batch
of kits necessitate a full recall, clinical sites will be notified at once and asked to return the
kits with the understanding that the biorepository will either pick up the kits or cover any
incurred shipping expenses. The operations manager should be sure to express thanks to
affected clinical site(s) for their patience and cooperation.
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Upon receipt of the recalled kit(s), biorepository personnel should label them with all
appropriate information, including the purpose of recall and the date of receipt. This
information should also be recorded in the database. The entire kit will then be checked
according to the appropriate kit manufacturing QC procedure and all findings recorded and
reported. If the identified discrepancy can be corrected, the corrected kit may be redistributed
to the previous site or a different site entirely. If the discrepancy cannot be corrected, the kit
must be discarded and any salvageable components recycled. The kit numbers, date of
receipt, date of QC, staff ID performing QC and then shipping kits, date of shipment,
tracking number, and destination or final disposition will all also be recorded in the database.
Tracking lost specimen collection kits. Whether by courier or biorepository delivery,
shipments of kits must be tracked and the receipt verified and recorded. If a shipment of kits
was delayed, delivered to an erroneous address, or lost in transit, the courier may be able to
assist in retrieving the package. If the courier cannot locate or retrieve the kit shipment, the
kits must be recorded as lost in the database. Another set of kits should be sent to the clinical
site in the requested time frame at no charge.
Redistribution of specimen collection kits. In multisite studies, if a clinical site
experiences an unexpected or unanticipated shortage of kits and none are available, the
biorepository may contact other clinical sites for assistance. Another site may be able to
spare a number of kits until such time that replacement kits are available. Biorepository
personnel should request that these sites send the kits back to the biorepository via a
convenient carrier with the understanding that the biorepository will cover any incurred
expense. Again, the operations manager should take extreme care to ensure that assisting
clinical site staff are thanked for both their patience and cooperation.
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Upon receipt, the shipping box should be labeled as returned from the specific site for
the purposes of redistribution and the date of receipt. The receipt date of the kit shipment will
be recorded in the database. The entire kit contents will be checked according to the
appropriate QC procedure for kit manufacture. The specific kit numbers, the site, and the
date of return will be recorded. If personnel must make any changes to the kit, the changes
(e.g., replacement of vacutainers, for example) will be recorded. Prior to redistribution, all
kits must undergo a second full QC, and the date the QC is performed and staff ID must be
recorded. Finally the redistributed kits will be shipped to the new site. All shipment
information (carrier, tracking number, and date) will be recorded in the database, and the
clinical site will be notified of the impending delivery.
Change management procedure in specimen collection kits.

During the course

of a study, particularly in longitudinal studies, the number or type of kit components may
change due to study requirements or the discontinuation of a product by a manufacturer. Any
proposed changes to previously approved kit specifications must be thoroughly tested,
discussed with clinical sites, approved, documented, and implemented. Implementation of
any such changes must proceed through the following steps:
1. Recommendations or proposed changes in kit manufacturing must be discussed
among all concerned parties, including investigators, study personnel,
manufacturing personnel, and IT (who may be required to reconfigure or
reprogram the database).
2. Any changes in labor or manufacturing supply costs must be determined.
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3. If deemed appropriate, a test protocol may be designed. Necessary materials will
be obtained, the cost of the test protocol determined, and the protocol performed
(including a time study, if applicable).
4. The results of the test protocol and the changes in labor and manufacturing costs
will be reviewed internally by biorepository management before being presented
to investigators, study personnel, and sponsors for their consideration.
5. If proposed changes in kit manufacturing are accepted, written approval will be
endorsed by the study PI and sponsor as well as the biorepository director prior to
procedural change and implementation.
6. Two new examples of the revised specimen collection kit will be prepared and
stored at the biorepository for reference.
Retrospective samples. Prior to accepting studies using retrospective samples,
biorepository management must determine the sample identification method utilized by the
client and obtain the following information in order to accept samples and offer biorepository
services:
•

What information is available on the sample label? The name of participant,
abbreviated Protected Health Information (PHI), demographic data, participant
ID, or a barcode? For acceptance at the biorepository, the name of the participant,
demographic data, and PHI should be redacted, though the unique sample ID
should be protected.

•

What type of barcode, if any, was utilized? If the samples used a 1D or linear
barcode, what barcode symbology was used?

•

What provider or BIMS system was used to generate the barcodes?
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•

Did the provider or BIMS have protections in place to prevent multiple users
(within the same institution, for example) or multiple studies (by the same
sponsor or investigator) from generating and utilizing the same set of barcode
SIDs?

•

What are the barcode SIDs or range of SIDs?

•

Do these barcode SIDs or range of SIDs conflict with those used at the
biorepository? The biorepository must actively prevent duplicate barcodes from
multiple studies in the database.

•

Is the client’s barcode system compatible with the biorepository barcode
system/database?
i) If the systems are compatible but barcode SIDs overlap with other
biorepository studies, study and biorepository personnel must consider risk
mitigation and develop a plan of action is required.
ii) If the systems are incompatible or barcode SIDs overlap with other
biorepository studies, study and biorepository personnel must perform a
feasibility study and risk assessment to determine whether samples can be
relabeled while preserving sample identification. Any developed workflow
and protocol must be approved and endorsed by both the client and
biorepository director.

Sample Shipment
Shipment of biospecimens to and from the biorepository can be one of the most
tenuous and unpredictable stages of the sample storage and processing life cycle. Rigorous
procedures, QA strategies, site communication and training regarding sample notifications
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and shipments must be in place long before the first shipment is sent to or accepted by the
biorepository.
During the initial design phase of any study, sites should plan to collect multiple
aliquots of any given sample for back up purposes and further potential future analyses.
Samples may then be divided into different shipments to the biorepository in order to prevent
potential loss or accidental thawing.
Shipment instructions for clinical sites. Clients will be instructed to send any
shipments via Federal Express Priority Overnight service on Monday through Wednesday
only. This shipment method will allow for next day delivery but also provide an additional
weekday in case of a shipment delay. The biorepository will inform clients of holidays or
other days of closure to allow them to plan in advance for shipments. The biorepository will
also provide training, supply recommendations, and procedures for shipping Category B
Biological Substances, UN3373 according to IATA and DOT shipping regulations, or
transporting biological substances via motorized vehicle.
Additionally, all clients will be instructed to include a printed shipping manifest, i.e.,
a list of the specimens’ barcodes (identification) and specimen type as well as send an
electronic copy of the manifest via email. Biorepository staff assigned to sample check-in
will utilize this document to QC any incoming shipments.
Sample notifications. In order to ensure safe receipt of biospecimens and minimize
the risk of thawed or partially-thawed shipments, the biorepository will treat communication
with its clients as a highest priority. Sites will be instructed to notify a designated group of
biorepository staff (including the sample check-in lead and the operations manager) of their
intent to ship and wait to receive a confirmation statement prior to sending the shipment.
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This system will ensure that biorepository personnel will be available to receive the
shipment. This same procedure will be followed for shipments that are picked up by
biorepository personnel or dropped off at the biorepository. All intakes must be agreed upon
by the biorepository and its clients in advance.
Upon receiving a message from a site indicating their intent to send a shipment
(including an intended carrier and tracking number), biorepository staff will send an e-mailed
“received shipment” message that will confirm delivery details with all biorepository and
site-specific personnel. Should the site not indicate a carrier or tracking number,
biorepository staff will request this information in the text of the message. This email
communication will then be posted on the sample check-in corkboard so that sample checkin personnel can track the shipment through the shipping carrier to determine its location and
status. If an expected shipment is delayed, the operations manager and site will be promptly
notified and any information or status updates communicated accordingly. Any such email
communication should be marked with the word “Delayed.”
At the time the shipment arrives, biorepository personnel will send a “Notification of
Receipt” message to the site indicating that the shipment was received, the shipping carrier,
and the tracking number. The previous email communication will be posted on the sample
check-in board and checked to ensure the appropriate shipment (and the correct number of
boxes) has arrived. At that time, the word “Received” will be written on hard copy of the
email message posted on the board. As an extra QC measure, all the messages posted on the
corkboard will be checked each day at 2 p.m. to determine whether they have been
appropriately marked as “Received” or “Delayed.” If delayed, the operations manager or
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designated biorepository personnel will track and retrieve shipments from another location or
the courier’s facility, if necessary, to secure shipments in as timely a manner as possible.
The biorepository will continually monitor shipment communications and conditions
and communicate the quality of specimens to clients in order to alert them of damage,
compromised samples or protocol deviations. Any issues identified during this process can
be addressed to resolve ongoing issues, eliminate likely sources of error, and improve the
process moving forward.
Sample receipt. All samples accepted, processed, and stored at the biorepository
should be considered potentially infectious. Therefore, Universal Precautions and the
appropriate PPE (such as lab coat, safety glasses, waterproof cryo-gloves, or non-latex
gloves) will be required at the time of check-in. Sample racks and boxes will be placed on
dry ice at all times during the sample check in process to ensure samples stay frozen.
The biorepository will employ an electronic biospecimen chain of custody form in
order to track the shipments and samples from the moment of receipt to check in, processing,
analysis, storage, and redistribution. This form will include the name and signatures of any
biorepository staff members and study personnel involved in any shipment of samples to or
release of samples from the biorepository.
Once a shipment is accepted, personnel will check that the shipment arrived in good
order. The shipping container should be intact, supplied with adequate dry ice or liquid
nitrogen, and filled with the correct number of samples (according to the client’s manifest).
Samples should be tightly capped with vials intact (not cracked or broken). Sample labels
must be legible, and samples should be completely frozen with no evidence of sample thaw
or partial thaw. Sample vials will be marked using an indelible pen (such as a permanent
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marker) with a ‘P’ or a ‘T’ for partial or potentially thawed and noted as such in the database
upon check-in.
Check-in personnel should record any discrepancies between the number of samples
listed on the site manifest and the actual number of samples received in the shipment as well
as any damage and/ thawing that may have occurred en route. These notes should be
communicated to the site upon receipt and further investigation conducted as appropriate.
Likewise, personnel should record shipment information in the database and electronically
assign the shipment a shipment identification (ID) number. All the following information
must be recorded when documenting such shipping information: the date of receipt, shipping
carrier or method of shipment, tracking number (if applicable), clinical site, key
investigator’s ID, study name or identifier, number of samples, sample type(s), size of vials
(2 mL, for example), and shipping conditions. Evidence of thaw, partial-thaw, or damage of
any kind should be recorded both in the database and in the laboratorian’s notebook.
If the check-in process is delayed at any time (perhaps due to an excess of shipments
arriving at once or shipments arriving later in the day), samples may be labeled with the
shipment number, site information, and date of receipt. These samples may then be stored in
a temporary alarmed freezer (with generator backup) at the required storage temperature.
The temporary storage location should be recorded in the database and the laboratorian’s
notebook.
Sample acceptance criteria. Samples should be evaluated for vial integrity, sample
label security and accuracy, barcode legibility, and gross sample condition. Each individual
study will have pre-established procedures, including sample acceptance and rejection
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criteria as well as necessary subsequent instructions. Policies and procedures including
correcting information on sample labels and relabeling sample vials will also be established.
Sample check-in. The number and type of samples recorded at the biorepository will
be compared to the site’s provided manifest. If discrepancies between the site manifest and
the actual shipment exist, that information should be communicated to the site immediately.
Once samples have been compared to the manifest, they will be individually checked
in to the database. The shipment ID must be selected so that the shipment and corresponding
samples are linked. The staff ID must also be selected, but date and time stamps will be
updated in the database automatically as individual samples are scanned. The following
information must then be recorded: sample ID, vial type and size, sample type, sample
volume, and any relevant sample observations (such as evidence of hemolysis or thawing).
Explicit instructions will be provided to check-in personnel in documented project-specific
check-in procedures.
Some studies may have their own databases for managing samples and corresponding
participant demographic and clinical data. In these instances, they may request the
biorepository store their samples for a fee without need on the biorepository’s part for
checking in samples at the individual vial level. Other studies may have the biorepository
QC the study samples by granting biorepository personnel access to restricted portions of
their database through a password protected and encrypted website. Both of these services
may be provided as appropriate.
The currently proposed biorepository will follow procedures currently in favor at
Johns Hopkins. For projects in which biorepository staff will check samples into the database
before transferring the samples into barcode-labeled boxes, the staff will place a uniquely-
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barcoded indicator tube in the first row and column position of each box and check this tube
into the database to create a permanent record. If the indicator tube experiences an increase
in temperature, the pH will change and the tube will change color, thereby alerting personnel
that a temperature excursion occurred and samples stored in that box were subject to the
same circumstance. When temperature excursions are recorded in the database, biorepository
staff will conduct a further investigation to check all other freezer storage boxes in that
freezer. Management will also contact the investigator and study personnel to inform them
of the situation. Indicator tubes will be routinely checked as part of the quality assurance
audits. Results of these audits will be permanently documented.
Each investigator and study will have individual storage boxes; samples from
multiple projects will never be stored in the same storage box. This procedure will prevent
delays when personnel are required to pull samples from storage in a timely and efficient
manner.
As an additional QA strategy, the proposed biorepository will split and store
replicated samples among different freezers. During sample check-in, samples will be
assigned alternatively into even and odd numbered storage boxes. Even numbered boxes will
be stored in one freezer and odd numbered boxes will be stored in another. Personnel may
then proceed to scan the barcode label of the vial, weigh the vial (to obtain sample volume
determination), record the weight, and assign the sample to a specified storage location. The
row and column position within the storage box as well as the storage box ID (a unique
barcode) will be recorded in the database.
Each barcoded vial must have a unique identifier. The database will not accept
duplicate samples. Procedures must be in place to address duplicate samples with
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consideration for IT issues, site issues, and laboratory issues. Furthermore, the risk of
misidentification must be routinely monitored and subject to continuous quality
improvement.
Sample QC after check-in. When sample check in is complete, a list of the sample
IDs, box numbers, row and column positions, freezer rack IDs, and freezer IDs will be
printed and storage boxes placed in the freezer. All shipments will be subject to a full quality
control check. After check in procedures have been completed, a different staff member will
take the list of entered samples, pull the samples from storage, and compare all recorded data
to ensure 100% accuracy. Corrections to the database will be made if necessary and QC of
the shipment will be recorded as complete in the database along with the second staff
member’s initials and a date and time stamp. Finally, the list generated by the
biorepository’s QC will be checked again against the clinical site’s manifest. If there are
discrepancies, the clinical site will be notified so it may investigate further and resolve the
issue.
Once the check-in and QC processes are complete, an electronic list of the sample
IDs, sample type, size of vial, and sample volume will be sent electronically to the clinical
site in a “Confirmation of Receipt” email. Other means of checking samples the
biorepository received (after the check-in process is complete) may be available to clients as
appropriate. A list of samples successfully checked into system will be emailed to study
personnel for their review.
Sample audits. The biorepository will also perform monthly audits of sample IDs
and their respective locations to ensure the correct information is recorded in the database.
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Discrepancies will be corrected. Results of such audits will be reviewed, documented, and
incorporated into ongoing QMS reports.
If during an audit a sample entered into the inventory system cannot be located, staff
will first search the same freezer storage box for the sample. If the sample is not found within
the same storage box, the samples list from the corresponding shipment will be re-examined
for possible clues to its location. Personnel will also conduct an electronic search of sample
pick lists, as the sample may already have been pulled for a processing request. If not,
personnel will query the database and conduct an electronic search of previous pick lists to
determine if the sample was used in its entirety for derivatives or aliquots or destroyed. If
necessary a full search of the inventory starting with the same rack and freezer will be
conducted until either the sample is located or the operations manager is satisfied the sample
is not stored at the biorepository.
Tracking shipment and sample data. The majority of tracking functions will be
documented via licensed LabVantage software. This software package is equipped to handle
all of a biorepository’s tracking needs with respect to sample management. These specific
fields are outlined in Figure 3. Should the biorepository consider collecting and annotating
clinical data to support investigator studies in future, however, management may consider
further customization of LabVantage or purchase of the full version of the software.
Any modifications made to LabVantage’s database must be completely documented,
including information on the original date of implementation, the date any information was
modified, the name of the staff member or staff ID who made the modification, the reason for
the modification, the specific data that was modified, and how the modification was made.
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Additional details regarding LabVantage functionality and requirements are described
in “Informatics.” (page 55).
ü

ü

ü

Sample Receipt
o Shipment ID
o Shipping carrier
o Tracking ID, if applicable
o BR staff name who accepted shipment
o Clinical staff name who handed off shipment
o Clinical site name
o Study name
o Study ID
o Date shipment received
o Time shipment received
o Shipment accepted, yes/no
Sample Check-In
o BR Staff name checking in samples
o Date sample checked in
o Time sample checked in
o Unique sample ID
o Sample material type
o Sample vial type
o Sample volume
o Sample observations on receipt, drop down
menu
Temperature Excursions
o Temperature excursions, yes/no
o Date(s) of temperature excursions
o Circumstances/Details of temperature
excursion
o Staff ID who reported temperature excursion

ü
ü

ü

ü

Quality Check (QC)
o QC check completed, yes/no
o Date QC check performed
Sample Retrieval
o Date sample pulled from storage
o Sample parent ID/child ID
o Sample parent volume, updated
o Sample child volume, new
o Date sample frozen/refrozen
o Number of freeze/thaw cycles
o Date sample returned to storage
o Number of times sent for storage
o Number of times sent elsewhere for
testing/ final distribution
o Missing sample or inventory update
Sample Delivery
o Date sent
o Shipment ID
o Tracking ID
o Recipient name/institution
o Location of recipient
o Date shipment received
o Time shipment received
o Date sample returned to clinical site
Sample Destruction
o Date sample destroyed
o Method of destruction

Figure 3. List of data fields in LabVantage for tracking purposes.

Storage
Storage of biospecimens must be of primary concern to biorepository personnel.
Failure to maintain biospecimens in specified, consistent temperature and environmental
conditions can lead to biospecimen degradation and loss of potency and, furthermore, reduce
the reliability, quality, and scientific integrity of research study results.
Environmental conditions. Room temperature and humidity must be monitored in
order to provide consistent and favorable environmental temperature and conditions for
freezer storage, laboratory activities, and, should the need arise, assay conditions.
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Laboratory and storage equipment can expel an excessive amount of heat. Exceedingly
warm temperatures can cause equipment to fail. Therefore, the biorepository must be certain
to control the temperature to ensure proper equipment performance and operation. Further
equipment damage through condensation, rust, or erosion of components may occur if proper
environmental humidity is not maintained. Temperature and humidity readings will therefore
be recorded at the beginning, middle, and end of each working shift, and this data will be
reviewed on a routine basis. If necessary, corrective action may be implemented and service
records maintained.
Freezer setup and validation. All specimen storage equipment must be approved
for use under the intended storage conditions. Mechanical refrigerators, freezers and -80
degree C ultralow freezers must be positioned and hooked up accordingly to appropriate
electrical requirements and specifications. An uninterruptible power supply (UPS) backup is
recommended (ISBER, 2011). Liquid nitrogen freezers must then be connected to liquid
nitrogen feeds. If individual LN2 tanks are employed, tanks must be secured to the wall or
the floor using specifically designed stands to prevent falling. Once monitoring equipment
has been installed, high and low temperature set points as well as alarm set points will be
programed. After they are initially switched on, freezers must run for a minimum of ten days
to validate proper function prior to use. As they are successfully installed, equipment
locations should be added to existing floor plans or schematic diagrams before freezers are
placed into service.
A freezer log must maintain the following information: freezer identification number,
model and serial number, institutional tag ID, required amperage and voltage, the
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corresponding power panel, circuit number, and whether the outlet is supported by primary,
secondary, or tertiary backup systems.
Verification of freezer temperature consistency. When freezers are placed into
service or repaired, personnel must conduct temperature mapping to verify and document
that proper temperature is maintained consistently throughout the freezer. During this
temperature mapping, personnel must utilize a procedural worksheet to capture the freezer
ID, the equipment used in the verification process, and its respective calibration information,
as well as the results of the mapping (including raw data), and finally review and approval
indicating freezer temperatures are within acceptable, previously defined tolerance limits.
Temperature mapping logs will be utilized to list the freezers checked and the date for
reference and routine review.
Freezer monitoring. A freezer monitoring log lists the freezer ID and corresponding
monitoring ID and ensures appropriate data collected is for a specific freezer and its
corresponding samples. The log should be updated any time a freezer or monitoring unit is
moved or replaced. Personnel should routinely perform quality assurance checks ensure the
freezer ID and corresponding monitoring ID are correct. Resulting information should be
entered or downloaded in the database in order to link samples with their respective storage
temperature history.
All freezer temperatures are monitored by three complementary methods:
1. Designated staff will check temperatures listed on the display panel of the freezer
and record data manually on the freezer log attached to each unit. Acceptable
temperature ranges will be posted on the logs. Staff members will record their
initials when recording the temperature. This manual check will occur twice daily
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seven days a week. Levy-Jennings graphs of temperature vs time points will be
constructed from this data and reviewed by the operations manager on a monthly
basis for trend analysis.
2. With a probe placed inside the freezer itself, staff will record temperatures from
an independent NIST certified thermometer. This method will verify that the
temperature on the display panel of the freezer is accurate within a few degrees
Celsius (C). This data will also be recorded on the freezer monitoring log.
3. Freezer temperatures will be automatically monitored at all hours via an
independent wireless monitoring system. A calibrated probe placed inside the
freezer will report temperature measurements to monitoring units attached to the
outside of a freezer.
Alarm system. Acceptable temperature ranges will be pre-defined for refrigerators,
-20 degree C freezers, ultralow freezers, and vapor phase storage in liquid nitrogen freezers.
Alarm set points will be adjusted to trigger before the temperature falls outside the acceptable
temperature range to allow for adequate staff response time before samples experience any
temperature deviation. The temperature monitoring units will be battery-operated to prevent
a system failure should power be interrupted. These batteries will be routinely checked to
ensure proper functionality, and the check will be documented, initialed, and dated.
The operations manager must provide the contracted monitoring company with an
approved procedure for setting the alarm set points and the appropriate response protocol.
The manager must also obtain written verification that the program has been set up according
to the specified requirements. The alarm system must be thoroughly validated (including
quantification of the response time) prior to initial use. After it has been implemented, the
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system will be tested every week by pulling a probe from alternating freezers rather than
repeatedly checking the same freezer. Staff will then document proper function, response
time, and protocol adherence. A procedural worksheet will provide instructions for
performing the alarm system test. It will also outline follow-up actions required should the
response protocol not be followed or if response time is outside acceptable limits. After
collecting data, staff will use the worksheet to capture the freezer and monitoring ID, the
date, and the initials of the staff member.
Freezer alert and response. If freezer temperature falls outside the acceptable range,
the alarm company will contact staff via home phone, cell, text, beeper, and email. On call
staff will report as quickly as possible to the biorepository and utilize the procedural
worksheet for freezer alert and response. This worksheet will provide a mechanism for
recording the date and time of the occurrence, define the acceptable temperature ranges for
all storage equipment, list contact information, provide step-by-step instructions on how to
most efficiently assess the situation, and determine whether the problem is a freezer failure, a
tripped circuit breaker, or a full power outage. In case of freezer failure, instructions will be
provided on identifying back up freezers, efficiently transferring samples to back up freezers
on dry ice, and recording the transfer of freezer contents both on the worksheet and in the
database the latter within a specified time period. In case of power outage, the secondary
generator, powered by natural gas, should automatically provide emergency lighting and
sufficient power to mechanical storage equipment and critical laboratory equipment. A third
backup system may be available through the use of a diesel-powered generator. Staff will be
trained on such emergency procedures, but additional support will be available contractually
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through a commercial provider. Depending on circumstances, the procedure for standby
generator connection to freezer loads may also be utilized.
Benefits of LN2 freezers in sample preservation. LN2 freezers not only reduce
dependence on electricity required for mechanical freezers but may also be utilized in a
power outage to freeze samples that are currently thawed for sample processing (ISBER,
2011). These freezers may draw LN2 from outdoor bulk LN2 tanks and dewars may be
filled from an indoor LN2 filling station (constructed from the LN2 supply in the bulk tank)
as needed.
LN2 usage in each LN2 freezer will be measured daily using either a sturdy wooden
dipstick or, if available, a LN2 level indicator on the freezer display panel. Such
measurements not only assist in anticipating LN2 needs for the facility but also may detect
potential leaks. A three thousand gallon bulk LN2 tank can accommodate twenty to forty
large LN2 freezers for approximately thirty days depending on the rate of usage. A batteryoperated telemetry system will also automatically monitor LN2 levels and send a dispatch to
the supplier to refill LN2 when the tanks are at 30% capacity. Additional LN2 can therefore
be obtained the same day. Individual cryoports may be filled or tanks obtained as well.
Alternative vendors should always be identified.
Benefits of vapor-phase liquid nitrogen storage. Storing samples in the vapor
phase (less than or equal to -150 degree C) of liquid nitrogen offers several advantages apart
from offering an alternative temperature (from -80 degree C, for example) for sample
preservation. Storage in vapor phase of LN2 also prevents safety hazards that arise from
storing samples in liquid phase LN2 storage. Furthermore, it maintains temperatures below
the glass transition temperature of -132 degree C (ISBER, 2011).
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Alternate freezer storage box inventory. In addition to the database maintaining
specimens and their respective freezer storage locations, a simple yet practical box inventory
will be maintained and posted on each freezer. If the database becomes unavailable due to a
power outage or scheduled maintenance, personnel can determine the number of boxes, the
box IDs, and the relative box position in each freezer at a moment’s notice. The manual
inventory should be updated with box ID, date, and staff ID each time a box is added to or
pulled from the freezer. Just as the database will be temporarily checked for accuracy, the
manual inventory will also be subject to quality checks on a routine basis, the results of
which will be documented.
Storage capacity. The biorepository should follow Best Practices and strive to
maintain a minimum of 10% backup freezer storage capacity (ISBER, 2011) regardless of
freezer type (mechanical or LN2). Incoming and outgoing samples will be closely monitored
for storage capacity, facility and equipment planning, and monthly billing purposes. Initial
projections, communications with clients, and study progress reports should all be taken into
account when considering remaining capacity. Specimen collection kits manufactured and
utilized by clients will also provide a strong indication of their recruitment and sample
collection pace as samples make their way to the biorepository for storage.
A summary of available freezer space will be updated and posted weekly. This
posted summary will also be available in case of emergency so staff will not need to open
freezers or access the electronic inventory system during power outages. These summaries
will also aid management in monitoring available freezer space over time. Analysis of these
summaries may prompt communication of freezer storage capacity to investigators and study
personnel.
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Backup power. Periodic load testing will ensure that the electrical requirements or
“load” of the mechanical freezers, refrigerators, and critical laboratory equipment remain
adequate. In cases of heavy load, power usage may be automatically transferred (in stages, if
necessary) to the generator. These required load tests must be performed and documented at
six month intervals.
As previously mentioned, two generators will be utilized: the secondary backup
generator, powered by natural gas, and the tertiary backup generator, powered by diesel.
Procedures detailing routine maintenance and service should be followed periodically to
ensure both generators will be ready when needed. Designated staff will perform weekly
maintenance; a licensed, reputable contracted vendor will perform more substantial monthly
and yearly maintenance. Service records will be documented and a log will detail performed
maintenance checks.
Freezer maintenance. Freezers must be routinely defrosted. A procedural
worksheet describes the defrost schedule, the defrost criteria and the requisite materials. It
also documents the freezer ID, date, temporary storage location, staff ID, and provides step
by step instructions including the acceptable criteria for returning freezer contents. A log is
utilized to track the freezer IDs, the corresponding date and staff ID.
Freezers must be properly maintained according to manufacturer’s specifications.
Preventive maintenance is conducted on a routine basis according to approved procedures.
Condensers, filters, and gaskets are cleaned and checked. Leaks are often indicated by a
streak of frost which forms at the point of gasket failure, so gaskets must be checked around
the door or lid for punctures or tears. Lid and door gaskets must be kept clean and frost free.
Freezer alarm batteries are replaced when indicator lights begin to flash. Electrical cords are
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routinely checked for damage; if damage is discovered, the unit is taken out of service until
repairs are made. A log is utilized to track preventive maintenance activities, the
corresponding dates and staff ID. All preventive maintenance activities including defrosting
freezers will be listed on the master schedule calendar.
When freezers require repair, preferred service providers, their respective contact
information and current service contracts or warranty information is listed in the procedure
for freezer repair. In addition, a freezer repair log is utilized to document the freezer ID, the
model and serial number, the date the freezer is taken out of service, the date the unit leaves
the facility (if applicable) for repair, the problem and subsequent resolution (for tracking and
evaluation purposes), the date of return, and finally, the date the freezer is placed back into
service. Service records are also maintained with the repair log. In addition, a procedural
worksheet is utilized to capture the specific box IDs that are transferred as well as the
temporary storage location. Designated personnel are required to enter this information in the
database within 48 hours and sign and date the procedural worksheet; the operations manager
will verify the information is entered in the database and sign the procedural worksheet as
well.
Sample storage room security. Freezer rooms will remain closed and locked
except when work is conducted in those rooms. Freezers will remain locked except at times
when staff actively pull or place samples in storage. Freezer locks will be checked at the end
of each workday. A log will maintain records of all activity. Procedures for keys are
described in “Equipment selection, qualification, maintenance, and replacement.,” (page 53).
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Analytic Variables
Established procedures govern all sample processing; however, a few added
precautions are of paramount importance. The identity of the specimen must be maintained
through all processing steps and the sample parent/child relationship must be linked at all
times. The risk of misidentification is continually monitored.
Secondly processing must occur in an efficient manner; samples must be processed
and stored at the appropriate temperature. Samples that experience temperature excursions
beyond recommended storage requirements will be tracked during routine processing and
distribution.
Sample retrieval (pull) from a specified storage location. Whenever necessary, the
database will generate pick lists and list their prioritized SIDs, their freezer storage location,
and the requested service. The pick list should also contain adequate space for each SID so
staff responsible for performing the processing can note sample observations to be linked to
the sample during every processing and storage step. Samples will generally be pulled the
day before the requested service is performed, whether that service is thawing, aliquoting,
analyzing, or shipping samples.
Universal Precautions must be observed at all times during sample processing,
including as when pulling samples from storage. Staff will place the freezer box and the
processing test tube rack or shipping box on dry ice to prevent thaw and ensure sample
integrity. They will then proceed to pull the required number of samples and the matching
SIDs specified on the pick list. They may also pull the appropriate quality control
preparations, if applicable. By visual inspection the sample IDs are checked against the pick
list. If any sample ID does not match the pick list, staff must immediately return the frozen
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sample to the location specified on the pick list and alert the operations manager to either
resolve the issue or give further instructions. When samples are pulled, they will be placed in
the specified storage location, generally a temporary ultralow mechanical freezer, and the
temporary storage location, date, and staff ID will be recorded on the pick list. Personnel
will record the date a sample is removed from storage as the date the sample is thawed or
shipped. Staff will alert the laboratorian responsible for the next processing step and check
off this step on the procedural worksheet for daily biorepository activities.
Quick-thaw and preparation of clinical research samples. Personnel should
follow all documented procedures for quick thawing samples and preparing samples for
processing or potential analysis. These documents will detail the steps necessary to thaw
samples in tepid, running water; to thoroughly mix, vortex, or centrifuge samples (if
applicable); and to record sample observations according to processing requirements.
Aliquoting samples. Thawed samples require rigorous vortexing to ensure
homogeneity. Researchers have previously reported that insufficient mixing of samples prior
to aliquoting has led to erroneous results. (Zhu, Pinsky, Huang, & Purdue, 2014).
Recording sample observations. At any time during the pre-analytic, analytic and
post-analytic process, personnel should link appropriate information with samples and ensure
any relevant information regarding specimen quality is available to both biorepository staff
and clinical site for future consideration, selection, and value in continued storage. Staff
enter the sample identification number (SID) in LabVantage and select “comment history” to
verify whether the sample observation was previously recorded. If relevant information was
not previously noted, the current comment, date and staff ID should be recorded.
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Snap freezing clinical research samples. After samples have been processed and
analyzed (if applicable), samples will be snap frozen according to an approved procedure
using liquid nitrogen.
Returning samples to a specified storage location. After samples have been snap
frozen, the samples may be returned to their original storage location as specified by the
appropriate pick list. Staff will pull the sample’s original freezer box from storage, place it
and the test tube rack with the samples on dry ice to prevent thaw, and return the samples to
the original storage location according to the pick list.
Staff will record their ID and the date samples are returned to the specified storage
location. This data will then be entered in the database. Designated staff will check to ensure
the data was entered and sign off on a procedural worksheet.
Assessing the quality of samples. The biorepository will also conduct audits on an
annual basis to assess the quality of samples collected, processed, analyzed (if applicable),
and stored. The operations manager will select samples from all sample types that have been
stored for specific time periods. Sample identification and selection criteria will be listed in
the appropriate procedural worksheet. Samples will then be evaluated for sample location,
vial integrity, sample label security, sample label accuracy, and gross condition of sample
(e.g. hemolysis, sublimation) determined by direct observation. Samples may also be
evaluated through examination of research record integrity or feedback from investigators,
depending on their specific study requirements, the types of samples stored, and their
respective analyses. Investigators may agree to comparative analysis and request retest
samples for specific analytes to determine potency after specific storage conditions and
duration of storage. If potency has decreased to an unacceptable level, further evaluation may
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be required for the same type of samples that have been stored under similar conditions for
the same duration. The operations manager or director will consult with investigators on an
individual basis regarding the feasibility of a requested analysis, method of evaluation, and
subsequent results. Sample identification, method of evaluation, and the subsequent results
will be recorded on the procedural worksheet and incorporated into QMS reports for
evaluation and future consideration.
Temperature checks using NIST certified thermometers will be conducted on all
temperature dependent equipment or instrumentation prior and during use; results will be
documented for review. Temperature probes are also calibrated and expiration dates are
documented.
All laboratory equipment will be validated prior to initial use. Equipment will be
calibrated according to procedures and manufacturer’s specifications and instructions.
Personnel will document calibration date, staff ID, the name of the device used for
calibration, as well as the results.
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Post-Analytic Variables
Returning samples to sponsors or investigators. Category B Biological
Substances, the only category of samples the proposed biorepository will receive, process,
and store, will be transported or shipped via commercial carrier according to approved
procedures (including IATA and DOT Regulations). Personnel will be certified in shipping
biological substances on an annual basis. Category B certified shipping containers, dry ice
and packing materials will be available at the biorepository. In the case of vapor-phase liquid
nitrogen storage, cryostorage containers will also be readily available for transport.
The same communications detailed in Sample notifications are applied to returning
samples to clients. An electronic copy of the shipping manifest will be included in the
“Intent to Ship” email sent to the client. A hardcopy of the shipping manifest will also be
included in shipments, whether transported by a shipping carrier such as FedEx or delivered
by biorepository personnel. If samples are delivered directly to the client, staff will obtain an
electronic signature using the electronic biospecimen chain of custody form.
Shipping freezers to sponsors or other repositories. Sponsors of research may
require transfer and storage of a large volume of biospecimens to previously specified
locations post collection, post analysis, or at study termination. For example, transfer of
specimens may be necessary to establish the highest quality, fit-for-purpose biospecimens
(those preserved and under the protection of the biorepository) as reference set material, in
order to facilitate future research.
Shipping a large volume of biospecimens via a shipping carrier such as Federal
Express is often cost prohibitive and also has a higher risk assessment due to the number of
shipments and lack of control. After many successful years of receiving and shipping
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clinical research samples, the author recommends Federal Express as a trusted carrier.
However, the average cost of a FedEx shipment of ten to thirty sample storage boxesdepending on the size of the storage boxes, the size and weight of the certified Category B
shipping container, and the destination- may exceed $280-$350, not including the relatively
small cost of dry ice. For instance, the author has had notable experience and success
coordinating the shipment of twenty-one full freezers from the University of Michigan to a
commercial biorepository (selected by the NIH) located in Rockville, MD over the course of
several years. Individual shipments of four fully loaded freezers at that time averaged
$3,500.
In order to ship full freezers in the most efficient and cost effective manner the
following safeguards will be necessary:
•

IRB approval.

•

Participant consent documentation, located at the clinical site(s) that specifies the
potential for future utilization or final disposition of samples.

•

Due diligence in investigating transportation companies and the respective costs
of their services.

•

Rigorous procedures to select biospecimens for shipment, prepare and QC
inventories, and manage the coordination, process and safe transfer of freezers.

•

An adequate budget to cover the management of this process and the associated
costs.

IRB approval must be verified prior to acceptance and onboarding of any study. The
sponsor routinely reviews documentation of participant consent at the clinical site(s) during

141

DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008)
monitoring activity. It is also important to note that material transfer agreements (addressed
in “
Limitations/Delimitations of the Study,” page 179) may be applicable in specific
project circumstances.
Biorepository information technology (IT) personnel will be responsible for
performing a database-driven QC procedure on samples or entire freezers selected for
shipment. They will also be responsible for generating an electronic inventory of the selected
samples. Biorepository staff support IT procedures through verification of a subset of
samples previously checked samples and their respective locations as well as providing a
separate yet complete box ID inventory as an additional QA step. All procedures will be well
documented as part of the biorepository manual of operations.
For shipping purposes, the biorepository will select a reputable firm that has notable
and demonstrated experience transporting freezers using back up power or liquid nitrogen
tanks on board as well as temperature monitoring capable of ensuring proper temperature and
storage conditions are maintained throughout the entire route. Such temperature information
must be documented and readily available for review by the operations manager. This
information will likewise be shared with the client or sponsor. The biorepository will
maintain a log of freezers shipped to clients or other repositories with the following
information: freezer manufacturer, model and serial number, tag number, freezer ID, date
shipped, delivery date, and date freezer returned to the biorepository (if applicable). Invoices
and methods of payment (purchase order numbers, for example) will also be documented.
The operations manager will ensure the proper tracking of capitalized equipment and
coordinate the shipment and receipt of freezers with the client and the shipping company.
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Additional considerations. If transferring samples from biorepository freezers into
cold recipient freezers, the size and configuration of rack systems may be (and very likely
will be) different. All biorepository freezers will have approved rack systems for storage
equipment. Freezers will likewise be required to have rack systems for transport. However,
personnel must recognize that some biorepositories may not have sufficient funding and
therefore simply stack boxes in mechanical freezers in order to save the cost of purchasing
freezer racks. Transferring samples from one freezer to another without the benefit of a rack
system will take additional time and effort. Lack of racks can also cause safety concerns.
Bending over freezers in order to reach boxes on the bottom of the freezer exposes staff to
cold temperatures. Personnel may also suffer from lack of oxygen or additional stressors on
the back and arms. Staff will use the appropriate PPE and wear oxygen-monitoring sensors.
The operations manager will provide close supervision and support and will ensure safety
and staff rotation. The operations manager must insist on reviewing freezer and rack
specifications in order to plan the workflow and the specific transfer of boxes IDs well before
the planned shipment date. Under close supervision, biorepository personnel would then be
able to systematically and efficiently load or transfer boxes between freezers using dry ice
chests or cryocarts. These personnel will also inventory the box IDs of each freezer and
perform a 100% QC of the box IDs prior to the operations manager releasing the shipment
for transport. The operations manager will maintain control of the number of freezers per
shipment. When transferring samples from biorepository freezers to cold recipient freezers,
two experienced staff teams may sufficiently manage a two- to four-freezer workload.
Personnel should also plan to utilize a biospecimen chain of custody form during the process.
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Shipping freezers can cause equipment considerable strain. Transport companies
may be required to provide extra packing and shipping material to protect freezers from dings
or scratches. Tipping mechanical freezers may cause operational problems, but freezer fluids
tend to return to normal within 48 hours.
Parking large trucks will require coordination. The operations manager should
confirm that the recipient’s facility has a dock available with an automatic lift in order to
accommodate moving one fully loaded freezer from the truck at a time. Parking and dock
requirements should be addressed well in advance of the shipment.
Upon receipt of the samples, the client or sponsor will likely assess if a full inventory
of samples is necessary on their part from their own risk assessment. Given the level of
communication, quality assurance, and access to biorepository procedures, clients may
decide not to re-inventory samples; however, they are likely to re-inventory the box IDs.
Final disposition of samples. Upon request of the clients, samples may be destroyed
according to approved procedures as well as applicable local, state, and federal regulations.
Sample destruction may be necessitated by any number of reasons: study termination, end of
funding period, depletion of sample, research participant’s request for discontinuation,
informed consent issues, IRB issues, discrepancies between any clinical data and samples (as
reported by clinical sites), or quality of the physical sample. A permanent record must be
established via a signed letter to investigators or clients. This letter must specify the date and
the sample IDs and include a written assurance that the samples were properly disposed
according to approved procedures as well as applicable local, state, and federal regulations.
Copies of such letters will be maintained as part of the study records.
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Chapter 10: Emergency Preparedness and Disaster Response
Emergency preparedness includes preparation, planning, training, and procedural and
system validation to prevent or minimize consequences of a potential situation or event that
could interrupt biorepository operations and place biospecimens at risk. As part of an overall
business continuity plan (see page 31), emergency preparedness must include risk assessment
and risk mitigation. Any emergency preparedness plans must prioritize the safety of
personnel and visitors who may be present, and then identify and addresses all critical
functions of the biorepository so that emergency response procedures can be initiated.
Having established procedures and validated systems in place will allow the biorepository to
protect the invaluable biospecimens entrusted to its care; support management in planning for
potential emergencies, events, or planned shutdowns; and provide the appropriate resources
and instructions in order to respond to such unforeseen circumstances in an efficient and
timely manner.
When an unexpected event or emergency occurs, the type of emergency and resulting
interruption of service will precipitate the implementation of established procedures as
defined in any comprehensive response plan. Standard operating procedures will outline
specific measures to be taken in a biorepository emergency. A subsequent review of actual
events and subsequent responses can also contribute to continuous quality improvement.
Sharing experiences from natural or man-made disasters and their subsequent
outcomes should be encouraged within the biorepository community (Simeon-Dubach,
Zaayenga, & Henderson, 2013). Shared problem-solving strategies, creating alliances to
foster partnership, and sharing resources may be instructive and beneficial to all involved.
However, some organizations may be reticent to share experiences due to real or perceived
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business consequences leading from loss of confidence or diminished reputation. Therefore,
this chapter will detail recommendations and considerations that have been published in the
literature.
Fire Response
In Learning by Erring: Fire!, Roger Bjugn and Jarle Hansen (2013) asserted that even
the most thorough planning could not have anticipated all the information learned at the time
of their emergency: a fire that took place in a biorepository located in a hospital in Norway.
In an attempt to improve organizational learning and emergency response, the authors
conducted an analysis of crisis management. They examined both the events preceding the
emergency situation and reviewed the resulting crisis situation. They concluded that “An
organization’s emergency preparedness is its readiness to react constructively to threats from
the environment in a way that minimizes the negative consequences of impact” for both the
safety of people and facilities and systems (p. 202).
Pre-event risk analysis. Before the fire, a formal risk analysis had identified fire as
a possible disaster and communication with the local fire department confirmed all resources
were committed to saving lives and excluded biospecimens entirely. As part of risk
planning, fire detectors and extinguishers were installed, flammable material was limited in
the facility, and freezers were required to have annual maintenance checks.
Water, foam, and gas fire extinguishers were considered for use; however, water
extinguishers were deemed inappropriate since flooding could cause mechanical failure in all
the freezers. The foam extinguishers contained water, so they presented the same problem.
Consequently, the hospital installed a gas fire extinguishing system that used a mixture of
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“argon and nitrogen whereby the oxygen concentration in the facility is reduced to 12%,
thereby causing fires to extinguish in less than one minute” (Bjugn & Hansen, 2013, p. 203).
The event. On November 7, 2007, a fire alarm sounded in the building, followed by
a second manual fire alarm activated by a person in the hallway who saw smoke coming
from under the doors and heard alarm bells going off inside the biorepository. Written
warning signs informed the passerby this was a restricted area and therefore did not enter.
As patient evacuation began in the hospital, the fire department arrived and found smoke and
a smell of burnt plastic. Fortunately, the fire had already been extinguished by the automatic
fire extinguishers. At the same time, staff arrived in response to an electronic alert for a
freezer failure, and found a power supply unit had caused two wires to burn. They discovered
that the power supply unit had been damaged by a blown fuse. After fire department
approval, staff members were able to enter the area and move specimens to a back up freezer.
Post-event analysis. In later analysis, management determined that ISBER Best
Practice guidelines had been followed, and a formal risk analysis had put risk reduction
measures in place. All predefined procedures had been followed at the time of the fire. Staff
found no injuries and no damage occurred to the building or facilities. However, an afteraction investigation did identify two immediate concerns that needed to be addressed:
•

Communication with local entities. The local fire department had intended to use
water to extinguish the fire because they were unaware of the gas-based
extinguishing system. If the fire had been more extensive and water had been
utilized, all twenty-seven freezers may have been damaged.

•

There were no back up contingency plans to relocate that many biospecimens.
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The communication issue was addressed by installing large signs on the doors of the
biorepository with instructions to emergency responders. The signs alerted responders that a
nontoxic gaseous fire extinguishing system was in place and only carbon dioxide could be
used in fire-fighting efforts.
The post-emergency investigation also identified problems with refilling the gas
extinguishers that had not been anticipated. The hospital did not have a contract in place for
refilling the gas extinguishers, and staff from the company that provided the gas were away
on an out-of-town business trip. No other suppliers were available, and for 48 hours the
biorepository had to have a fireguard on watch. To alleviate this gape in emergency response
plans, the biorepository entered a refill contract with the supplier of the gas mixture, and
wall-mounted manual extinguishers were also installed.
As part of their post-disaster analysis, Bjugn and Hansen (2013) found that most
emergency plans had too much emphasis on emergency response rather than risk analysis
and mitigation. Recognizing that the most comprehensive planning cannot prevent a disaster
from happening, they recommended that any emergency management process must include
more emphasis on prevention, risk analysis and mitigation. Their recommendations for
complete emergency planning guidelines include:
1. Mitigation and preparedness (the pre-crisis): the steps taken to prevent an
emergency from happening and a predetermination of the correct response for the
emergency.
2. Response (the acute crisis): actions necessary at the time of emergency, including
methods of controlling damage to facility and property beginning the recovery
process.
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3. Recovery (the post-crisis): the actions necessary for conditions and infrastructure
to return to normal.
Applicable lessons to proposed biorepository model. The fire emergency as
described by Bjorn and Hansen (2013) identify several strategies that any proposed
biorepository should apply when creating an emergency preparedness plan. As a longtime
biorepository manager, I highly recommend creating stable working relationships with local
fire and police departments by sharing contact information, emergency response procedures,
and special precautions and hazards unique to the biorepository. This exchange of
information and relationship building also provide an opportunity to promote the importance
of the facility and its services and may help in the prioritization of emergency response.
Likewise, establishing contracts with primary and back up providers for LN2, fuel, dry ice,
and supplies ensures that resupply is a priority.
In this particular biorepository model, fire safety training must include training in
extinguisher operation (see “Fire Safety,” page 69). External signage for the facility has also
been addressed in “Exterior and interior signage,” page 61).
Natural Disaster Response: Hurricanes
Hurricane Isabel. In “How Is Your Biobank Handling Disaster Recovery Efforts,”
Baird et al. (2013) addressed the issues of protection and recovery after Hurricane Isabel, a
Category 2 hurricane, struck the East Coast in September of 2013. A comprehensive
emergency preparedness plan allowed Fisher BioServices to operate 15 separate locations
with over 30 million biospecimens used for cancer and AIDS research during Hurricane
Isabel without losing a single sample, even though commercial power was out for up to 5
days at some of the biorepository locations.
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Fisher BioServices needed to ensure open communication with staff and customers to
keep them informed of the status of biospecimens. The company set up landline telephones
and back up computer support at company headquarters (off-site from its multiple
biorepository locations) where diesel-powered generators maintained internet connection and
other services. However, the generators had limited diesel fuel supply, and no system was in
place with vendors identifying off-site locations as critical for refueling. Staff members took
5-gallon containers to gas stations in order to procure diesel fuel, but many stations had run
out of gas or were without electricity to run pumps.
All sites had generators that were routinely checked, and part of the emergency
preparedness plan (before the hurricane) included filling diesel tanks and liquid nitrogen
freezers. No freezer thaws took place, and staff members were able to monitor the
biorepository sites 24 hours a day until the hurricane was over.
Post-event modifications to emergency plans. In order to mitigate the damage
caused by future disasters, Fisher BioServices established priority fuel supply contracts and
approached utility companies requesting prioritization of restoration of electricity (after
hospitals and life support services). Furthermore, the company procured all new “duel fuel”
generators, which can be powered by natural gas and propane or by diesel and propane,
providing more flexible options for refueling in emergency situations. As further precaution
against freezer failure, Fisher BioServices installed pre-wired connectors so mobile
generators could be brought in by trailer if necessary.
Hurricane Sandy. The Coriell Institute for Medical Research, located in Camden,
New Jersey, examined how quality improvement can be accomplished in post-disaster
planning after Hurricane Sandy struck the East Coast of the United Sates in October 2012.
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Established in 1953 as a nonprofit research center, the Coriell Institute established the first
biorepository in the United States in 1964 with a collection of biospecimens for the National
Institute of Health, and currently manages hundreds of thousands of cell lines and DNA
samples that have been used for research in 65 countries (Mintzer et al., 2013).
In “Preparedness for a Natural Disaster: How Coriell Planned for Hurricane Sandy,”
Mintzer et al. (2013) state that “Management of biomaterials is not simply a laboratory
process; their long-term survival is dependent on both the laboratory preparation and the
infrastructure designed for maintenance, safety and security” (p. 216). Coriell implemented
an aggressive Emergency Operations Plan (following both ISO 9001 Quality Management
standards and Homeland Security guidelines) that emphasizes backup systems,
communication solutions, and employee training. The plan was utilized to prepare for
Hurricane Sandy, a category I hurricane that was considered to be the deadliest storm of 2012
and caused an estimated $50 billion in damage (Mintzer et al., 2013).
Pre-planning. Coriell’s Disaster Preparedness Plan was vital in protecting the
biospecimens in their biorepository in the wake of Hurricane Sandy. The Institute houses
nearly 110 liquid nitrogen-filled cryogenic stainless steel freezers, more than 80 ultra-low -80
degrees C freezers, a dozen -20 degrees C freezers and two -20 degrees C walk-ins freezers,
in addition to over 20 refrigerators (4 degrees C) and eight walk-in refrigerators (Mintzer,
et.al., 2013). In the wake of Hurricane Sandy, Coriell was without electrical power for over
50 hours and had to rely exclusively on their backup system in order to protect the
biospecimens. As part of their preparations before the storm, Coriell purchased extra fuel for
its diesel generator and tested its four gas generators to make sure all biobank functions,
including computer needs, would be covered.
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Procedures employed by Coriell require regular documented inspection of all
laboratory equipment, such as freezers, that are essential for operations to continue in an
emergency. Disaster preparedness planning also included checking all vital facility systems,
including water supply and purification, steam and electrical service, and mechanical systems
and alarms. Detailed planning by Coriell management also included preparing for evacuation
by identifying locations of important elements, such as data, and making sure backup disks
were stored off-site at varying geographic locations. The locations of electrical outlets
powered by back-up generators were identified as well. Finally, a formal chain of command
specified the assignment of individual tasks, such as turning off equipment, to all available
personnel. Because Coriell received advance notice of the hurricane, the staff was able to
review their emergency preparedness plan, ensure all freezers were powered using back-up
outlets, duplicate data for safe storage and initiate phone trees before the storm.
The event. A State of Emergency was declared in New Jersey as Hurricane Sandy hit
the East Coast. Transportation was limited, and in the interest of safety for its employees,
Coriell closed. Although the biorepository lost electricity for over 50 hours, back-up
generators provided uninterrupted power to computers and freezers and no biospecimens
were compromised.
Post-event discussion. Thorough emergency preparation and planning, both longterm and just before the hurricane, led to Coriell’s successful response. Although postoutcome discussion identified areas for improvement, Mintzer et al. (2013) are correct in
stating, “The combined preparation both ‘years in advance’ and ‘immediately prior to the
event’ were both essential to achieve the positive outcome” (p. 219).
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Natural Disaster Response: Earthquakes
New Zealand earthquake swarms. Morrin and Robinson (2013) examined
priorities in emergency situations in “Sustaining a Biobank Through a Series of Earthquake
Swarms: Lessons Learned from our New Zealand Experience.” The profound earthquake
swarms occurred in Christchurch, New Zealand. They began September 4, 2010 with an
initial earthquake registering 7.1 on the Richter scale. In less than two years, the city
experienced continuing volcanic and seismic movements, including over 10,000 earthquakes
and aftershocks (Morrin & Robinson, 2013). Many of these seismic events necessitated
evacuation of all personnel in the biorepository facility, followed by the attempt to preserve
all biospecimen samples.
Fortunately, the biorepository was located within a hospital that could provide
essential supplies such as liquid nitrogen and carbon dioxide. However, a state of national
emergency was declared, and only emergency and medical personnel had access to the
hospital. Even after biorepository personnel were allowed to return to the facility, they were
forced to relocate as their space had been repurposed. Damage from each earthquake
required engineering inspections for safety before operations could be relocated, and
essential equipment had to be moved every time. By February, 2013, the biorepository had
moved five times. They were finally able to return to their original location in the hospital
after almost two years.
Morrin and Robinson had to examine damage to infrastructure and disruption of
essential resources and supplies as they initiated responses to the continued earthquake
disaster. For example, power in the city was lost for five days after the original earthquake,
and both of the hospital generators were damaged. The water supply was contaminated,
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pipes were broken, and the sewage system was compromised. The hospital received
emergency supplies, such as water and utilities, which allowed the biorepository to continue
to preserve specimens. The authors state, “both our generators were damaged during the
quake, but liquid carbon dioxide provided cover for the 4-hour period, particularly as our
freezers were full, providing a large thermal mass. Our liquid nitrogen freezer has an
automatic refill for vapor phase storage with a holding time of over 3 months” (Morrin &
Robinson, 2013, p. 213). Morrin and Robinson concluded that using smaller freezers was
advantageous, as piping and outside tanks were less likely to be damaged, and liquid nitrogen
delivery was able to continue from the supplier. Only one mechanical freezer failed, and that
was a year and a half after the initial earthquake.
Some temporary closures of the biorepository were necessary due to aftershock
evacuation, loss of personnel, and loss of business access due to construction. Morrin and
Robinson thoroughly examined personnel issues, with the resulting recognition of how
traumatic and challenging a disastrous event can be on staff. They remind managers that
personnel oftentimes “face damage and distress at home as well as at work, have distressed
family members to support, and fears for loved ones and for safety were reactivated with
every aftershock” (Morrin & Robinson, 2013, p. 213). Post-traumatic stress disorder (PTSD)
resulted in loss of personnel, as did continuing mental and physical fatigue from the
repeating earthquakes.
Conclusions. Several conclusions were drawn as a result of the New Zealand
experience, including the recognition that a major earthquake is not an isolated event, as
damage can continue through aftershocks for an unlimited length of time. The authors also
note the importance of the location of the biorepository within a hospital or supporting
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institution, which allowed them to have utilities restored quickly. Their suggestion of having
back up generators available in nearby cities, and discussions on how to transfer
biospecimens and equipment in the event of a disaster, should be included in any emergency
response plan. A long-term operations and contingency plan calls for consideration of the
following priorities that Morrin and Robinson (2013) suggested:
•

Prioritizing safety of personnel first, then biospecimens.

•

Evaluating the possibility of return to the facility.

•

Checking accessibility for re-supply and generator power.

•

Considering locations within a medical center. Medical centers will be given first
priority with regard to receiving emergency supplies, such as power and water, as
life safety is always a top priority for first responders.

•

Preparing for loss of autonomy. Biorepository management may have to step
aside for emergency personnel, and any damage to the construction site may
require repairs, the timing of which may be delayed depending on community
needs.

•

Storing at least one month of supplies away for an emergency situation.
Management must recognize that resupply may be limited due to state of
emergency regulations, which will vary depending on the type of disaster, the
hazardous conditions, and limited physical access to facilities or vendors.

•

Acknowledging the personnel may be traumatized. Staff trauma may result in
PTSD or even simply physical or mental fatigue. Staff, even vital staff, may
choose to leave under such circumstances, as disasters can significantly diminish
quality of life.
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•

Making preparations for relocation should equipment and specimens need to be
relocated to another facility or city.

•

Preparing for long-term operation and contingency plans in the wake of a massive
natural disaster.

A comprehensive risk assessment must also take geographic location of the
biorepository into account, as certain types of natural disasters may be more likely in certain
areas.
Examples of Freezer Failure
Harvard Brain Tissue Resource Center. Baird et al. (2013) also detail a less
successful example of biospecimen preservation. In June of 2012, the Harvard Brain Tissue
Resource Center located in McLean Hospital in Belmont, Massachusetts experienced a
complete freezer failure that unfortunately destroyed all tissue samples stored in that
particular freezer. Not only did the display on the freezer unit itself fail (it displayed an
acceptable temperature despite the actual freezer temperature being at ambient temperature),
the independent freezer monitoring system which utilized a probe inserted into the freezer
also failed to notify personnel of the rising temperature. In response they reviewed all SOPs
and implemented a third alarm continuous monitoring system that utilizes wireless
technology to alert staff.
Sanford Health. Sanford Health, the largest not-for-profit health care system in the
nation with locations in eight states, purchased multiple ultralow mechanical freezers
(identical models) for both primary storage and back up capacity for its biobank. Baird et al.
(2013) discuss how, after several months of service, multiple freezers began to “experience
temperature fluctuations followed by first stage compressor failure. The vendor identified an
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issue with a manufacturing defect in a specific lot of compressors” (p. 196), and the units
were repaired with new compressors. A few months later, however, one of the freezers with
the newly installed compressor failed. The vendor then informed Sanford Health that the
design of the original compressor was faulty. The vendor then offered to repair the freezer
using a completely different compressor design that had been thoroughly tested and that
repair solved the issue.
The biobank at Sanford Health utilized an independent wireless temperature
monitoring system, a liquid CO2 back up system, and requested and received loaner freezers
when necessary. The biobank performed an analysis of recorded temperatures that identified
multiple temperature fluctuations in the weeks leading up to the compressor failure, thus
giving the biobank an opportunity to correct the issues before tissue samples were lost.
Additionally, the biobank pro-actively had all faulty compressors replaced rather than
waiting for another failure. Effective communication with the vendor provided more detailed
information regarding the issue and provided a resolution, and the open dialogue played a
large part in maintaining the business relationship. The biobank “instituted weekly
maintenance schedules that include a review of temperature logs to spot potential problems,
tests of the liquid CO2 back-up system, and visual inspections of all door seals and
compressor filters” (Baird et al, 2013, p. 197). An annual preventive maintenance program
servicing the compressors and refrigeration systems was also established.
Applicable lessons to proposed biorepository model. Because of the importance of
consistent temperature in biospecimen preservation, monitoring freezer temperature must
always be of highest priority in biorepository functioning. I highly recommend a three-level
temperature monitoring system, including the built-in temperature display on the freezer
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itself, utilization of an independent NIST thermometer, and a separate independent wireless
temperature monitoring system. With three separate methods of monitoring freezer
temperature, such freezer failures as present at McLean Hospital are far less likely to occur.
Furthermore, staff should plan to validate all temperature monitoring systems and test
their functions and response times on a weekly basis (prior to the weekend) to ensure the
system captures these planned temperature deviations and alerts staff according to
established procedure in a timely manner. This procedure is discussed in greater detail under
“Verification of freezer temperature consistency” (page 129).
Additionally, I highly recommend routine review of temperature records plotted over
time, (utilizing Levy-Jennings graphs, for example) to detect temperature fluctuations and
trends. Any abnormal fluctuations can be examined and their root causes analyzed in
ongoing improvement efforts.
Proposed Biorepository Model Emergency Preparedness Plans
In “Disaster and Recovery: The Importance of Risk Assessment and Contingency
Planning for Biobanks,” Simeon-Dubach, Zaavenga, and Henderson (2013) suggested that
Disaster recovery plans include the availability of the right monitoring equipment,
backup systems for storage and data, and redundant spare parts and supplies, testing
of standby equipment, on-call staffing, quality control and safety plans; tested
standard operating procedures for each of the risk scenarios, and financial plans and
insurance. (p. 133)
Biorepository management has a fundamental responsibility to protect both the health
and safety of biorepository personnel and visitors as well as the biospecimens entrusted to
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their care. That responsibility can only be met through effective planning for unforeseen
circumstances.
An effective emergency preparedness and disaster recovery plan requires thorough
risk analysis, mitigation, planning, and preparation; implementation of the plan according to
established procedures; creating procedures for recovering data and re-establishing services;
and finally performing a post-event assessment and evaluation for the purposes of continuous
quality improvement. With all of the previous anecdotes and recommendations in mind, I
have assembled essential components for a comprehensive emergency response strategy that
demonstrate an organization’s commitment to safety, quality assurance, emergency
preparedness and disaster recovery.
Emergency response measures must always begin with considerations of safety in all
areas of biorepository operations. As such, several of the items have been addressed in other
sections of this document, including in “Chapter 7: Resource Management-Work
Environment” (page 60). However, for ease of reference these considerations have also been
addressed here.
LN2 hazards. Biospecimens for this facility would be stored primarily in vaporphase LN2, so a bulk source of LN2 is necessary for that purpose. Safety and operational
training must include freezer room safety, freezer safety and operation, LN2 training
(including required PPE), training in evacuation, clean up in the event of an LN2 spill from a
bulk source, and the immediate treatment of an individual overcome by toxic fumes. The
cryogenic system (encompassing the bulk source of LN2) and the delivery system (pipes to
individual LN2 freezers, shut off valves, and the filling station) must be properly designed,
constructed, and maintained. Records and results of inspections, maintenance and repairs on
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the system must be reviewed and documented. (See “Principle Chemical Hazards in this
Biorepository Model” on page 87 for further information.)
Freezer monitoring. (Also detailed in “Freezer monitoring,”page 129.) As
suggested earlier, freezer temperatures will be monitored both manually and electronically
using three independent methods, including the built-in temperature display on the freezer
itself, utilization of an independent NIST thermometer with probe, and a separate
independent wireless temperature monitoring system. The wireless monitoring system will
be battery-operated, and a pre-determined number of backup batteries will be maintained at
all times.
All freezers will be labeled with unique ID numbers. These IDs (and in the case of
mechanical freezers, their respective electrical requirements and corresponding electrical
panels, circuits, and outlets) will be linked to freezer monitoring logs. If a freezer warms
beyond established parameters and alarms have sounded, the specific freezer in question will
be easily identifiable by that ID. Temperature deviations for the freezer and all the samples
stored within it will be recorded in the database. The log will be continuously maintained and
will be updated any time a freezer or monitoring unit is moved or replaced.
A quality assurance check will be performed on a routine basis to ensure the freezer
IDs and their corresponding monitoring IDs are correct. All information will be entered or
downloaded into the database in order to maintain a link between individual samples and
their respective storage temperature history.
Alarm system. Acceptable temperature ranges will be pre-defined for refrigerators, 20 degree C freezers, ultralow freezers, and vapor phase storage in liquid nitrogen freezers.
Alarm set points will be adjusted to trigger before the temperature falls outside the acceptable
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temperature range to allow for adequate staff response time before samples experience any
temperature deviation. The temperature monitoring units will be battery-operated to prevent
a system failure should power be interrupted. These batteries will be routinely checked to
ensure proper functionality, and the check will be documented, initialed and dated.
The operations manager must provide the contracted monitoring company with an
approved procedure for setting the alarm set points and the appropriate response protocol.
The manager must also obtain written verification that the program has been set up according
to the specified requirements. The alarm system must be thoroughly validated (including
quantification of the response time) prior to initial use. After it has been implemented, the
system will be tested every week by pulling a probe from alternating freezers rather than
repeatedly checking the same freezer. Staff will then document proper function, response
time, and protocol adherence. A procedural worksheet will provide instructions for
performing the alarm system test. It will also outline follow-up actions required should the
response protocol not be followed or if response time is outside acceptable limits. After
collecting data, staff will use the worksheet to capture the freezer and monitoring ID, the
date, and the initials of the staff member.
Freezer alert and response. If freezer temperature falls outside the acceptable range,
the alarm company will contact staff via home phone, cell, text, beeper, and email. On call
staff will report as quickly as possible to the biorepository and utilize the procedural
worksheet for freezer alert and response. This worksheet will provide a mechanism for
recording the date and time of the occurrence, define the acceptable temperature ranges for
all storage equipment, list contact information, provide step-by-step instructions on how to
most efficiently assess the situation, and determine whether the problem is a freezer failure, a
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tripped circuit breaker, or a full power outage. In case of freezer failure, instructions will be
provided on identifying back up freezers, efficiently transferring samples to back up freezers
on dry ice, and recording the transfer of freezer contents both on the worksheet and in the
database. In case of power outage, the secondary generator, powered by natural gas, should
automatically provide emergency lighting and sufficient power to mechanical storage
equipment and critical laboratory equipment. A third backup system may be available
through the use of a diesel-powered generator. Staff will be trained on such emergency
procedures, but additional support will be available contractually through a commercial
provider. Depending on circumstances, the procedure for standby generator connection to
freezer loads may also be utilized.
Benefits of LN2 freezers in sample preservation. The proposed Biorepository
model will predominantly use LN2 freezers that store samples in the vapor phase of LN2.
These freezers not only reduce dependence on electricity required for mechanical freezers but
may also be utilized in a power outage to freeze samples that are currently thawed for sample
processing (ISBER Best Practices, 2011). These freezers may draw LN2 from outdoor bulk
LN2 tanks and dewars may also be filled from an indoor LN2 filling station (constructed
from the LN2 supply in the bulk tank) as needed.
LN2 usage in each freezer will be measured daily using either a sturdy wooden
dipstick or, if available, a LN2 level indicator on the freezer display panel. This not only
assists in anticipating LN2 needs for the facility but also may detect potential leaks. A three
thousand gallon bulk LN2 tank is able to accommodate twenty to forty large LN2 freezers for
approximately thirty days depending on the rate of usage. A battery-operated telemetry
system also automatically monitors LN2 levels and sends a dispatch to the supplier to refill
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LN2 when the tanks are at 30% capacity. Additional LN2 can be obtained the same day.
Individual cryoports may be filled or tanks obtained as well. Alternative vendors have been
identified.
Benefits of vapor phase liquid nitrogen storage. Storing samples in the vapor phase
(less than or equal to -150 degree C) of liquid nitrogen offers several advantages apart from
offering an alternative temperature (from -80 degree C, for example) for sample preservation.
Storage in vapor phase of LN2 also prevents safety hazards that arise from storing samples in
liquid phase LN2 storage. Furthermore, it maintains temperatures below the glass transition
temperature (-132 degrees C) (ISBER Best Practices, 2011).
Specimen storage capacity. The biorepository will follow Best Practices and strive
to maintain a minimum of 10% backup freezer storage capacity (ISBER Best Practices,
2011) regardless of freezer type (mechanical or LN2). Incoming and outgoing samples will
be closely monitored to manage storage capacity, facility and equipment planning, and
monthly billing purposes. Initial projections will be combined with communications with
clients and study progress reports to determine overall storage needs. Specimen collection
kits manufactured and utilized by clients will also provide strong indications of their
recruitment and sample collection pace as samples make their way to the biorepository for
storage.
Alternate freezer storage box inventory. In addition to the database maintaining
specimens and their respective freezer storage locations, a simple yet practical summary of
available freezer space in each freezer will be updated and posted weekly. If the database
becomes unavailable due to a power outage or scheduled maintenance, personnel can
determine the number of boxes, the box IDs, and the relative box position in each freezer at a
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moment’s notice. The manual inventory should be updated with box ID, date and staff ID
each time a box is added to or pulled from the freezer. Just as the database will be
temporarily checked for accuracy, the manual inventory will also be subject to quality checks
on a routine basis, the results of which will be documented.
A summary of the total available freezer space will be updated and posted weekly.
This posted summary will also be available in case of emergency so staff will not need to
open freezers or access the electronic inventory system during power outages. These hard
copy tools will also aid management in monitoring available freezer space over time,
prompting communication of freezer storage capacity to investigators and study personnel.
Backup power. As previously mentioned, two generators will be utilized to support
all mechanical freezers, critical equipment, portable HVAC and cooling units, and the
emergency lighting system. The secondary backup generator will be powered by natural gas;
the tertiary backup generator will be powered by diesel. Should the biorepository experience
a supply disruption of natural gas, the diesel-fuel powered generator will be utilized; this
switch will involve connecting the generator to a pre-existing connection according to
established procedure.
In order to confidently rely on the operation of both generators when needed,
procedures detailing routine maintenance and service will be followed. Designated
biorepository staff will perform weekly generator maintenance and the generators will be
tested on a weekly basis and run for a half hour to an hour to ensure proper function. A
licensed, reputable vendor (under contract) will perform monthly and yearly maintenance.
The biorepository will also vet various back up providers as well. Service records are
documented and a log captures maintenance checks.

164

DESIGNING A BIOREPOSITORY UTILIZING ISO:9001(2008)
Load testing will ensure the electrical requirements or “load” of the mechanical
freezers, refrigerators and critical laboratory equipment, are adequately met and may be
automatically transferred (in stages, if necessary) to the generator. Load tests will be
required, performed and documented at six-month intervals.
Additional emergency preparedness measures. The following additional risk
mitigation processes should be in place prior to the opening of any biorepository:
Utilities. In the event of utility failures, the biorepository should enter into advanced
planning, communication, and agreements with utility companies to ensure that utilities for
the Biorepository are given highest priority after medical centers. Flashlights and flashlight
batteries are required to supplement emergency lighting.
Natural Gas. The tertiary generator (maintained as an extra contingency plan in the
event of electrical failure) will be powered by diesel fuel should natural gas (the designated
fuel for the secondary generator) become unavailable. However, many gas stations do not
have emergency power in order to keep pumps running should a power outage occur, or
stations may exhaust fuel supplies quickly. Maintaining fuel supplies should remain a
priority in order to operate all fuel-powered equipment. However, responding quickly to
unplanned power outages should also be considered a necessity. Gas cans and a petty cash
fund must be available in case credit card and ATM machines are not available and
identifying stations with backup power to maintain pump operations is recommended.
Equipment-generated heat. Depending on the time of year, outside environment,
and the availability and functionality of windows, portable HVAC/cooling units and fans to
circulate air should be made available to combat heat generated by equipment. Instruments
and equipment may be temperature and humidity sensitive and thus may need to be taken
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off-line according to established procedures. All nonessential equipment will be shut down
and disconnected according to procedure. Conversely, if heat is unavailable to the building,
particularly in colder months, temperatures in the building may become unacceptably cold
and the facilities may be closed.
Water loss. In the event of loss of water utilities, laboratory processing may halt.
Reagent grade water may be obtained from other accredited laboratories. As available, water
may be obtained from external sources or other municipalities.
Forced building closures. In extreme circumstances, an official law enforcement
officer or a fire marshal may close the building. Should that occur, no access to the building
will be granted for operational activities. However, staff must be available to ensure freezers
and critical equipment continue to function properly whenever the building reopens.
On call staffing. Designated staff must remain on call around the clock in case of a
power outage or freezer failure. Additional technical staff should likewise be available for
assistance at any time necessary. Proper supervision from management and other personnel
support will be provided whenever necessary.
Communication planning. The biorepository will utilize a communication plan for
both biorepository personnel and clients to ensure proper communication and timely
response in the event of any emergency or disaster event. Emergency contact lists should be
posted throughout the facility for easy access. Current names, addresses, phone numbers,
and contract numbers should also be readily available for maintenance providers, equipment
manufacturers, and suppliers. In the case that cell towers become unavailable, staff should be
prepared to communicate via beeper or e-mail.
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Chain of command. In preparation for an emergency event, personnel should be
assigned clearly defined roles and responsibilities for potential events. A chain of
communication, including appropriate supervision and defined workflows will be vital to
ensuring all personnel remain aware of individual responsibilities for communicating with
clients or powering down (or starting up) equipment, for example. All personnel will have
important roles and will contribute to biorepository operations and to interpersonal support.
Emergency preparedness training.

All staff should be thoroughly trained in fire

safety; freezer room safety; chemical or biological spills; evacuation; first aid; emergency
response; freezer alert and response; and freezer, generator, and equipment maintenance.
Staff must also be trained to respond in the event of an LN2 spill from a bulk source and the
immediate treatment of an individual overcome by toxic fumes. Additionally, staff must be
evaluated annually on their training on validated, documented manual processes that may be
utilized when instrumentation and automated processes are unavailable.
Resupply of LN2 or dry ice. The biorepository should maintain contractual
agreements with LN2, fuel, dry ice, and other critical suppliers should an emergency require
an immediate replenishment of these resources. The biorepository should also identify back
up vendors should primary vendors be unable to deliver needed resources promptly.
Support for staff. Bottled water, provisions, and support services are necessary for
staff who may have to work for extended periods of time, even overnight.
Equipment protection and calibration. To the greatest extent possible, staff will
ensure instruments and equipment are protected and maintained according to established
procedures. Instruments and equipment shall be recalibrated prior to resumption of routine
operations/ processes. Additionally, documentation should be maintained and readily
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available regarding each piece of equipment and its corresponding outlet with equipment
cords labeled, if necessary.
Disaster recovery. Once an emergency or catastrophic event has passed, the
Biorepository must have pre-determined procedures for bringing the Biorepository back into
operation. These processes must address:
•

Clean up.

•

Reconnection and restarting of all equipment.

•

Data recovery and verification.

•

Assessment of damage, losses, and documentation, as applicable.

•

Re-establishment of services.

•

Resuming the normal state of operations.

•

Communicating re-opening to clients with both a report of the incident and the
status of any samples in ongoing research studies.

•

Debriefing all personnel on post event recovery.

•

Assessing, with participating staff, any potential improvements to be made on
pre-established emergency preparedness procedures. Every crisis presents a
unique opportunity for reflection and continuous quality improvement of current
Biorepository practices.

Proactive Measures in Emergency Preparedness
In conclusion, a successful response to any emergency or catastrophic event depends
upon proactive measures established by an organization before the event occurs. To that end,
the current biorepository model identifies four proactive measures that should be taken when
planning for emergency response.
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1. Identify critical resources and supplies, current suppliers and their respective
contact information, as well as alternate suppliers and their contact information.
Plan for obtaining supplies or stockpiling whenever appropriate (e.g., liquid
nitrogen, diesel fuel for generator, and dry ice).
2. Identify essential contract services, their contact information, their procedures and
contingency plans in order to continue services (such as generator maintenance)
in the event of an emergency.
3. Implement an effective communications plan in order to maintain contact with
staff and clients, including readily available contact information for all parties and
all pertinent information for building and facility management.
4. Consider critical functions that will not be able to be performed in the event of
loss of an essential utility. Identify contingency plans for maintaining critical
operations, consider critical utility load list, and include locations and room
numbers in any documented plans (e.g. electricity, generator, natural gas, water
loss, potable water loss, HVAC, telephone system including paging, network and
information systems, other IT systems, and facility or building damage).
Businesses thrive or crumble when presented with moments of crisis. Proactive
planning, established procedures, and effective teamwork can bring a biorepository and its
personnel through a crisis situation.
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Chapter 11: Methods of Assessment, Analysis, and Improvement
ISO 9001:2008 requires that organizations “apply suitable methods for monitoring
and, where applicable, measurement of the quality management system processes. These
methods shall demonstrate the ability of the processes to achieve planned results” (p. 13).
The current proposed biorepository model will take into account a number of methods of
assessment to ensure that the QMS adequately provides the structure necessary to meet the
quality objectives of the organization.
Quality Management System Review
The biorepository director and the operations manager will review the quality
management system once per year (or more frequently if warranted) in order to ensure the
QMS is effectively achieving biorepository objectives and requirements. These reviews
ensure compliance with respect to policies and procedures; ensure proper documentation and
product conformity; expose weaknesses in the QMS; identify potential improvements; note
accomplishments; evaluate the effectiveness of corrective and preventive actions; identify
issues that may require root cause analysis; identify trends; review customer requirements,
suggestions, or complaints; review results of internal audits and external inspections; identify
additional resource needs; and reassess organizational and quality objectives and
management review.
Key performance indicators. The four key performance indicators (KPIs) of the
biorepository’s performance and services will be quality, dependability, time, and cost. KPIs
will be closely monitored through a monthly review of business productivity (i.e., a balance
sheet), routine audits, and customer feedback. Expected outcomes and indicators of previous
problems will be evaluated against benchmarks. New programs will be evaluated. These
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evaluations will include potential impacts of service. Plans of action will be developed as
needed.
Publications and grants. A key indicator of the biorepository’s quality of services
will be the number of publications that cite the biorepository as well as the number of grants,
investigators, and biotech/pharmaceutical companies that utilize the biorepository for
research support services, particularly if such individuals or organizations become repeat
customers.
Peer review. Peer review will be an important indicator of quality as well. The
biorepository will benefit from site visits and inspections from the National Institute of
Health, pharmaceutical companies, investigators, and other sponsors, as well as laboratory
oversight committees and consultants.
Customer feedback and surveys. The biorepository will strongly encourage the
evaluation of customer feedback through the use of customer survey instruments. The results
of these instruments will play an important role in assessing the quality of biorepository
services and measuring client satisfaction. These instruments will capture researcher input,
issues, concerns, and suggestions for continuous quality improvement. The results of these
instruments will be reviewed and incorporated into business practices and the QMS as
deemed appropriate. A lost business analysis will capture data that may be useful as well
(ISO 9001:2008, p. 12).
ISBER Self-Assessment Tool. The biorepository will participate in the International
Society of Biological and Environmental Repository (ISBER) Self-Assessment Tool (SAT),
which evaluates how well a repository follows ISBER’s Best Practices. The SAT
furthermore identifies areas in need of improvement. The assessment is confidential. SAT
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results will be reviewed, and areas of potential improvement will be identified and
incorporated in the QMS and operations.
External Review of QMS
In addition to the application of several internal processes, the biorepository will also
use external standards when evaluating effectiveness of implemented QMS techniques.
These external processes may include such assessments as external audits or accreditation
procedures.
College of American Pathologists’ Biorepository Accreditation Program. A
biorepository may apply for accreditation through the College of American Pathologists by
submitting an application containing the following biorepository information:
•

Contact information.

•

The organization chart.

•

The floor plan.

•

The director’s curriculum vitae.

•

The Master Activity Menu.

•

The responsible person for each service (e.g., sample receipt, processing, and
storage would be considered one service).

•

The annual volume or units processed.

•

The number of full time employees.

•

The number and type of temperature-controlled storage equipment.

•

An agreement to the Terms of Accreditation.
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Once receipt of the application has been acknowledged, the CAP Biorepository and
Laboratory General Checklists are sent to the biorepository. (N.B.: These checklists detail the
requirements for accreditation and may not be shared.)
Generally six months after the CAP Accreditation application is accepted, an
inspection is scheduled with a CAP staff inspector and one or more repository experts,
depending on the size of the biorepository and the scope of its services. At the conclusion of
the inspection, a debriefing session is held. Inspectors will provide management with an
inspector summation report, which may include Phase I or Phase II deficiencies that require
satisfactory responses. A Phase I deficiency requires a written response detailing the
corrective action taken. A Phase II deficiency requires not only a written response but also
supporting documentation demonstrating compliance with the requirement. Such supporting
documentation may include new or revised policies or standard operating procedures with
evidence of review and approval; evidence of staff training or retraining on new, revised, or
existing policies and SOPs; quality control records; log sheets including specific data; and
floor plans, photos, diagrams, purchase orders, or work orders. Within thirty calendar days,
biorepositories must address and correct these deficiencies and submit any necessary
documentation (including the Deficiency Response Signature Page, signed by the director) to
CAP for final review. At the inspector’s discretion, some deficiencies may be corrected on
site and do not require a later written response. In such an instance, the inspector will note
“corrected on site” on the inspection summation report.
If CAP grants accreditation to the biorepository, the decision is communicated via
written letter and a certificate of accreditation is provided to the biorepository management.
The biorepository must then add a policy addressing compliance with the terms and
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conditions of CAP Accreditation to the biorepository’s manual of operations. Biorepository
accreditation is valid for three years. After the first year of accreditation, a member of
biorepository staff must conduct a self-inspection. This inspection should be conducted by
someone in the organization that is knowledgeable in operations and the accreditation
requirements and should be a personnel member other than the director (ideally the
operations manager or quality assurance manager). The second year, a desk review of
documentation by the director is required. Unlike as in laboratory accreditation, subsequent
inspections will be scheduled; they are conducted every three years within a three- month
window leading up to the third anniversary of the initial date of accreditation.
CAP inspectors are a valuable resource both at appropriate moments during the
inspection and post-inspection debriefing session; they are pleased to make recommendations
based on their considerable experience, share insight and answer questions. The inspection
can be a learning experience because the idea is to not only meet the standards but also
demonstrate continuous quality improvement.
Dash et al. (2012) stated, “Many of the critical steps in establishing and running a
biorepository fall within existing procedures in today’s CLIA-certified laboratories or can be
implemented with modifications to existing procedures in use in CLIA-certified laboratories”
(p. 670). For those who have not managed or have significant work experience in a CAP
accredited, CLIA-certified laboratory, I have developed a list of items that a Biorepository
should have in place or be prepared to address prior to a CAP inspection. The list is based on
five consecutive successful CAP Laboratory Accreditation Cycles and one successful CAP
Biorepository Inspection. This list of accreditation items that operations managers should
prepare for inspection can be found in Figure 4.
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Figure 4. Author-recommended CAP Items Checklist.

Audits. The biorepository will conduct both internal audits and be subject to external
audits and inspections on a routine basis. Some of these audits may be unannounced. The
operations manager and trained staff will perform internal audits to assess compliance with
policies, procedures, best practices, and applicable regulations. External audits will be
conducted by well-qualified representatives from OSHA, inspectors from the College of
American Pathologists (CAP), as well as designated representatives from sponsors and
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stakeholders. Results of all audits will be thoroughly reviewed and documented. Positive
results will be recognized, and nonconformance to established standards will be appropriately
addressed with any subsequent actions documented.
Incident Reporting and Corrective and Preventive Action (CAPA)
Once internal and audits have been completed, management will turn to correcting or
adjusting any unfavorable results. The QMS will therefore contain a program to identify,
report, and document errors, non-conformities, incidents, illness, injury, or complaints that
could potentially impact safety, operations, or research result integrity. Should errors or
complaints occur, the biorepository will perform further investigation, including a root cause
analysis. Corrective and preventive action shall be taken in a timely manner to eliminate
potential or existing nonconformance. All instances of CAPA will be evaluated,
documented, monitored, and tracked for trend analysis and effectiveness.
Quality Risk Management Program
In order to identify, assess, minimize, monitor, and document risks associated with
research services, the biorepository will implement a quality risk management program.
Risks will be logged and assessed. Risk mitigation strategies will be considered and, if
beneficial, procedures will be revised and approved, training conducted, and changes tracked
through implementation. Documentation of these revisions will be subject to document
control and will be readily available to all personnel and inspectors. ISO 9001:2015 Quality
management systems-Requirements, due to release later this year, will incorporate risk
management principles into the new standard (ISO 9001:2008). In the interim, principles of
quality risk management may be derived from the ISO standard, ISO 31000:2009, Risk
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management – Principles and guidelines, and the International Conference of Harmonisation
(ICH) Quality Risk Management guideline (Q9, 2005).
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Chapter 12: Conclusion
In the context of a biorepository organization, an effective quality management
system will define the requisite quality policies, processes, and strategies in order to assure
potential stakeholders and clients that operations will perform to the highest quality
standards. A well-conceived and implemented QMS will ensure that samples are collected,
processed, and stored in standardized ways. This standardization will in turn allow the
Biorepository to maintain the highest standards of biospecimen quality, integrity, and data
throughout the collection, processing, cryopreservation, storage and distribution lifecycle.
A quality management system based on ISO 9001(2008) may go even further,
however, in that it can establish the necessary framework and provide a “roadmap” for
building and operating a state-of-the-science, accredited, commercially successful
biorepository. Such a roadmap may prove beneficial to the scientific community, as it
addresses a gap in current literature. As demonstrated in the example presented in this paper,
such a QMS can address a plethora of procedural components: authority, responsibility,
commitment and communication; organizational structure; customer focus, documentation
requirements; business considerations; resource management, including human resources and
facility infrastructure and maintenance; equipment selection, qualification, maintenance and
replacement; property control and disposition; informatics; and work environment; safety;
security; product realization; emergency preparedness and disaster response; business
continuity; procurement; regulatory considerations; and quality management methods of
assessment, analysis, and continuous quality improvement. Strengthened with the addition of
procedures, processes and specific quality assurance strategies in order to meet customer
requirements, a QMS can help establish a successful commercial BSL-2 biorepository and
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ensure the highest quality, fit-for-purpose biospecimens for clinical and translational
research.
Limitations/Delimitations of the Study
Material transfer agreements (MTAs) have not been addressed in the current study.
Both ISBER and NCI Best Practices include introductions to MTAs; furthermore, the NCI
Best Practices includes a sample material transfer agreement in their appendices. I would
refer any parties interested in reading more about MTAs to these specific documents.
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Appendix A: Personnel Sanitation and Safety
As adapted from Biosafety Manual in Microbiology and Biomedical Laboratories (U.S.
Department of Health and Human Services, 200, pages 30-38).
The following protocols must be followed at all times personnel are working in or
visitors are touring the proposed biorepository:
Food / Drink / Personal Hygiene and Attire
•

Food and beverages will be strictly prohibited in refrigerators or freezers
designated for specimens only according to 29 CFR 1910.1030(d)(2)(x).

•

Food, beverages, and chewing gum will be banned from all laboratory rooms
designated for biospecimens.

•

A separate refrigerator in a clean room will be designated for food for human
consumption only. No biological materials may be taken into a clean room or
stored in the clean room/ break room refrigerator.

•

Eating, drinking, smoking, applying cosmetics or lip balm or handling contact
lenses will be prohibited in accordance with 29 CFR 1910.1030(d)(2)(ix). The
application of cosmetics and lip balm as well as the manipulation of contact
lenses is prohibited in the laboratory.

•

Mouth pipetting will be prohibited in accordance with 29 CFR
1910.1030(d)(2)(xii).

•

Laboratory personnel will not be permitted to wear open toe sandals, shorts or
other apparel that leave the legs exposed while handling biohazard material or
performing any laboratory activity.

•

Staff should avoid working alone in the laboratory, particularly when working
with hazardous material.
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•

Headphones will be prohibited in the lab; staff must be able to hear alarms and
respond appropriately.

•

Computer workstations, specifically keyboards, will be labeled either “clean”
(i.e., free from biological or chemical contamination) or “not clean.” If a
computer workstation is labeled “not clean,” staff must touch the keyboard only
when wearing gloves.

•

Universal Precautions must be followed in the laboratory at all times and these
precautions are detailed in the Procedure for Universal Precautions as well as all
specific procedures involving biospecimens. All biospecimens, and biological
materials, e.g. reagents, quality control pools and preparations are to be
considered potentially infectious.

•

Laboratory work surfaces are to be decontaminated with an appropriate germicide
when work is complete or after a spill. A good germicidal agent is sodium
hypochlorite (household bleach) prepared fresh daily in concentrations of 1:10.
The daily preparation of bleach is to be labeled according to procedures for
labeling secondary reagent containers. Scientific instruments should also be
decontaminated after use according to established procedures.

Proper Needle Handling Procedures
•

The Needlestick Safety and Prevention Act of 2001 was intended to promote the
selection of safer needle devices and prevent needlesticks. Needles must never to
be manipulated (purposefully bent, recapped, or removed) by hand. Staff may
only use approved mechanical devices or scoop the needle cap with the needle
itself.
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•

Procedures must be followed for safe handling and disposal of sharps (needles,
pipettes, broken glassware).

Personal Protective Equipment (PPE)
•

Personal protective equipment (PPE) must be utilized according to The PPE
Standard, 29 CFR 1910.132. Staff shall complete training regarding the selection,
proper utilization, care and disposal of PPE prior to performing laboratory
activities.

•

Eye and face protection (full face shield and goggles) must be used to protect
staff’s mucous membranes when the potential exists for splashes or sprays
according to the Eye and Face Protection Standard, 29 CFR 1910.133.

•

Lab coats should never be worn while eating or drinking in clean rooms. Lab
coats are to be laundered through the designated vendor only; staff may not take
lab coats home or launder.

•

The Hand Protection Standard, 29 CFR 1910.138, requires the appropriate hand
protection for exposure to hazards in the workplace. In addition, gloves must be
worn when handling blood or working in contaminated areas according to 29 CFR
1910.1030(d)(3)(ix). Non-latex gloves may be utilized to protect those with latex
(derived from plants) allergies or sensitivity according to 29 CFR 1910.1030
(c)(3)(iii).

•

Gloves and other personal protective equipment (PPE) must be changed when
contaminated or when integrity has been or may soon become compromised.
Gloves are never to be re-used or washed for the purposes of re-use.
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•

Hands must be thoroughly washed after the removal of gloves. In addition, staff
members are to remove protective clothing and wash their hands with an
appropriate decontaminating/ germicidal soap prior to leaving the laboratory.

•

Gloves are to be properly disposed with other contaminated, solid lab waste.
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